LOINC #,Long Common Name,Short Name,CLASS,Rank
2160-0,Creatinine [Mass/volume] in Serum or Plasma,Creat SerPl-mCnc,Chem,1
718-7,Hemoglobin [Mass/volume] in Blood,Hgb Bld-mCnc,HEM/BC,2
2823-3,Potassium [Moles/volume] in Serum or Plasma,Potassium SerPl-sCnc,Chem,3
2345-7,Glucose [Mass/volume] in Serum or Plasma,Glucose SerPl-mCnc,Chem,4
2951-2,Sodium [Moles/volume] in Serum or Plasma,Sodium SerPl-sCnc,Chem,5
3094-0,Urea nitrogen [Mass/volume] in Serum or Plasma,BUN SerPl-mCnc,Chem,6
2028-9,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",CO2 SerPl-sCnc,Chem,7
2075-0,Chloride [Moles/volume] in Serum or Plasma,Chloride SerPl-sCnc,Chem,8
789-8,Erythrocytes [#/volume] in Blood by Automated count,RBC # Bld Auto,HEM/BC,9
786-4,Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume] by Automated count,MCHC RBC Auto-mCnc,HEM/BC,10
785-6,Erythrocyte mean corpuscular hemoglobin [Entitic mass] by Automated count,MCH RBC Qn Auto,HEM/BC,11
17861-6,Calcium [Mass/volume] in Serum or Plasma,Calcium SerPl-mCnc,Chem,12
2339-0,Glucose [Mass/volume] in Blood,Glucose Bld-mCnc,Chem,13
4544-3,Hematocrit [Volume Fraction] of Blood by Automated count,Hct VFr Bld Auto,HEM/BC,14
6690-2,Leukocytes[#/volume] in Blood by Automated count ,WBC # Bld Auto,HEM/BC,15
1742-6,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,ALT SerPl-cCnc,Chem,16
787-2,Erythrocyte mean corpuscular volume [Entitic volume] by Automated count,MCV RBC Auto,HEM/BC,17
777-3,Platelets [#/volume] in Blood by Automated count,Platelet # Bld Auto,HEM/BC,18
1920-8,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,AST SerPl-cCnc,Chem,19
1751-7,Albumin [Mass/volume] in Serum or Plasma,Albumin SerPl-mCnc,Chem,20
1975-2,Bilirubin.total [Mass/volume] in Serum or Plasma,Bilirub SerPl-mCnc,Chem,21
2885-2,Protein [Mass/volume] in Serum or Plasma,Prot SerPl-mCnc,Chem,22
6768-6,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,ALP SerPl-cCnc,Chem,23
788-0,Erythrocyte distribution width [Ratio] by Automated count,RDW RBC Auto-Rto,HEM/BC,24
770-8,Neutrophils/100 leukocytes in Blood by Automated count,Neutrophils/leuk NFr Bld Auto,HEM/BC,25
33914-3,Glomerular filtration rate/1.73 sq M.predicted by Creatinine-based formula (MDRD),GFR/BSA.pred SerPl MDRD-ArVRat,Chem,26
704-7,Basophils [#/volume] in Blood by Automated count,Basophils # Bld Auto,HEM/BC,27
20570-8,Hematocrit [Volume Fraction] of Blood,Hct VFr Bld,HEM/BC,28
48642-3,Glomerular filtration rate/1.73 sq M predicted among non-blacks by Creatinine-based formula (MDRD),GFR/BSA pred.non black SerPl MDRD-ArVRat,Chem,29
48643-1,Glomerular filtration rate/1.73 sq M predicted among blacks by Creatinine-based formula (MDRD),GFR/BSA pred.black SerPl MDRD-ArVRat,Chem,30
26515-7,Platelets [#/volume] in Blood,Platelet # Bld,HEM/BC,31
2093-3,Cholesterol [Mass/volume] in Serum or Plasma,Cholest SerPl-mCnc,Chem,32
26464-8,Leukocytes [#/volume] in Blood,WBC # Bld,HEM/BC,33
30428-7,Erythrocyte mean corpuscular volume [Entitic volume],MCV RBC,HEM/BC,34
731-0,Lymphocytes [#/volume] in Blood by Automated count,Lymphocytes # Bld Auto,HEM/BC,35
2571-8,Triglyceride [Mass/volume] in Serum or Plasma,Trigl SerPl-mCnc,Chem,36
10466-1,Anion gap 3 in Serum or Plasma,Anion Gap3 SerPl-sCnc,Chem,37
2085-9,Cholesterol in HDL [Mass/volume] in Serum or Plasma,HDLc SerPl-mCnc,Chem,38
6463-4,Bacteria identified in Unspecified specimen by Culture,Bacteria XXX Cult,MICRO,39
26485-3,Monocytes/100 leukocytes in Blood,Monocytes/leuk NFr Bld,HEM/BC,40
736-9,Lymphocytes/100 leukocytes in Blood by Automated count,Lymphocytes/leuk NFr Bld Auto,HEM/BC,41
706-2,Basophils/100 leukocytes in Blood by Automated count,Basophils/leuk NFr Bld Auto,HEM/BC,42
713-8,Eosinophils/100 leukocytes in Blood by Automated count,Eosinophil/leuk NFr Bld Auto,HEM/BC,43
5905-5,Monocytes/100 leukocytes in Blood by Automated count,Monocytes/leuk NFr Bld Auto,HEM/BC,44
26478-8,Lymphocytes/100 leukocytes in Blood,Lymphocytes/leuk NFr Bld,HEM/BC,45
751-8,Neutrophils [#/volume] in Blood by Automated count,Neutrophils # Bld Auto,HEM/BC,46
5902-2,Prothrombin time (PT) in Platelet poor plasma by Coagulation assay,Prothrombin time,COAG,47
5902-2,Prothrombin time (PT),Prothrombin time,COAG,47
33069-6,Fetal Neck.soft tissue Translucency width US,Fet Width.translucency US.meas,OB.US,48
26450-7,Eosinophils/100 leukocytes in Blood,Eosinophil/leuk NFr Bld,HEM/BC,49
711-2,Eosinophils [#/volume] in Blood by Automated count,Eosinophil # Bld Auto,HEM/BC,50
22637-3,Pathology report final diagnosis,Path report.final Dx Spec,TUMRRGT,51
742-7,Monocytes [#/volume] in Blood by Automated count,Monocytes # Bld Auto,HEM/BC,52
6301-6,INR in Platelet poor plasma by Coagulation assay,INR PPP,COAG,53
30180-4,Basophils/100 leukocytes in Blood,Basophils/leuk NFr Bld,HEM/BC,54
3097-3,Urea nitrogen/Creatinine [Mass ratio] in Serum or Plasma,BUN/Creat SerPl,Chem,55
5802-4,Nitrite [Presence] in Urine by Test strip,Nitrite Ur Ql Strip,UA,56
26499-4,Neutrophils [#/volume] in Blood,Neutrophils # Bld,HEM/BC,57
5778-6,Color of Urine,Color Ur,SPEC,58
5803-2,pH of Urine by Test strip,pH Ur Strip,UA,59
1759-0,Albumin/Globulin [Mass ratio] in Serum or Plasma,Albumin/Glob SerPl,Chem,60
26484-6,Monocytes [#/volume] in Blood,Monocytes # Bld,HEM/BC,61
10834-0,Globulin [Mass/volume] in Serum by calculation,Globulin Ser Calc-mCnc,Chem,62
13457-7,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,LDLc SerPl Calc-mCnc,Chem,63
5770-3,Bilirubin [Presence] in Urine by Test strip,Bilirub Ur Ql Strip,UA,64
5799-2,Leukocyte esterase [Presence] in Urine by Test strip,Leukocyte esterase Ur Ql Strip,UA,65
5767-9,Appearance of Urine,Appearance Ur,SPEC,66
26449-9,Eosinophils [#/volume] in Blood,Eosinophil # Bld,HEM/BC,67
13458-5,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,VLDLc SerPl Calc-mCnc,Chem,68
2777-1,Phosphate [Mass/volume] in Serum or Plasma,Phosphate SerPl-mCnc,Chem,69
26474-7,Lymphocytes [#/volume] in Blood,Lymphocytes # Bld,HEM/BC,70
5811-5,Specific gravity of Urine by Test strip,Sp Gr Ur Strip,UA,71
5794-3,Hemoglobin [Presence] in Urine by Test strip,Hgb Ur Ql Strip,UA,72
5792-7,Glucose [Mass/volume] in Urine by Test strip,Glucose Ur Strip-mCnc,UA,73
5804-0,Protein [Mass/volume] in Urine by Test strip,Prot Ur Strip-mCnc,UA,74
11579-0,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,TSH SerPl DL<=0.05 mIU/L-aCnc,Chem,75
26511-6,Neutrophils/100 leukocytes in Blood,Neutrophils/leuk NFr Bld,HEM/BC,76
3173-2,Activated partial thromboplastin time (aPTT) in Blood by Coagulation assay,aPTT Bld,COAG,77
2601-3,Magnesium [Moles/volume] in Serum or Plasma,Magnesium SerPl-sCnc,Chem,78
5821-4,Leukocytes [#/area] in Urine sediment by Microscopy high power field,WBC #/area UrnS HPF,UA,79
5797-6,Ketones [Mass/volume] in Urine by Test strip,Ketones Ur Strip-mCnc,UA,80
4548-4,Hemoglobin A1c/Hemoglobin.total in Blood,Hgb A1c MFr Bld,HEM/BC,81
1968-7,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirub Direct SerPl-mCnc,Chem,82
2336-6,Globulin [Mass/volume] in Serum,Globulin Ser-mCnc,Chem,83
11555-0,Base excess in Blood,Base excess Bld Calc-sCnc,Chem,84
47527-7,Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep,Cytology Cvx/Vag Doc Thin Prep,CYTO,85
11557-6,Carbon dioxide [Partial pressure] in Blood,pCO2 Bld,Chem,86
11556-8,Oxygen [Partial pressure] in Blood,pO2 Bld,Chem,87
22636-5,Pathology report relevant history,Path report.relevant Hx Spec,TUMRRGT,88
5769-5,Bacteria [#/area] in Urine sediment by Microscopy high power field,Bacteria #/area UrnS HPF,UA,89
2157-6,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,CK SerPl-cCnc,Chem,90
9830-1,Cholesterol.total/Cholesterol in HDL [Mass ratio] in Serum or Plasma,Cholest/HDLc SerPl,Chem,91
2089-1,Cholesterol in LDL [Mass/volume] in Serum or Plasma,LDLc SerPl-mCnc,Chem,92
630-4,Bacteria identified in Urine by Culture,Bacteria Ur Cult,MICRO,93
19123-9,Magnesium [Mass/volume] in Serum or Plasma,Magnesium SerPl-mCnc,Chem,94
2713-6,Oxygen saturation.calculated from oxygen partial pressure in Blood,SaO2 % Bld from pO2,Chem,95
22638-1,Pathology report comments,Path report.comments Imp Spec,TUMRRGT,96
11558-4,pH of Blood,pH Bld,Chem,97
22639-9,Pathology report supplemental reports,Path report.supplemental reports Spec,TUMRRGT,98
20454-5,Protein [Presence] in Urine by Test strip,Prot Ur Ql Strip,UA,99
13945-1,Erythrocytes [#/area] in Urine sediment by Microscopy high power field,RBC #/area UrnS HPF,UA,100
738-5,Macrocytes [Presence] in Blood by Light microscopy,Macrocytes Bld Ql Smear,HEM/BC,101
2514-8,Ketones [Presence] in Urine by Test strip,Ketones Ur Ql Strip,Chem,102
741-9,Microcytes [Presence] in Blood by Light microscopy,Microcytes Bld Ql Smear,HEM/BC,103
19146-0,Reference lab test results,Ref Lab Test Results,MISC,104
3016-3,Thyrotropin [Units/volume] in Serum or Plasma,TSH SerPl-aCnc,Chem,105
6298-4,Potassium [Moles/volume] in Blood,Potassium Bld-sCnc,Chem,106
3107-0,Urobilinogen [Mass/volume] in Urine,Urobilinogen Ur-mCnc,Chem,107
19764-0,Statement of adequacy [interpretation] of Cervical or vaginal smear or scraping by Cyto stain,Stat of Adq Cvx/Vag Cyto-Imp,CYTO,108
19767-3,Cytologist who read Cyto stain of Cervical or vaginal smear or scraping,Cytologist Cvx/Vag Cyto,CYTO,109
19763-2,Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain,Specimen source Cvx/Vag Cyto,CYTO,110
13969-1,Creatine kinase.MB [Mass/volume] in Serum or Plasma,CK MB SerPl-mCnc,Chem,111
18314-5,Morphology [interpretation] in Blood Narrative,Morphology Bld-Imp,HEM/BC,112
10839-9,Troponin I.cardiac [Mass/volume] in Serum or Plasma,Troponin I SerPl-mCnc,Chem,113
19773-1,Recommended follow-up [Identifier] in Cervical or vaginal smear or scraping by Cyto stain,Recom F/U Cvx/Vag Cyto,CYTO,114
19769-9,Pathologist who read Cyto stain of Cervical or vaginal smear or scraping,Pathologist Cvx/Vag Cyto,CYTO,115
2349-9,Glucose [Presence] in Urine,Glucose Ur Ql,Chem,116
20405-7,Urobilinogen [Mass/volume] in Urine by Test strip,Urobilinogen Ur Strip-mCnc,UA,117
33037-3,Anion gap in Serum or Plasma,Anion Gap SerPl-sCnc,Chem,118
728-6,Hypochromia [Presence] in Blood by Light microscopy,Hypochromia Bld Ql Smear,HEM/BC,119
1959-6,Bicarbonate [Moles/volume] in Blood,HCO3 Bld-sCnc,Chem,120
26444-0,Basophils [#/volume] in Blood,Basophils # Bld,HEM/BC,121
2965-2,Specific gravity of Urine,Sp Gr Ur,Chem,122
23658-8,Other Antibiotic [Susceptibility],Other Antibiotic Susc Islt,ABXBACT,123
2857-1,Prostate specific Ag [Mass/volume] in Serum or Plasma,PSA SerPl-mCnc,Chem,124
1971-1,Bilirubin.indirect [Mass/volume] in Serum or Plasma,Bilirub Indirect SerPl-mCnc,Chem,125
20409-9,Erythrocytes [#/volume] in Urine by Test strip,RBC # Ur Strip,UA,126
1989-3,Calcidiol [Mass/volume] in Serum or Plasma,25(OH)D3 SerPl-mCnc,Chem,127
8247-9,Mucus [Presence] in Urine sediment by Light microscopy,Mucous Threads UrnS Ql Micro,UA,128
2947-0,Sodium [Moles/volume] in Blood,Sodium Bld-sCnc,Chem,129
1994-3,Calcium.ionized [Moles/volume] in Blood,Ca-I Bld-sCnc,Chem,130
600-7,Bacteria identified in Blood by Culture,Bacteria Bld Cult,MICRO,131
6742-1,Erythrocyte morphology finding [Identifier] in Blood,RBC morph Bld,HEM/BC,132
3024-7,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,T4 Free SerPl-mCnc,Chem,133
5818-0,Urobilinogen [Presence] in Urine by Test strip,Urobilinogen Ur Ql Strip,Chem,134
11054-4,Cholesterol in LDL/Cholesterol in HDL [Mass ratio] in Serum or Plasma,LDLc/HDLc SerPl,Chem,135
764-1,Neutrophils.band form/100 leukocytes in Blood by Manual count,Neuts Band/leuk NFr Bld Manual,HEM/BC,136
4537-7,Erythrocyte sedimentation rate by Westergren method,ESR Bld Qn Westrgrn,HEM/BC,137
8310-5,Body temperature,Body temperature,BDYTMP.ATOM,138
3040-3,Lipase [Enzymatic activity/volume] in Serum or Plasma,Lipase SerPl-cCnc,Chem,139
2498-4,Iron [Mass/volume] in Serum or Plasma,Iron SerPl-mCnc,Chem,140
9317-9,Platelets [Presence] in Blood by Light microscopy,Platelet Bld Ql Smear,HEM/BC,141
3084-1,Urate [Mass/volume] in Serum or Plasma,Urate SerPl-mCnc,Chem,142
20565-8,"Carbon dioxide, total [Moles/volume] in Blood",CO2 Bld-sCnc,Chem,143
925-8,Blood product disposition [Type],Bld Prod Disposition BPU,BLDBK,144
3026-2,Thyroxine (T4) [Mass/volume] in Serum or Plasma,T4 SerPl-mCnc,Chem,145
13317-3,Methicillin resistant Staphylococcus aureus [Presence] in Unspecified specimen by Organism specific culture,MRSA XXX Ql Cult,MICRO,146
14979-9,Activated partial thromboplastin time (aPTT) in Platelet poor plasma by Coagulation assay,aPTT PPP,COAG,147
11277-1,Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field,Squamous #/area UrnS HPF,UA,148
32623-1,Platelet mean volume [Entitic volume] in Blood by Automated count,PMV Bld Auto,HEM/BC,149
2132-9,Cobalamin (Vitamin B12) [Mass/volume] in Serum,Vit B12 SerPl-mCnc,Chem,150
20453-7,Epithelial cells [Presence] in Urine sediment by Light microscopy,Epi Cells UrnS Ql Micro,UA,151
1798-8,Amylase [Enzymatic activity/volume] in Serum or Plasma,Amylase SerPl-cCnc,Chem,152
2276-4,Ferritin [Mass/volume] in Serum or Plasma,Ferritin SerPl-mCnc,Chem,153
1988-5,C reactive protein [Mass/volume] in Serum or Plasma,CRP SerPl-mCnc,Chem,154
5808-1,Erythrocytes [#/volume] in Urine sediment by Microscopy high power field,RBC # UrnS HPF,UA,155
2532-0,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,LDH SerPl-cCnc,Chem,156
2500-7,Iron binding capacity [Mass/volume] in Serum or Plasma,TIBC SerPl-mCnc,Chem,157
5782-8,Crystals [type] in Urine sediment by Light microscopy,Crystals UrnS Micro,UA,158
21000-5,Erythrocyte distribution width [Entitic volume] by Automated count,RDW RBC Auto,HEM/BC,159
2753-2,pH of Serum or Plasma,pH SerPl,Chem,160
2161-8,Creatinine [Mass/volume] in Urine,Creat Ur-mCnc,Chem,161
20408-1,Leukocytes [#/volume] in Urine by Test strip,WBC # Ur Strip,UA,162
27045-4,Microscopic exam [interpretation] of Urine by Cytology,Microscopic Ur-Imp,CYTO,163
31100-1,Hematocrit [Volume Fraction] of Blood by Impedance,Hct VFr Bld Imped,HEM/BC,164
11580-8,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L,TSH SerPl DL<=0.005 mIU/L-aCnc,Chem,165
5787-7,Epithelial cells [#/area] in Urine sediment by Microscopy high power field,Epi Cells #/area UrnS HPF,UA,166
735-1,Lymphocytes Variant/100 leukocytes in Blood by Manual count,Variant Lymphs/leuk NFr Bld Manual,HEM/BC,167
934-0,Blood product unit ID [#],BPU ID,BLDBK,168
882-1,ABO & Rh group [Type] in Blood,ABO + Rh Bld,BLDBK,169
19161-9,Urobilinogen [Units/volume] in Urine by Test strip,Urobilinogen Ur Strip-aCnc,UA,170
1978-6,Bilirubin [Mass/volume] in Urine,Bilirub Ur-mCnc,Chem,171
30167-1,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe & signal amplification method,HPV I/H Risk 1 DNA Cvx Ql bDNA,MICRO,172
20507-0,Reagin Ab [Presence] in Serum by RPR,RPR Ser Ql,MICRO,173
3151-8,Inhaled oxygen flow rate,Inhaled O2 flow rate,CLIN,174
14957-5,Microalbumin [Mass/volume] in Urine,Microalbumin Ur-mCnc,Chem,175
58448-2,Microalbumin ug/min [Mass/time] in 24 hour Urine,Microalbumin ug/min 24H Ur-mRate,Chem,176
26508-2,Neutrophils.band form/100 leukocytes in Blood,Neuts Band/leuk NFr Bld,HEM/BC,177
24111-7,Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe & target amplification method,N gonorrhoea DNA XXX Ql PCR,MICRO,178
11279-7,Urine sediment comments by Light microscopy Narrative,UrnS Cmnt Micro,UA,179
21613-5,Chlamydia trachomatis DNA [Presence] in Unspecified specimen by Probe & target amplification method,C trach DNA XXX Ql PCR,MICRO,180
2284-8,Folate [Mass/volume] in Serum or Plasma,Folate SerPl-mCnc,Chem,181
1995-0,Calcium.ionized [Moles/volume] in Serum or Plasma,Ca-I SerPl-sCnc,Chem,182
11282-1,Cells Counted Total [#] in Blood,Total Cells Counted Bld,HEM/BC,183
2106-3,Choriogonadotropin (Pregnancy test) [Presence] in Urine,HCG Preg Ur Ql,Chem,184
933-2,Blood product type,Bld Prod Typ BPU,BLDBK,185
737-7,Lymphocytes/100 leukocytes in Blood by Manual count,Lymphocytes/leuk NFr Bld Manual,HEM/BC,186
2744-1,pH of Arterial blood,pH BldA,Chem,187
30313-1,Hemoglobin [Mass/volume] in Arterial blood,Hgb BldA-mCnc,HEM/BC,188
10378-8,Polychromasia [Presence] in Blood by Light microscopy,Polychromasia Bld Ql Smear,HEM/BC,189
2324-2,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,GGT SerPl-cCnc,Chem,190
25162-9,Hyaline casts [Presence] in Urine sediment by Light microscopy,Hyaline Casts UrnS Ql Micro,UA,191
2502-3,Iron saturation [Mass Fraction] in Serum or Plasma,Iron Satn MFr SerPl,Chem,192
2703-7,Oxygen [Partial pressure] in Arterial blood,pO2 BldA,Chem,193
664-3,Microscopic observation [Identifier] in Unspecified specimen by Gram stain,Gram Stn XXX,MICRO,194
3879-4,Opiates [Presence] in Urine,Opiates Ur Ql,DRUG/TOX,195
3390-2,Benzodiazepines [Presence] in Urine,Benzodiaz Ur Ql,DRUG/TOX,196
27353-2,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,Est. average glucose Bld gHb Est-mCnc,Chem,197
890-4,Blood group antibody screen [Presence] in Serum or Plasma,Bld gp Ab Scn SerPl Ql,BLDBK,198
26507-4,Neutrophils.band form [#/volume] in Blood,Neuts Band # Bld,HEM/BC,199
3050-2,Triiodothyronine resin uptake (T3RU) in Serum or Plasma,T3RU NFr SerPl,Chem,200
30405-5,Leukocytes [#/volume] in Urine,WBC # Ur,HEM/BC,201
48345-3,HIV 1+O+2 Ab [Presence] in Serum or Plasma,HIV 1+O+2 Ab SerPl Ql,MICRO,202
2986-8,Testosterone [Mass/volume] in Serum or Plasma,Testost SerPl-mCnc,Chem,203
30934-4,Natriuretic peptide B [Mass/volume] in Serum or Plasma,BNP SerPl-mCnc,Chem,204
2019-8,Carbon dioxide [Partial pressure] in Arterial blood,pCO2 BldA,Chem,205
34714-6,INR in Blood by Coagulation assay,INR Bld,COAG,206
3377-9,Barbiturates [Presence] in Urine,Barbiturates Ur Ql,DRUG/TOX,207
8061-4,Nuclear Ab [Presence] in Serum,ANA Ser Ql,SERO,208
11529-5,Surgical pathology study,,ATTACH.CLINRPT,209
5196-1,Hepatitis B virus surface Ag [Presence] in Serum by Immunoassay,HBV surface Ag SerPl Ql IA,MICRO,210
49136-5,Creatine kinase.MB/Creatine kinase.total [Ratio] in Serum or Plasma,CK MB SerPl-Rto,Chem,211
14959-1,Microalbumin/Creatinine [Mass ratio] in Urine,Microalbumin/Creat Ur,Chem,212
48346-1,HIV 1+O+2 Ab [Units/volume] in Serum or Plasma,HIV 1+O+2 Ab SerPl-aCnc,MICRO,213
3349-8,Amphetamines [Presence] in Urine,Amphetamines Ur Ql,DRUG/TOX,214
17856-6,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,Hgb A1c MFr Bld HPLC,HEM/BC,215
11253-2,Tacrolimus [Mass/volume] in Blood,Tacrolimus Bld-mCnc,DRUG/TOX,216
33903-6,Ketones [Presence] in Urine,Ketones Ur Ql,Chem,217
883-9,ABO group [Type] in Blood,ABO Group Bld,BLDBK,218
2091-7,Cholesterol in VLDL [Mass/volume] in Serum or Plasma,VLDLc SerPl-mCnc,Chem,219
2458-8,IgA [Mass/volume] in Serum,IgA SerPl-mCnc,Chem,220
2501-5,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,UIBC SerPl-mCnc,Chem,221
32215-6,Thyroxine (T4) free index in Serum or Plasma,FT4I SerPl Calc-mCnc,Chem,222
3053-6,Triiodothyronine (T3) [Mass/volume] in Serum or Plasma,T3 SerPl-mCnc,Chem,223
18282-4,Cannabinoids [Presence] in Urine by Screen method,Cannabinoids Ur Ql Scn,DRUG/TOX,224
744-3,Monocytes/100 leukocytes in Blood by Manual count,Monocytes/leuk NFr Bld Manual,HEM/BC,225
5195-3,Hepatitis B virus surface Ag [Presence] in Serum,HBV surface Ag Ser Ql,MICRO,226
1003-3,Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma,IAT Comp-Sp Reag SerPl Ql,BLDBK,227
769-0,Neutrophils.segmented/100 leukocytes in Blood by Manual count,Neuts Seg/leuk NFr Bld Manual,HEM/BC,228
714-6,Eosinophils/100 leukocytes in Blood by Manual count,Eosinophil/leuk NFr Bld Manual,HEM/BC,229
15067-2,Follitropin [Units/volume] in Serum or Plasma,FSH SerPl-aCnc,Chem,230
2243-4,Estradiol (E2) [Mass/volume] in Serum or Plasma,Estradiol SerPl-mCnc,Chem,231
53927-0,Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe & target amplification method,N gonorrhoea rRNA Urth Ql PCR,MICRO,232
60256-5,Neisseria gonorrhoeae rRNA [Presence] in Urine by Probe & target amplification method,N gonorrhoea rRNA Ur Ql PCR,MICRO,233
702-1,Anisocytosis [Presence] in Blood by Light microscopy,Anisocytosis Bld Ql Smear,HEM/BC,234
707-0,Basophils/100 leukocytes in Blood by Manual count,Basophils/leuk NFr Bld Manual,HEM/BC,235
19145-2,Reference lab test name,Ref Lab Test Name,MISC,236
29265-6,Calcium [Moles/volume] corrected for albumin in Serum or Plasma,Calcium Album cor SerPl-sCnc,Chem,237
5796-8,Hyaline casts [#/area] in Urine sediment by Microscopy low power field,Hyaline Casts #/area UrnS LPF,UA,238
5198-7,Hepatitis C virus Ab [Units/volume] in Serum by Immunoassay,HCV Ab Ser IA-aCnc,MICRO,239
2731-8,Parathyrin.intact [Mass/volume] in Serum or Plasma,PTH-Intact SerPl-mCnc,Chem,240
2465-3,IgG [Mass/volume] in Serum,IgG SerPl-mCnc,Chem,241
53925-4,Chlamydia trachomatis rRNA [Presence] in Urethra by Probe & target amplification method,C trach rRNA Urth Ql PCR,MICRO,242
774-0,Ovalocytes [Presence] in Blood by Light microscopy,Ovalocytes Bld Ql Smear,HEM/BC,243
12454-5,Urate crystals amorphous [Presence] in Urine sediment by Light microscopy,Amorph Urate Cry UrnS Ql Micro,UA,244
30341-2,Erythrocyte sedimentation rate,ESR Bld Qn,HEM/BC,245
798-9,Erythrocytes [#/volume] in Urine by Automated count,RBC # Ur Auto,HEM/BC,246
1250-0,Major crossmatch [interpretation],Maj XM SerPl-Imp,BLDBK,247
22634-0,Pathology report gross observation,Path report.gross Spec,TUMRRGT,248
18262-6,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,LDLc SerPl Direct Assay-mCnc,Chem,249
56598-6,Epstein Barr virus early IgM Ab [Units/volume] in Serum by Immunoassay,EBV EA IgM Ser IA-aCnc,MICRO,250
11572-5,Rheumatoid factor [Units/volume] in Serum,Rheumatoid fact SerPl-aCnc,SERO,251
19080-1,Choriogonadotropin [Units/volume] in Serum or Plasma,HCG SerPl-aCnc,Chem,252
18998-5,Trimethoprim+Sulfamethoxazole [Susceptibility],TMP SMX Susc Islt,ABXBACT,253
43304-5,Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by Probe & target amplification method,C trach rRNA XXX Ql PCR,MICRO,254
10331-7,Rh [Type] in Blood,Rh Bld,BLDBK,255
43305-2,Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by Probe & target amplification method,N gonorrhoea rRNA XXX Ql PCR,MICRO,256
10701-1,Ova+Parasites identified in Stool by Concentration,O+P Stl Conc,MICRO,257
13362-9,Collection duration of Urine,Collect duration Time Ur,SPEC,258
11125-2,Platelet morphology finding [Identifier] in Blood,Plat morph Bld,HEM/BC,259
15180-3,Hypochromia [Presence] in Blood by Automated count,Hypochromia Bld Ql Auto,HEM/BC,260
12258-0,Epithelial cells.squamous [Presence] in Urine sediment by Microscopy high power field,Squamous UrnS Ql Micro,UA,261
22633-2,Pathology report site of origin,Path report.site of origin Spec,TUMRRGT,262
2472-9,IgM [Mass/volume] in Serum,IgM SerPl-mCnc,Chem,263
31208-2,Specimen source [Identifier] of Unspecified specimen,Specimen source XXX,SPEC,264
18928-2,Gentamicin [Susceptibility],Gentamicin Susc Islt,ABXBACT,265
5671-3,Lead [Mass/volume] in Blood,Lead Bld-mCnc,DRUG/TOX,266
3255-7,Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay,Fibrinogen PPP-mCnc,COAG,267
3184-9,Activated clotting time in Blood by Coagulation assay,ACT Bld,COAG,268
19139-5,Pathologist name,Pathologist name,CLIN,269
6462-6,Bacteria identified in Wound by Culture,Bacteria Wnd Cult,MICRO,270
10501-5,Lutropin [Units/volume] in Serum or Plasma,LH SerPl-aCnc,Chem,271
19244-3,Character of Urine,Character Ur,SPEC,272
19659-2,Phencyclidine [Presence] in Urine by Screen method,PCP Ur Ql Scn,DRUG/TOX,273
3051-0,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,T3Free SerPl-mCnc,Chem,274
624-7,Bacteria identified in Sputum by Respiratory culture,Bacteria Spt Resp Cult,MICRO,275
634-6,Bacteria identified in Unspecified specimen by Aerobe culture,Bacteria XXX Aerobe Cult,MICRO,276
50387-0,Chlamydia trachomatis rRNA [Presence] in Cervix by Probe & target amplification method,C trach rRNA Cvx Ql PCR,MICRO,277
50388-8,Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe & target amplification method,N gonorrhoea rRNA Cvx Ql PCR,MICRO,278
35691-5,XXX microorganism DNA [Presence] in Unspecified specimen by Probe & target amplification method,Other microorganism DNA XXX Ql PCR,MICRO,279
51656-7,Hepatitis C virus Ab Signal/Cutoff [Ratio] in Body fluid,HCV Ab s/co Fld,MICRO,280
4679-7,Reticulocytes/100 erythrocytes in Blood,Retics/100 RBC NFr,HEM/BC,281
22635-7,Pathology report microscopic observation Other stain,Path report.microscopic Spec Other Stn,TUMRRGT,282
38483-4,Creatinine [Mass/volume] in Blood,Creat Bld-mCnc,Chem,283
15150-6,Anisocytosis [Presence] in Blood by Automated count,Anisocytosis Bld Ql Auto,HEM/BC,284
14338-8,Prealbumin [Mass/volume] in Serum or Plasma,Prealb SerPl-mCnc,Chem,285
15198-5,Macrocytes [Presence] in Blood by Automated count,Macrocytes Bld Ql Auto,HEM/BC,286
33051-4,Erythrocytes [Presence] in Urine,RBC Ur Ql,UA,287
6299-2,Urea nitrogen [Mass/volume] in Blood,BUN Bld-mCnc,Chem,288
43396-1,Cholesterol non HDL [Mass/volume] in Serum or Plasma,NonHDLc SerPl-mCnc,Chem,289
2842-3,Prolactin [Mass/volume] in Serum or Plasma,Prolactin SerPl-mCnc,Chem,290
6598-7,Troponin T.cardiac [Mass/volume] in Serum or Plasma,Troponin T SerPl-mCnc,Chem,291
2888-6,Protein [Mass/volume] in Urine,Prot Ur-mCnc,UA,292
3393-6,Benzoylecgonine [Presence] in Urine,BZE Ur Ql,DRUG/TOX,293
9842-6,Casts [#/area] in Urine sediment by Microscopy low power field,Casts #/area UrnS LPF,UA,294
2069-3,Chloride [Moles/volume] in Blood,Chloride Bld-sCnc,Chem,295
5334-8,Rubella virus IgG Ab [Units/volume] in Serum by Immunoassay,RUBV IgG SerPl IA-aCnc,MICRO,296
20569-0,Creatine kinase.MB/Creatine kinase.total in Serum or Plasma,CK MB CFr SerPl,Chem,297
42931-6,Chlamydia trachomatis rRNA [Presence] in Urine by Probe & target amplification method ,C trach rRNA Ur Ql PCR,MICRO,298
15199-3,Microcytes [Presence] in Blood by Automated count,Microcytes Bld Ql Auto,HEM/BC,299
20629-2,Levofloxacin [Susceptibility],Levofloxacin Susc Islt,ABXBACT,300
3397-7,Cocaine [Presence] in Urine,Cocaine Ur Ql,DRUG/TOX,301
779-9,Poikilocytosis [Presence] in Blood by Light microscopy,Poikilocytosis Bld Ql Smear,HEM/BC,302
35591-7,Creatinine renal clearance predicted by Cockcroft-Gault formula,Creat Cl predicted SerPl C-G-vRate,Chem,303
32356-8,Yeast [Presence] in Urine sediment by Light microscopy,Yeast UrnS Ql Micro,UA,304
18878-9,Cefazolin [Susceptibility],Cefazolin Susc Islt,ABXBACT,305
740-1,Metamyelocytes/100 leukocytes in Blood by Manual count,Metamyelocytes/leuk NFr Bld Manual,HEM/BC,306
12851-2,Protein Fractions [interpretation] in Serum or Plasma by Electrophoresis,Prot Pattern SerPl Elph-Imp,Chem,307
31147-2,Reagin Ab [Titer] in Serum by RPR,RPR Ser-Titr,MICRO,308
25428-4,Glucose [Presence] in Urine by Test strip,Glucose Ur Ql Strip,UA,309
1960-4,Bicarbonate [Moles/volume] in Arterial blood,HCO3 BldA-sCnc,Chem,310
2111-3,Choriogonadotropin.beta subunit [Moles/volume] in Serum or Plasma,B-HCG SerPl-sCnc,Chem,311
2039-6,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,CEA SerPl-mCnc,Chem,312
2862-1,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,Albumin SerPl Elph-mCnc,Chem,313
2871-2,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,B-Globulin SerPl Elph-mCnc,Chem,314
2865-4,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha1 Glob SerPl Elph-mCnc,Chem,315
2868-8,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Alpha2 Glob SerPl Elph-mCnc,Chem,316
18906-8,Ciprofloxacin [Susceptibility],Ciprofloxacin Susc Islt,ABXBACT,317
2839-9,Progesterone [Mass/volume] in Serum or Plasma,Progest SerPl-mCnc,Chem,318
13950-1,Hepatitis A virus IgM Ab [Presence] in Serum by Immunoassay,HAV IgM SerPl Ql IA,MICRO,319
28541-1,Metamyelocytes/100 leukocytes in Blood,Metamyelocytes/leuk NFr Bld,HEM/BC,320
3936-2,Phencyclidine [Presence] in Urine,PCP Ur Ql,DRUG/TOX,321
48159-8,Hepatitis C virus Ab Signal/Cutoff [Ratio] in Serum or Plasma by Immunoassay,HCV Ab s/co SerPl IA,MICRO,322
2874-6,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,Gamma glob SerPl Elph-mCnc,Chem,323
31201-7,HIV 1+2 Ab [Presence] in Serum by Immunoassay,HIV1+2 Ab SerPl Ql IA,MICRO,324
2991-8,Testosterone Free [Mass/volume] in Serum or Plasma,Testost Free SerPl-mCnc,Chem,325
58413-6,Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Automated count,nRBC/100 WBC Bld Auto-Rto,HEM/BC,326
36903-3,Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Identifier] in Unspecified specimen by Probe & target amplification method,C trach+GC DNA XXX PCR,MICRO,327
580-1,Fungus identified in Unspecified specimen by Culture,Fungus XXX Cult,MICRO,328
2692-2,Osmolality of Serum or Plasma,Osmolality SerPl,Chem,329
18865-6,Ampicillin+Sulbactam [Susceptibility],Ampicillin+Sulbac Susc Islt,ABXBACT,330
18864-9,Ampicillin [Susceptibility],Ampicillin Susc Islt,ABXBACT,331
1558-6,Fasting glucose [Mass/volume] in Serum or Plasma,Glucose p fast SerPl-mCnc,CHAL,332
635-3,Bacteria identified in Unspecified specimen by Anaerobe culture,Bacteria XXX Anaerobe Cult,MICRO,333
547-0,Streptococcus.beta-hemolytic [Presence] in Unspecified specimen by Organism specific culture,B-Hem Strep XXX Ql Cult,MICRO,334
5194-6,Hepatitis B virus surface Ab [Units/volume] in Serum by Radioimmunoassay (RIA),HBV surface Ab Ser RIA-aCnc,MICRO,335
18955-5,Nitrofurantoin [Susceptibility],Nitrofurantoin Susc Islt,ABXBACT,336
18481-2,Streptococcus pyogenes Ag [Presence] in Throat,S pyo Ag Throat Ql,MICRO,337
1504-0,Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO,Glucose 1h p 50 g Glc PO SerPl-mCnc,CHAL,338
12235-8,Microscopic observation [Identifier] in Urine sediment by Light microscopy,Micro UrnS,UA,339
7791-7,Dacrocytes [Presence] in Blood by Light microscopy,Dacryocytes Bld Ql Smear,HEM/BC,340
2143-6,Cortisol [Mass/volume] in Serum or Plasma,Cortis SerPl-mCnc,Chem,341
46744-9,Organic acidemias newborn screen interpretation,OA DBS-Imp,Chem,342
14611-8,Nuclear Ab pattern [interpretation] in Serum,ANA Pat Ser-Imp,SERO,343
8099-4,Thyroperoxidase Ab [Units/volume] in Serum or Plasma,Thyroperoxidase Ab SerPl-aCnc,SERO,344
5048-4,Nuclear Ab [Titer] in Serum by Immunofluorescence,ANA Titr Ser IF,SERO,345
2524-7,Lactate [Moles/volume] in Serum or Plasma,Lactate SerPl-sCnc,Chem,346
763-3,Neutrophils.band form [#/volume] in Blood by Manual count,Neuts Band # Bld Manual,HEM/BC,347
30522-7,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,CRP SerPl HS-mCnc,Chem,348
11156-7,Leukocyte morphology finding [Identifier] in Blood,WBC morph Bld,HEM/BC,349
19000-9,Vancomycin [Susceptibility],Vancomycin Susc Islt,ABXBACT,350
2335-8,Hemoglobin.gastrointestinal [Presence] in Stool,Hemoccult Stl Ql,Chem,351
6824-7,Color of Body fluid,Color Fld,SPEC,352
24113-3,Hepatitis B virus core IgM Ab [Presence] in Serum by Immunoassay,HBV core IgM SerPl Ql IA,MICRO,353
14578-9,ABO group [Type] in Blood from Blood product unit,ABO Group Bld BPU,BLDBK,354
14907-0,Rh [Type] in Blood from Blood product unit,Rh Bld BPU,BLDBK,355
3968-5,Phenytoin [Mass/volume] in Serum or Plasma,Phenytoin SerPl-mCnc,DRUG/TOX,356
10535-3,Digoxin [Mass/volume] in Serum or Plasma,Digoxin SerPl-mCnc,DRUG/TOX,357
13965-9,Homocysteine [Moles/volume] in Serum or Plasma,Hcys SerPl-sCnc,Chem,358
35674-1,Creatinine [Mass/volume] in unspecified time Urine,Creat ?Tm Ur-mCnc,Chem,359
18893-8,Ceftazidime [Susceptibility],Ceftazidime Susc Islt,ABXBACT,360
18970-4,Piperacillin+Tazobactam [Susceptibility],Pip+Tazo Susc Islt,ABXBACT,361
54218-3,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,CD3+CD4+ Cells/CD3+CD8+ Cells Bld,CELLMARK,362
800-3,Schistocytes [Presence] in Blood by Light microscopy,Schistocytes Bld Ql Smear,HEM/BC,363
21198-7,Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma,B-HCG SerPl-aCnc,Chem,364
5643-2,Ethanol [Mass/volume] in Serum or Plasma,Ethanol SerPl-mCnc,DRUG/TOX,365
22763-7,Ammonia [Mass/volume] in Plasma,Ammonia Plas-mCnc,Chem,366
16362-6,Ammonia [Moles/volume] in Plasma,Ammonia Plas-sCnc,Chem,367
3426-4,Tetrahydrocannabinol [Presence] in Urine,THC Ur Ql,DRUG/TOX,368
26487-9,Monocytes/100 leukocytes in Body fluid,Monocytes/leuk NFr Fld,HEM/BC,369
11031-2,Lymphocytes/100 leukocytes in Body fluid,Lymphocytes/leuk NFr Fld,HEM/BC,370
749-2,Myelocytes/100 leukocytes in Blood by Manual count,Myelocytes/leuk NFr Bld Manual,HEM/BC,371
18932-4,Imipenem [Susceptibility],Imipenem Susc Islt,ABXBACT,372
18943-1,Meropenem [Susceptibility],Meropenem Susc Islt,ABXBACT,373
32673-6,Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma,CK MB SerPl-cCnc,Chem,374
22322-2,Hepatitis B virus surface Ab [Presence] in Serum,HBV surface Ab Ser Ql,MICRO,375
13655-6,Leukocytes [Presence] in Stool by Light microscopy,WBC Stl Ql Micro,HEM/BC,376
8123-2,CD3+CD4+ (T4 helper) cells/100 cells in Blood,CD3+CD4+ Cells NFr Bld,CELLMARK,377
26498-6,Myelocytes/100 leukocytes in Blood,Myelocytes/leuk NFr Bld,HEM/BC,378
19162-7,Varicella zoster virus IgG Ab [Presence] in Serum,VZV IgG Ser Ql,MICRO,379
18879-7,Cefepime [Susceptibility],Cefepime Susc Islt,ABXBACT,380
5783-6,Unidentified crystals [Presence] in Urine sediment by Light microscopy,Unident Crys UrnS Ql Micro,UA,381
4092-3,Vancomycin [Mass/volume] in Serum or Plasma --trough,Vancomycin Trough SerPl-mCnc,DRUG/TOX,382
8124-0,CD3 cells/100 cells in Blood,CD3 Cells NFr Bld,CELLMARK,383
31017-7,Tissue transglutaminase IgA Ab [Units/volume] in Serum,tTG IgA Ser-aCnc,SERO,384
3150-0,Inhaled oxygen concentration (FIO2),Inhaled O2 concentration,CLIN,385
1834-1,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,AFP SerPl-mCnc,Chem,386
3167-4,Volume of 24 hour Urine,Specimen vol 24h Ur,SPEC,387
18895-3,Ceftriaxone [Susceptibility],Ceftriaxone Susc Islt,ABXBACT,388
1925-7,Base excess in Arterial blood,Base excess BldA Calc-sCnc,Chem,389
1990-1,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,Vitamin D3 SerPl-mCnc,Chem,390
2236-8,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,Vitamin D2 SerPl-mCnc,Chem,391
20448-7,Insulin [Units/volume] in Serum or Plasma,Insulin SerPl-aCnc,Chem,392
18993-6,Tetracycline [Susceptibility],Tetracycline Susc Islt,ABXBACT,393
17790-7,Leukocytes Left Shift [Presence] in Blood by Automated count,WBC Left Shift Bld Ql Auto,HEM/BC,394
13955-0,Hepatitis C virus Ab [Presence] in Serum by Immunoassay,HCV Ab SerPl Ql IA,MICRO,395
18996-9,Tobramycin [Susceptibility],Tobramycin Susc Islt,ABXBACT,396
8101-8,CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood,CD3+CD8+ Cells NFr Bld,CELLMARK,397
13451-0,Creatinine dialysis fluid clearance,Creat Cl Dial fld+SerPl-vRate,Chem,398
1305-2,D Ag [Presence] in Blood,D Ag Bld Ql,BLDBK,399
5130-0,DNA double strand Ab [Units/volume] in Serum,dsDNA Ab Ser-aCnc,SERO,400
46737-3,Galactosemias newborn screen interpretation,Galactosemias DBS-Imp,Chem,401
3298-7,Acetaminophen [Mass/volume] in Serum or Plasma,APAP SerPl-mCnc,DRUG/TOX,402
14895-7,Protein Fractions [interpretation] in Serum or Plasma by Immunofixation,Prot Pattern SerPl IFE-Imp,Chem,403
18886-2,Cefotaxime [Susceptibility],Cefotaxime Susc Islt,ABXBACT,404
46733-2,Amino acidemias newborn screen interpretation,Amino acidemias DBS-Imp,Chem,405
35492-8,Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] by Probe & target amplification method,MRSA DNA XXX Ql PCR,ABXBACT,406
46736-5,Fatty acid oxidation defects newborn screen interpretation,FOD DBS-Imp,Chem,407
4086-5,Valproate [Mass/volume] in Serum or Plasma,Valproate SerPl-mCnc,DRUG/TOX,408
38478-4,Biotinidase [Presence] in Dried blood spot,Biotinidase DBS Ql,Chem,409
34148-7,Borrelia burgdorferi IgG+IgM Ab [Units/volume] in Serum,B burgdor IgG+IgM Ser-aCnc,MICRO,410
18969-6,Piperacillin [Susceptibility],Piperacillin Susc Islt,ABXBACT,411
2955-3,Sodium [Moles/volume] in Urine,Sodium Ur-sCnc,Chem,412
10381-2,Target cells [Presence] in Blood by Light microscopy,Targets Bld Ql Smear,HEM/BC,413
18860-7,Amikacin [Susceptibility],Amikacin Susc Islt,ABXBACT,414
12238-2,Neutrophils/100 leukocytes in Body fluid by Manual count,Neutrophils/leuk NFr Fld Manual,HEM/BC,415
8098-6,Thyroglobulin Ab [Units/volume] in Serum or Plasma,Thyroglob Ab SerPl-aCnc,SERO,416
3773-9,Methadone [Presence] in Urine,Methadone Ur Ql,DRUG/TOX,417
26452-3,Eosinophils/100 leukocytes in Body fluid,Eosinophil/leuk NFr Fld,HEM/BC,418
18961-3,Oxacillin [Susceptibility],Oxacillin Susc Islt,ABXBACT,419
10352-3,Bacteria identified in Genital specimen by Aerobe culture,Bacteria Genital Aerobe Cult,MICRO,420
4073-3,Tricyclic antidepressants [Presence] in Serum or Plasma,Tricyclics SerPl Ql,DRUG/TOX,421
1006-6,Direct antiglobulin test.IgG specific reagent [interpretation] on Red Blood Cells,DAT IgG-Sp Reag RBC-Imp,BLDBK,422
31160-5,Polymorphonuclear cells/100 leukocytes in Blood by Manual count,Polys/leuk NFr Bld Manual,HEM/BC,423
7790-9,Burr cells [Presence] in Blood by Light microscopy,Burr Cells Bld Ql Smear,HEM/BC,424
543-9,Mycobacterium sp identified in Unspecified specimen by Organism specific culture,Mycobacterium XXX Cult,MICRO,425
20564-1,Oxygen saturation in Blood,SaO2 % Bld,HEMODYN.MOLEC,426
8122-4,CD3 cells [#/volume] in Blood,CD3 Cells # Bld,CELLMARK,427
21667-1,F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,F5 gene Mut Anal Bld/T,MOLPATH.MUT,428
584-3,Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture,Gp B Strep Vag Ql Cult,MICRO,429
10334-1,Cancer Ag 125 [Units/volume] in Serum or Plasma,Cancer Ag125 SerPl-aCnc,Chem,430
34713-8,Clostridium difficile toxin A+B [Presence] in Stool,C dif Tox A+B Stl Ql,MICRO,431
26510-8,Neutrophils.band form/100 leukocytes in Body fluid,Neuts Band/leuk NFr Fld,HEM/BC,432
8246-1,Amorphous sediment [Presence] in Urine sediment by Light microscopy,Amorph Sed UrnS Ql Micro,UA,433
18919-1,Erythromycin [Susceptibility],Erythromycin Susc Islt,ABXBACT,434
26455-6,Erythrocytes [#/volume] in Body fluid,RBC # Fld,HEM/BC,435
4485-9,Complement C3 [Mass/volume] in Serum or Plasma,C3 SerPl-mCnc,HEM/BC,436
4498-2,Complement C4 [Mass/volume] in Serum or Plasma,C4 SerPl-mCnc,HEM/BC,437
57845-0,Leukocytes [#/volume] in Body fluid by Automated count,WBC # Fld Auto,HEM/BC,438
5176-3,Helicobacter pylori IgG Ab [Units/volume] in Serum by Immunoassay,H pylori IgG Ser IA-aCnc,MICRO,439
16128-1,Hepatitis C virus Ab [Presence] in Serum,HCV Ab Ser Ql,MICRO,440
14135-8,CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood,CD3+CD8+ Cells # Bld,CELLMARK,441
7918-6,HIV 1+2 Ab [Presence] in Serum,HIV1+2 Ab Ser Ql,MICRO,442
19312-8,Tricyclic antidepressants [Presence] in Urine by Screen method,Tricyclics Ur Ql Scn,DRUG/TOX,443
18908-4,Clindamycin [Susceptibility],Clindamycin Susc Islt,ABXBACT,444
2162-6,Creatinine [Mass/time] in 24 hour Urine,Creat 24h Ur-mRate,Chem,445
13518-6,Lymphocytes Variant/100 leukocytes in Body fluid by Manual count,Variant Lymphs/leuk NFr Fld Manual,HEM/BC,446
12179-8,Basophils/100 leukocytes in Body fluid by Manual count,Basophils/leuk NFr Fld Manual,HEM/BC,447
6864-3,Hemoglobin S [Presence] in Blood by Solubility test,Hgb S Bld Ql Soly,HEM/BC,448
49563-0,Troponin I.cardiac [Mass/volume] in Serum or Plasma by Detection limit = 0.01 ng/mL,Troponin I SerPl DL<=0.01 ng/mL-mCnc,Chem,449
33255-1,Cell Fractions/Differential [interpretation] in Blood,Cell Fract Bld-Imp,HEM/BC,450
2708-6,Oxygen saturation in Arterial blood,SaO2 % BldA,Chem,451
5209-2,Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay,HSV2 IgG Ser IA-aCnc,MICRO,452
18964-7,Penicillin [Susceptibility],Penicillin Susc Islt,ABXBACT,453
18868-0,Aztreonam [Susceptibility],Aztreonam Susc Islt,ABXBACT,454
1863-0,Anion gap 4 in Serum or Plasma,Anion Gap4 SerPl-sCnc,Chem,455
29574-1,Thyrotropin [Presence] in Dried blood spot,TSH DBS Ql,Chem,456
19994-3,Oxygen/Inspired gas setting [Volume Fraction] Ventilator,O2/Inspired gas setting VFr Vent,PULM,457
32854-2,17-Hydroxyprogesterone [Presence] in Dried blood spot,17OHP DBS Ql,CHEM,458
29571-7,Phenylalanine [Presence] in Dried blood spot,Phe DBS Ql,Chem,459
21654-9,CFTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,CFTR Mut Anal Bld/T,MOLPATH.MUT,460
38486-7,Homocystine [Presence] in Dried blood spot,(Hcys)2 DBS Ql,Chem,461
38479-2,Branched chain keto-acid dehydrogenase complex [Presence] in Dried blood spot,BCKAD DBS Ql,CHEM,462
46779-5,Medium/Short chain acyl-CoA dehydrogenase deficiency newborn screen interpretation,M/SCHADD DBS-Imp,Chem,463
4024-6,Salicylates [Mass/volume] in Serum or Plasma,Salicylates SerPl-mCnc,DRUG/TOX,464
2095-8,Cholesterol in HDL/Cholesterol.total [Mass ratio] in Serum or Plasma,HDLc SerPl,Chem,465
19113-0,IgE [Units/volume] in Serum,IgE SerPl-aCnc,Chem,466
12232-5,Measles virus Ag [Presence] in Unspecified specimen by Immunofluorescence,MeV Ag XXX Ql IF,MICRO,467
2191-5,Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma,DHEA-S SerPl-mCnc,Chem,468
625-4,Bacteria identified in Stool by Culture,Bacteria Stl Cult,MICRO,469
24475-6,F2 gene p.G20210A [Presence] in Blood or Tissue by Molecular genetics method,F2 c.20210G>A Bld/T Ql,MOLPATH.MUT,470
30318-0,Base deficit in Blood,Base deficit Bld-sCnc,Chem,471
743-5,Monocytes [#/volume] in Blood by Manual count,Monocytes # Bld Manual,HEM/BC,472
5569-9,Acetone [Presence] in Urine,Acetone Ur Ql,DRUG/TOX,473
3520-4,Cyclosporine [Mass/volume] in Blood,Cyclosporin Bld-mCnc,DRUG/TOX,474
32693-4,Lactate [Moles/volume] in Blood,Lactate Bld-sCnc,Chem,475
48065-7,Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma,D dimer FEU PPP-mCnc,COAG,476
2110-5,Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Serum or Plasma,B-HCG Preg SerPl Ql,Chem,477
13952-7,Hepatitis B virus core Ab [Presence] in Serum by Immunoassay,HBV core Ab SerPl Ql IA,MICRO,478
610-6,Bacteria identified in Body fluid by Aerobe culture,Bacteria Fld Aerobe Cult,MICRO,479
5403-1,Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay,VZV IgG Ser IA-aCnc,MICRO,480
803-7,Toxic granules [Presence] in Blood by Light microscopy,Toxic Granules Bld Ql Smear,HEM/BC,481
33358-3,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,M Protein SerPl Elph-mCnc,Chem,482
65633-0,Hepatitis B virus surface Ag [Presence] in Serum by Confirmatory method,HBV surface Ag SerPl Ql Cfm,MICRO,483
10524-7,Microscopic observation [Identifier] in Cervix by Cyto stain,Cyto Cvx,CYTO,484
29247-4,Sirolimus [Mass/volume] in Blood,Sirolimus Bld-mCnc,DRUG/TOX,485
739-3,Metamyelocytes [#/volume] in Blood by Manual count,Metamyelocytes # Bld Manual,HEM/BC,486
2889-4,Protein [Mass/time] in 24 hour Urine,Prot 24h Ur-mRate,Chem,487
18887-0,Cefotetan [Susceptibility],Cefotetan Susc Islt,ABXBACT,488
10335-8,Color of Cerebral spinal fluid,Color CSF,SPEC,489
2505-6,Iron/Iron binding capacity.total [Mass ratio] in Serum or Plasma,Iron/TIBC SerPl,Chem,490
30089-7,Transitional cells [#/area] in Urine sediment by Microscopy high power field,Trans Cells #/area UrnS HPF,UA,491
20761-3,Clostridium difficile [Presence] in Stool by Agglutination,C dif Stl Ql Aggl,MICRO,492
2828-2,Potassium [Moles/volume] in Urine,Potassium Ur-sCnc,Chem,493
29891-9,Helicobacter pylori [Presence] in Stomach by urea breath test,Urea Breath Test Ql,MICRO,494
19107-2,Histoplasma capsulatum Ag [Units/volume] in Serum by Radioimmunoassay (RIA),H capsul Ag Ser RIA-aCnc,MICRO,495
2639-3,Myoglobin [Mass/volume] in Serum or Plasma,Myoglobin SerPl-mCnc,Chem,496
5028-6,Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by DNA probe,N gonorrhoea rRNA XXX Ql Prb,MICRO,497
1922-4,Base deficit in Arterial blood,Base deficit BldA-sCnc,Chem,498
48058-2,Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma by Immunoassay,D dimer DDU PPP IA-mCnc,COAG,499
35365-6,Vitamin D+Metabolites [Mass/volume] in Serum or Plasma,Vit D+metab SerPl-mCnc,Chem,500
772-4,Nucleated erythrocytes [#/volume] in Blood by Manual count,nRBC # Bld Manual,HEM/BC,501
806-0,Leukocytes [#/volume] in Cerebral spinal fluid by Manual count,WBC # CSF Manual,HEM/BC,502
1649-3,Calcitriol [Mass/volume] in Serum or Plasma,"1,25(OH)2D3 SerPl-mCnc",Chem,503
3181-5,Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay,Cardiolipin IgG Ser IA-aCnc,COAG,504
3182-3,Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay,Cardiolipin IgM Ser IA-aCnc,COAG,505
4546-8,Hemoglobin A/Hemoglobin.total in Blood,Hgb A MFr Bld,HEM/BC,506
49541-6,Fasting status [Presence] - Reported,Fasting status Patient Ql Reported,MISC,507
4576-5,Hemoglobin F/Hemoglobin.total in Blood,Hgb F MFr Bld,HEM/BC,508
2890-2,Protein/Creatinine [Mass ratio] in Urine,Prot/Creat Ur,Chem,509
33935-8,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum,cCP IgG SerPl-aCnc,SERO,510
16935-9,Hepatitis B virus surface Ab [Units/volume] in Serum,HBV surface Ab Ser-aCnc,MICRO,511
5193-8,Hepatitis B virus surface Ab [Units/volume] in Serum by Immunoassay,HBV surface Ab SerPl IA-aCnc,MICRO,512
20399-2,Nuclear Ab pattern.nucleolar [Titer] in Serum,ANA nucleolar Titr Ser,SERO,513
25145-4,Bacteria [Presence] in Urine sediment by Light microscopy,Bacteria UrnS Ql Micro,UA,514
24467-3,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,CD3+CD4+ Cells # Bld,CELLMARK,515
33762-6,Natriuretic peptide.B prohormone [Mass/volume] in Serum or Plasma,NT-proBNP SerPl-mCnc,Chem,516
48066-5,Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma,D dimer DDU PPP-mCnc,COAG,517
4625-0,Hemoglobin S/Hemoglobin.total in Blood,Hgb S MFr Bld,HEM/BC,518
2746-6,pH of Venous blood,pH BldV,Chem,519
3376-1,"Barbiturates [Presence] in Serum, Plasma or Blood",Barbiturates SerPlBld Ql,DRUG/TOX,520
546-2,Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture,B-Hem Strep Throat Ql Cult,MICRO,521
21484-1,Mother's race,Mother's race,CLIN,522
2021-4,Carbon dioxide [Partial pressure] in Venous blood,pCO2 BldV,Chem,523
30446-9,Myelocytes [#/volume] in Blood,Myelocytes # Bld,HEM/BC,524
748-4,Myelocytes [#/volume] in Blood by Manual count,Myelocytes # Bld Manual,HEM/BC,525
17898-8,Bacteria identified in Throat by Aerobe culture,Bacteria Throat Aerobe Cult,MICRO,526
673-4,Microscopic observation [Identifier] in Unspecified specimen by Ova & Parasite Preparation,O+P XXX Micro,MICRO,527
5064-1,Borrelia burgdorferi IgM Ab [Units/volume] in Serum by Immunoassay,B burgdor IgM Ser IA-aCnc,MICRO,528
32998-7,Tissue transglutaminase IgG Ab [Units/volume] in Serum,tTG IgG Ser-aCnc,SERO,529
56537-4,Tissue transglutaminase IgG Ab [Units/volume] in Serum by Immunoassay,tTG IgG Ser IA-aCnc,SERO,530
11011-4,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe & target amplification method,HCV RNA SerPl PCR-aCnc,MICRO,531
12841-3,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,PSA Free MFr SerPl,Chem,532
11006-4,Borrelia burgdorferi Ab [Presence] in Serum,B burgdor Ab Ser Ql,MICRO,533
2880-3,Protein [Mass/volume] in Cerebral spinal fluid,Prot CSF-mCnc,Chem,534
33944-0,Immunoglobulin light chains.lambda.free [Mass/volume] in Serum or Plasma,Lambda LC Free SerPl-mCnc,Chem,535
3389-4,Benzodiazepines [Presence] in Serum or Plasma,Benzodiaz SerPl Ql,DRUG/TOX,536
5206-8,Herpes simplex virus 1 IgG Ab [Units/volume] in Serum by Immunoassay,HSV1 IgG Ser IA-aCnc,MICRO,537
19066-0,Blood bank comment,Blood Bank Cmnt Patient-Imp,BLDBK,538
48803-1,Neural tube defect risk in Fetus,Neural tube defect risk Fetus,Chem,539
4563-3,Hemoglobin C/Hemoglobin.total in Blood,Hgb C MFr Bld,HEM/BC,540
49049-0,Collection time of Unspecified specimen,Collect Tme XXX,SPEC,541
13503-8,Borrelia burgdorferi Ab.IgM band pattern [interpretation] in Serum by Immunoblot (IB),B burgdor IgM Patrn Ser IB-Imp,MICRO,542
14725-6,[Type] of Body fluid,Body fld type,SPEC,543
21299-3,Gestational age method,GA method,OB.US,544
4545-0,Hematocrit [Volume Fraction] of Blood by Centrifugation,Hct VFr Bld Spun,HEM/BC,545
46765-4,Sickle cell anemia newborn screen interpretation,Sickle Cell Anemia DBS-Imp,Chem,546
10362-2,Endomysium IgA Ab [Presence] in Serum,Endomysium IgA Ser Ql,SERO,547
49048-2,Protein feed time,Protein feed time Patient,Chem,548
18862-3,Amoxicillin+Clavulanate [Susceptibility],Amoxicillin+Clav Susc Islt,ABXBACT,549
2342-4,Glucose [Mass/volume] in Cerebral spinal fluid,Glucose CSF-mCnc,Chem,550
18965-4,Penicillin G [Susceptibility],Penicillin G Susc Islt,ABXBACT,551
9587-7,Borrelia burgdorferi 41kD IgM Ab [Presence] in Serum by Immunoblot (IB),B burgdor41kD IgM Ser Ql IB,MICRO,552
18390-5,Opiates [Presence] in Urine by Confirmatory method,Opiates Ur Ql Cfm,DRUG/TOX,553
10886-0,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,PSA Free SerPl-mCnc,Chem,554
14196-0,Reticulocytes [#/volume] in Blood,Retics #,HEM/BC,555
2695-5,Osmolality of Urine,Osmolality Ur,Chem,556
42481-2,Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe & signal amplification method,HPV Low Risk DNA Cvx Ql bDNA,MICRO,557
13951-9,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,HAV Ab Ser Ql IA,MICRO,558
13502-0,Borrelia burgdorferi Ab.IgG band pattern [interpretation] in Serum by Immunoblot (IB),B burgdor IgG Patrn Ser IB-Imp,MICRO,559
11090-8,Smith extractable nuclear Ab [Units/volume] in Serum,ENA SM Ab Ser-aCnc,SERO,560
606-4,Bacteria identified in Cerebral spinal fluid by Culture,Bacteria CSF Cult,MICRO,561
6561-5,Treponema pallidum IgG Ab [Presence] in Serum,T pallidum IgG Ser Ql,MICRO,562
47238-1,Treponema pallidum IgG Ab [Presence] in Serum by Immunoassay,T pallidum IgG Ser Ql IA,MICRO,563
18185-9,Gestational age,GA,OB.US,564
9597-6,Borrelia burgdorferi 93kD IgG Ab [Presence] in Serum by Immunoblot (IB),B burgdor93kD IgG Ser Ql IB,MICRO,565
31418-7,Heterophile Ab [Presence] in Serum,Heteroph Ab Ser Ql,MICRO,566
17792-3,Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum,ENA SS-A Ab Ser-aCnc,SERO,567
11004-9,Tricyclic antidepressants [Presence] in Urine,Tricyclics Ur Ql,DRUG/TOX,568
17791-5,Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum,ENA SS-B Ab Ser-aCnc,SERO,569
9593-5,Borrelia burgdorferi 41kD IgG Ab [Presence] in Serum by Immunoblot (IB),B burgdor41kD IgG Ser Ql IB,MICRO,570
9590-1,Borrelia burgdorferi 28kD IgG Ab [Presence] in Serum by Immunoblot (IB),B burgdor28kD IgG Ser Ql IB,MICRO,571
9594-3,Borrelia burgdorferi 45kD IgG Ab [Presence] in Serum by Immunoblot (IB),B burgdor45kD IgG Ser Ql IB,MICRO,572
9589-3,Borrelia burgdorferi 23kD IgG Ab [Presence] in Serum by Immunoblot (IB),B burgdor23kD IgG Ser Ql IB,MICRO,573
9591-9,Borrelia burgdorferi 30kD IgG Ab [Presence] in Serum by Immunoblot (IB),B burgdor30kD IgG Ser Ql IB,MICRO,574
9592-7,Borrelia burgdorferi 39kD IgG Ab [Presence] in Serum by Immunoblot (IB),B burgdor39kD IgG Ser Ql IB,MICRO,575
9599-2,Borrelia burgdorferi 39kD IgM Ab [Presence] in Serum by Immunoblot (IB),B burgdor39kD IgM Ser Ql IB,MICRO,576
9598-4,Borrelia burgdorferi 23kD IgM Ab [Presence] in Serum by Immunoblot (IB),B burgdor23kD IgM Ser Ql IB,MICRO,577
9595-0,Borrelia burgdorferi 58kD IgG Ab [Presence] in Serum by Immunoblot (IB),B burgdor58kD IgG Ser Ql IB,MICRO,578
9596-8,Borrelia burgdorferi 66kD IgG Ab [Presence] in Serum by Immunoblot (IB),B burgdor66kD IgG Ser Ql IB,MICRO,579
47000-5,Candida sp rRNA [Presence] in Vaginal fluid by DNA probe,Candida rRNA Vag Ql Prb,MICRO,580
9588-5,Borrelia burgdorferi 18kD IgG Ab [Presence] in Serum by Immunoblot (IB),B burgdor18kD IgG Ser Ql IB,MICRO,581
44357-2,Galactomannan Ag [Units/volume] in Serum or Plasma by Immunoassay,Galactomannan Ag SerPl IA-aCnc,MICRO,582
6410-5,Gardnerella vaginalis rRNA [Presence] in Genital specimen by DNA probe,G vaginalis rRNA Genital Ql Prb,MICRO,583
6568-0,Trichomonas vaginalis rRNA [Presence] in Genital specimen by DNA probe,T vaginalis rRNA Genital Ql Prb,MICRO,584
14564-9,Hemoglobin.gastrointestinal [Presence] in Stool --2nd specimen,Hemoccult sp2 Stl Ql,Chem,585
2164-2,Creatinine renal clearance in 24 hour Urine,Creat Cl 24h Ur+SerPl-vRate,Chem,586
43371-4,Salmonella sp/Shigella sp identified in Stool by Organism specific culture,Salm + Shig Stl Cult,MICRO,587
6331-3,Campylobacter sp identified in Stool by Organism specific culture,Campylobacter Stl Cult,MICRO,588
21262-1,Escherichia coli shiga-like [Presence] in Stool by Immunoassay,E coli SXT Stl Ql IA,MICRO,589
29374-6,Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum,ENA RNP Ab Ser-aCnc,SERO,590
9335-1,Appearance of Body fluid,Appearance Fld,SPEC,591
19157-7,Tube number of Cerebral spinal fluid,Tube # CSF,SPEC,592
29463-7,Body weight,Weight,BDYWGT.ATOM,593
36916-5,Immunoglobulin light chains.kappa.free [Mass/volume] in Serum,Kappa LC Free Ser-mCnc,Chem,594
15189-4,Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda [Mass ratio] in Serum,Kappa LC/Lambda Ser,Chem,595
4542-7,Haptoglobin [Mass/volume] in Serum or Plasma,Haptoglob SerPl-mCnc,HEM/BC,596
5640-8,Ethanol [Mass/volume] in Blood,Ethanol Bld-mCnc,DRUG/TOX,597
19993-5,Oxygen/Inspired gas Inhaled gas by Gas dilution.rebreath,FIO2 Gas Dil.rebreath,PULM,598
6420-4,Helicobacter pylori IgA Ab [Units/volume] in Serum by Immunoassay,H pylori IgA Ser IA-aCnc,MICRO,599
14565-6,Hemoglobin.gastrointestinal [Presence] in Stool --3rd specimen,Hemoccult sp3 Stl Ql,Chem,600
17842-6,Cancer Ag 27-29 [Units/volume] in Serum or Plasma,Cancer Ag27-29 SerPl-aCnc,Chem,601
32515-9,CD3+CD4+ (T4 helper) cells [#/volume] in Unspecified specimen,CD3+CD4+ Cells # XXX,CELLMARK,602
7886-5,Epstein Barr virus capsid IgM Ab [Units/volume] in Serum,EBV VCA IgM Ser-aCnc,MICRO,603
5159-9,Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay,EBV VCA IgM Ser IA-aCnc,MICRO,604
26052-1,Epithelial cells.renal [#/area] in Urine sediment by Microscopy high power field,Renal Epi Cells #/area UrnS HPF,UA,605
7885-7,Epstein Barr virus capsid IgG Ab [Units/volume] in Serum,EBV VCA IgG Ser-aCnc,MICRO,606
5157-3,Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay,EBV VCA IgG Ser IA-aCnc,MICRO,607
33768-3,Leukocyte clumps [#/volume] in Urine by Automated count,WBC clumps # Ur Auto,UA,608
23811-3,Alpha-1-Fetoprotein [Multiple of the median] adjusted in Serum or Plasma,AFP adj MoM SerPl,Chem,609
3013-0,Thyroglobulin [Mass/volume] in Serum or Plasma,Thyroglob SerPl-mCnc,Chem,610
6206-7,Peanut IgE Ab [Units/volume] in Serum,Peanut IgE Qn,Allergy,611
2756-5,pH of Urine,pH Ur,Chem,612
46769-6,Cystic fibrosis newborn screen interpretation,CF DBS-Imp,Chem,613
2484-4,Insulin-like growth factor-I [Mass/volume] in Serum or Plasma,IGF-I SerPl-mCnc,Chem,614
2118-8,Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma,HCG Preg SerPl Ql,Chem,615
18974-6,Rifampin [Susceptibility],Rifampin Susc Islt,ABXBACT,616
12710-0,Hemoglobin pattern [interpretation] in Blood,Hgb Fract Bld-Imp,HEM/BC,617
34705-4,Carbon dioxide [Partial pressure] adjusted to patients actual temperature in Blood,pCO2 temp adj Bld,Chem,618
19254-2,Oxygen [Partial pressure] adjusted to patients actual temperature in Blood,pO2 temp adj Bld,Chem,619
4993-2,Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by DNA probe,C trach rRNA XXX Ql Prb,MICRO,620
1977-8,Bilirubin [Presence] in Urine,Bilirub Ur Ql,Chem,621
44877-9,Insulin dependent diabetes mellitus [Presence],IDDM Patient Ql,MISC,622
23641-4,Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC),Quinupristin+Dalfoprist Islt MIC,ABXBACT,623
46740-7,Hemoglobin disorders newborn screen interpretation,Hemoglobin disorders DBS-Imp,Chem,624
14563-1,Hemoglobin.gastrointestinal [Presence] in Stool --1st specimen,Hemoccult sp1 Stl Ql,Chem,625
20447-9,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method,HIV1 RNA # SerPl PCR,MICRO,626
5244-9,Measles virus IgG Ab [Units/volume] in Serum by Immunoassay,MeV IgG Ser IA-aCnc,MICRO,627
2250-9,Estriol (E3).unconjugated [Mass/volume] in Serum or Plasma,u Estriol SerPl-mCnc,Chem,628
19550-3,Methadone [Presence] in Urine by Screen method,Methadone Ur Ql Scn,DRUG/TOX,629
49090-4,Trisomy 21 risk based on maternal age in Fetus,Fet Ts 21 risk from Mat age,Chem,630
21026-0,Pathologist interpretation of Blood tests,Path Interp Bld-Imp,PATH,631
62292-8,25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma,25(OH)D2+25(OH)D3 SerPl-mCnc,Chem,632
2761-5,Phenylketones [Presence] in Blood,Phenylketones Bld Ql,Chem,633
3779-6,Methamphetamine [Presence] in Urine,Methamphet Ur Ql,DRUG/TOX,634
35663-4,Protein [Mass/volume] in unspecified time Urine,Prot ?Tm Ur-mCnc,UA,635
20506-2,Specimen drawn from,Specimen drawn from Patient,SPEC,636
19057-9,ABO & Rh group [Type] in Blood from newborn,ABO + Rh Bld NB,BLDBK,637
626-2,Bacteria identified in Throat by Culture,Bacteria Throat Cult,MICRO,638
13532-7,Xanthochromia [Presence] of Cerebral spinal fluid,Xanthochromia CSF Ql,SPEC,639
34660-1,Hemoglobin A2/Hemoglobin.total in Blood by Chromatography column,Hgb A2 MFr Bld Column Chrom,HEM/BC,640
26454-9,Erythrocytes [#/volume] in Cerebral spinal fluid,RBC # CSF,HEM/BC,641
10333-3,Appearance of Cerebral spinal fluid,Appearance CSF,SPEC,642
5822-2,Yeast [#/area] in Urine sediment by Microscopy high power field,Yeast #/area UrnS HPF,UA,643
49092-0,Second trimester quad maternal screen [interpretation] in Serum or Plasma Narrative,2nd trimester 4 screen SerPl-Imp,Chem,644
6276-0,Wheat IgE Ab [Units/volume] in Serum,Wheat IgE Qn,Allergy,645
6248-9,Soybean IgE Ab [Units/volume] in Serum,Soybean IgE Qn,Allergy,646
75882-1,Lupus anticoagulant three screening tests W Reflex [interpretation],LA 3 screen W Reflex-Imp,COAG,647
6095-4,American house dust mite IgE Ab [Units/volume] in Serum,D farinae IgE Qn,Allergy,648
25160-3,Granular casts [Presence] in Urine sediment by Light microscopy,Gran Casts UrnS Ql Micro,UA,649
33804-6,RBC casts [Presence] in Urine sediment by Light microscopy,RBC Casts UrnS Ql Micro,UA,650
703-9,Basophilic stippling [Presence] in Blood by Light microscopy,Baso Stipl Bld Ql Smear,HEM/BC,651
6020-2,Alternaria alternata IgE Ab [Units/volume] in Serum,A alternata IgE Qn,Allergy,652
20496-6,Gliadin IgG Ab [Units/volume] in Serum by Immunoassay,Gliadin IgG Ser IA-aCnc,SERO,653
29541-0,HIV 1 RNA [Log #/volume] (viral load) in Plasma by Probe & target amplification method,HIV1 RNA Plas PCR-Log#,MICRO,654
6584-7,Virus identified in Unspecified specimen by Culture,Virus XXX Cult,MICRO,655
19343-3,Amphetamine [Presence] in Urine by Screen method,Amphet Ur Ql Scn,DRUG/TOX,656
13964-2,Methylmalonate [Moles/volume] in Serum or Plasma,Methylmalonate SerPl-sCnc,Chem,657
802-9,Spherocytes [Presence] in Blood by Light microscopy,Spherocytes Bld Ql Smear,HEM/BC,658
10704-5,Ova+Parasites identified in Stool by Light microscopy,O+P Stl Micro,MICRO,659
5185-4,Hepatitis B virus core IgM Ab [Units/volume] in Serum by Immunoassay,HBV core IgM SerPl IA-aCnc,MICRO,660
49054-0,25-Hydroxycalciferol [Mass/volume] in Serum or Plasma,25(OH)D2 SerPl-mCnc,Chem,661
7258-7,Cow milk IgE Ab [Units/volume] in Serum,Cow Milk IgE Qn,Allergy,662
19554-5,Methamphetamine [Presence] in Urine by Screen method,Methamphet Ur Ql Scn,DRUG/TOX,663
10328-3,Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count,Lymphocytes/leuk NFr CSF Manual,HEM/BC,664
2705-2,Oxygen [Partial pressure] in Venous blood,pO2 BldV,Chem,665
43994-3,Trisomy 18 risk in Fetus,Ts 18 risk Fetus,Chem,666
14334-7,Lithium [Moles/volume] in Serum or Plasma,Lithium SerPl-sCnc,DRUG/TOX,667
41477-1,Bacterial sialidase [Presence] in Unspecified specimen,Bacterial sialidase XXX Ql,MICRO,668
33254-4,pH of Arterial blood adjusted to patients actual temperature,pH temp adj BldA,Chem,669
21612-7,Age - Reported,Age - Reported,MISC,670
3432-2,Carbamazepine [Mass/volume] in Serum or Plasma,Carbamazepine SerPl-mCnc,DRUG/TOX,671
43995-0,Trisomy 21 risk in Fetus,Ts 21 risk Fetus,Chem,672
5124-3,Cytomegalovirus IgG Ab [Units/volume] in Serum by Immunoassay,CMV IgG SerPl IA-aCnc,MICRO,673
10366-3,Cotinine [Mass/volume] in Urine,Cotinine Ur-mCnc,DRUG/TOX,674
6096-2,European house dust mite IgE Ab [Units/volume] in Serum,D pteronyss IgE Qn,Allergy,675
26473-9,Leukocytes other/100 leukocytes in Body fluid,WBC Other/leuk NFr Fld,HEM/BC,676
24108-3,Cancer Ag 19-9 [Units/volume] in Serum or Plasma,Cancer Ag19-9 SerPl-aCnc,Chem,677
5859-4,Herpes simplex virus identified in Unspecified specimen by Organism specific culture,HSV XXX Cult,MICRO,678
5774-5,Calcium oxalate crystals [Presence] in Urine sediment by Light microscopy,CaOx Cry UrnS Ql Micro,UA,679
49121-7,Erythrocyte inclusion bodies [Identifier] in Blood,RBC inclusions Bld,HEM/BC,680
13967-5,Sex hormone binding globulin [Moles/volume] in Serum or Plasma,SHBG SerPl-sCnc,Chem,681
3095-7,Urea nitrogen [Mass/volume] in Urine,UUN Ur-mCnc,Chem,682
6025-1,Aspergillus fumigatus IgE Ab [Units/volume] in Serum,A fumigatus IgE Qn,Allergy,683
21264-7,Estriol (E3).unconjugated [Multiple of the median] adjusted in Serum or Plasma,u Estriol adj MoM SerPl,Chem,684
25836-8,HIV 1 RNA [#/volume] (viral load) in Unspecified specimen by Probe & target amplification method,HIV1 RNA # XXX PCR,MICRO,685
46640-9,Secondary diagnosis RFC,,SURVEY.RFC,686
42216-2,Reference lab name [Identifier],Ref Lab Name,MISC,687
48391-7,"Carbon dioxide, total [Moles/volume] in Venous blood by calculation",CO2 BldV Calc-sCnc,Chem,688
35678-2,Sodium [Moles/volume] in unspecified time Urine,Sodium ?Tm Ur-sCnc,Chem,689
10459-6,Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain,AFP Ag Tiss Ql ImStn,PATH,690
5793-5,Granular casts [#/area] in Urine sediment by Microscopy low power field,Gran Casts #/area UrnS LPF,UA,691
6099-6,Dog epithelium IgE Ab [Units/volume] in Serum,Dog Epith IgE Qn,Allergy,692
34701-3,Platelet Ab.heparin induced [Presence] in Serum,PF4 heparin cmplx Ab Ser Ql,SERO,693
20495-8,Gliadin IgA Ab [Units/volume] in Serum by Immunoassay,Gliadin IgA Ser IA-aCnc,SERO,694
1761-6,Aldolase [Enzymatic activity/volume] in Serum or Plasma,Aldolase SerPl-cCnc,Chem,695
8248-7,Spermatozoa [Presence] in Urine sediment by Light microscopy,Sperm UrnS Ql Micro,UA,696
2078-4,Chloride [Moles/volume] in Urine,Chloride Ur-sCnc,Chem,697
31374-2,Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum,EBV NA IgG Ser-aCnc,MICRO,698
30083-0,Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunoassay,EBV NA IgG Ser IA-aCnc,MICRO,699
47223-3,Trisomy 18 risk based on maternal age in Fetus,Fet Ts 18 risk from Mat age,Chem,700
1986-9,C peptide [Mass/volume] in Serum or Plasma,C peptide SerPl-mCnc,Chem,701
23883-2,Inhibin A [Mass/volume] in Serum,Inhibin A SerPl-mCnc,Chem,702
34468-9,Clostridium difficile toxin A+B [Presence] in Stool by Immunoassay,C dif Tox A+B Stl Ql IA,MICRO,703
2881-1,Protein [Mass/volume] in Body fluid,Prot Fld-mCnc,Chem,704
3243-3,Thrombin time in Platelet poor plasma by Coagulation assay,Thrombin time,COAG,705
3243-3,Thrombin time,Thrombin time,COAG,705
19270-8,Barbiturates [Presence] in Urine by Screen method,Barbiturates Ur Ql Scn,DRUG/TOX,706
15432-8,Testosterone Free/Testosterone.total in Serum or Plasma,Testost Free MFr SerPl,Chem,707
26466-3,Leukocytes [#/volume] in Body fluid,WBC # Fld,HEM/BC,708
21440-3,Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by DNA probe,HPV I/H Risk DNA Cvx Ql Prb,MICRO,709
3948-7,Phenobarbital [Mass/volume] in Serum or Plasma,Phenobarb SerPl-mCnc,DRUG/TOX,710
10835-7,Lipoprotein a [Mass/volume] in Serum or Plasma,LPa SerPl-mCnc,Chem,711
22330-5,Hepatitis D virus Ab [Units/volume] in Serum,HDV Ab Ser-aCnc,MICRO,712
38526-0,Number of specimens tested of Stool,# Spec Tst Stl,SPEC,713
40752-8,Epstein Barr virus early IgG Ab [Presence] in Serum by Immunoassay,EBV EA IgG Ser Ql IA,MICRO,714
6833-8,Cat dander IgE Ab [Units/volume] in Serum,Cat Dander IgE Qn,Allergy,715
5813-1,Trichomonas vaginalis [Presence] in Urine sediment by Light microscopy,T vaginalis UrnS Ql Micro,UA,716
6189-5,White Oak IgE Ab [Units/volume] in Serum,White Oak IgE Qn,Allergy,717
6075-6,Cladosporium herbarum IgE Ab [Units/volume] in Serum,C herbarum IgE Qn,Allergy,718
14314-9,Benzoylecgonine [Presence] in Urine by Screen method,BZE Ur Ql Scn,DRUG/TOX,719
5332-2,Rubella virus Ab [Presence] in Serum by Latex agglutination,RUBV Ab Ser Ql LA,MICRO,720
12248-1,Epithelial cells.renal [Presence] in Urine sediment by Light microscopy,Renal Epi Cells UrnS Ql Micro,UA,721
5892-5,Protein S [Units/volume] in Platelet poor plasma by Coagulation assay,Prot S PPP-aCnc,COAG,722
4552-6,Hemoglobin A2/Hemoglobin.total in Blood by Electrophoresis,Hgb A2 MFr Bld Elph,HEM/BC,723
22314-9,Hepatitis A virus IgM Ab [Presence] in Serum,HAV IgM Ser Ql,MICRO,724
46154-1,Trichomonas vaginalis rRNA [Presence] in Unspecified specimen by Probe & target amplification method,T vaginalis rRNA XXX Ql PCR,MICRO,725
6357-8,Chlamydia trachomatis DNA [Presence] in Urine by Probe & target amplification method,C trach DNA Ur Ql PCR,MICRO,726
36904-1,Inhibin A [Multiple of the median] adjusted in Serum,Inhibin A adj MoM SerPl,Chem,727
5862-8,Influenza virus A Ag [Presence] in Unspecified specimen by Immunoassay,FLUAV Ag XXX Ql IA,MICRO,728
45371-2,Multiple pregancy,Multiple Pregnancy,CLIN,729
2742-5,Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma,ACE SerPl-cCnc,Chem,730
32764-3,Clue cells [Presence] in Unspecified specimen by Wet preparation,Clue Cells XXX Ql Wet Prep,MICRO,731
42247-7,Hemoglobin pattern [interpretation] in Blood by HPLC Narrative,Hgb Fract Bld HPLC-Imp,HEM/BC,732
11153-4,Hematocrit [Volume Fraction] of Body fluid,Hct VFr Fld,HEM/BC,733
6875-9,Cancer Ag 15-3 [Units/volume] in Serum or Plasma,Cancer Ag15-3 SerPl-aCnc,Chem,734
32166-1,Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma,HCG adj MoM SerPl,Chem,735
6741-3,Erythrocytes [#/volume] in Body fluid by Manual count,RBC # Fld Manual,HEM/BC,736
7900-4,Helicobacter pylori Ab [Units/volume] in Serum,H pylori Ab Ser-aCnc,MICRO,737
6087-1,Corn IgE Ab [Units/volume] in Serum,Corn IgE Qn,Allergy,738
5763-8,Zinc [Mass/volume] in Serum or Plasma,Zinc SerPl-mCnc,DRUG/TOX,739
11259-9,Hepatitis C virus RNA [Presence] in Serum or Plasma by Probe & target amplification method,HCV RNA SerPl Ql PCR,MICRO,740
38180-6,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe & target amplification method,HCV RNA SerPl PCR-Log IU,MICRO,741
3299-5,Acetaminophen [Presence] in Urine,APAP Ur Ql,DRUG/TOX,742
2283-0,Folate [Mass/volume] in Red Blood Cells,Folate RBC-mCnc,Chem,743
5370-2,Streptolysin O Ab [Units/volume] in Serum,ASO Ab SerPl-aCnc,MICRO,744
6041-8,Bermuda grass IgE Ab [Units/volume] in Serum,Bermuda grass IgE Qn,Allergy,745
53962-7,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,AFP-TM SerPl-mCnc,Chem,746
17859-0,Helicobacter pylori IgG Ab [Presence] in Serum by Immunoassay,H pylori IgG SerPl Ql IA,MICRO,747
6212-5,Penicillium notatum IgE Ab [Units/volume] in Serum,P notatum IgE Qn,Allergy,748
22496-4,Rubella virus Ab [Presence] in Serum,RUBV Ab Ser Ql,MICRO,749
49050-8,Microscopic observation [Identifier] in Endocervical brush by Cyto stain,Cyto Endocvx brush,CYTO,750
21190-4,Chlamydia trachomatis DNA [Presence] in Cervix by Probe and target amplification method,C trach DNA Cvx Ql PCR,MICRO,751
30457-6,Nonhematic cells/100 leukocytes in Body fluid,Nonhematic Cells/leuk NFr Fld,HEM/BC,752
34985-2,Unidentified cells/100 leukocytes in Body fluid,Unident Cells/leuk NFr Fld,HEM/BC,753
7966-5,Mumps virus IgG Ab [Units/volume] in Serum,MuV IgG Ser-aCnc,MICRO,754
20512-0,Turbidity [Presence] of Cerebral spinal fluid,Turbidity CSF Ql,SPEC,755
32198-4,Neisseria gonorrhoeae rRNA [Presence] in Cervix by DNA probe,N gonorrhoea rRNA Cvx Ql Prb,MICRO,756
6085-5,Common Ragweed IgE Ab [Units/volume] in Serum,Common Ragweed IgE Qn,Allergy,757
6110-1,English Plantain IgE Ab [Units/volume] in Serum,Engl plantain IgE Qn,Allergy,758
6303-2,dRVVT LA screen,Screen dRVVT,COAG,759
27811-9,Antithrombin actual/normal in Platelet poor plasma by Chromogenic method,AT III Act/Nor PPP Chro,COAG,760
47213-4,Cholesterol in LDL real size pattern [Identifier] in Serum or Plasma,LDLc real size Pat SerPl,Chem,761
31144-9,Thyroxine (T4) [Mass/volume] in Dried blood spot,T4 DBS-mCnc,Chem,762
2087-5,Cholesterol in IDL [Mass/volume] in Serum or Plasma,IDLc SerPl-mCnc,Chem,763
50194-0,Cholesterol in IDL+Cholesterol in VLDL 3 [Mass/volume] in Serum or Plasma,IDLc+VLDL3c SerPl-mCnc,Chem,764
46986-6,Cholesterol in VLDL 3 [Mass/volume] in Serum or Plasma,VLDL3c SerPl-mCnc,Chem,765
49062-3,Lipid risk factors [Finding],Lipid risk factors Patient,Chem,766
32046-5,Pregnancy associated plasma protein A (PAPPA) [Units/volume] in Serum or Plasma,PAPP-A SerPl-aCnc,Chem,767
26760-9,Cannabinoids [Units/volume] in Urine,Cannabinoids Ur-aCnc,DRUG/TOX,768
13183-9,White Elm IgG Ab [Units/volume] in Serum,White Elm IgG Qn,Allergy,769
29967-7,Neutrophil cytoplasmic IgG Ab [Titer] in Serum by Immunofluorescence,ANCA IgG Titr Ser IF,SERO,770
1795-4,Amylase [Enzymatic activity/volume] in Body fluid,Amylase Fld-cCnc,Chem,771
1871-3,Apolipoprotein B-100 [Mass/volume] in Serum or Plasma,Apo B100 SerPl-mCnc,Chem,772
33716-2,Non-gynecological cytology method study,,ATTACH.CLINRPT,773
1763-2,Aldosterone [Mass/volume] in Serum or Plasma,Aldost SerPl-mCnc,Chem,774
34574-4,Pathology report final diagnosis,Path report.final Dx Spec,TUMRRGT,775
45353-0,Date of analysis of unspecified specimen,Date Of Analysis XXX,MISC,776
2064-4,Ceruloplasmin [Mass/volume] in Serum or Plasma,Ceruloplasmin SerPl-mCnc,Chem,777
792-2,Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count,RBC # CSF Manual,HEM/BC,778
29771-3,Hemoglobin.gastrointestinal [Presence] in Stool by Immunologic method,Occult Bld Stl Ql Imm,Chem,779
30170-5,American Cockroach IgE Ab [Units/volume] in Serum,Amer Roach IgE Qn,Allergy,780
14627-4,Bicarbonate [Moles/volume] in Venous blood,HCO3 BldV-sCnc,Chem,781
31204-1,Hepatitis B virus core IgM Ab [Presence] in Serum,HBV core IgM Ser Ql,MICRO,782
1952-1,Beta-2-Microglobulin [Mass/volume] in Serum,B2 Microglob SerPl-mCnc,Chem,783
13514-5,Hemoglobin pattern [interpretation] in Blood by Electrophoresis Narrative,Hgb Fract Bld Elph-Imp,HEM/BC,784
24012-7,HIV 1 Ag [Presence] in Serum,HIV1 Ag Ser Ql,MICRO,785
5222-5,HIV 1 Ag [Presence] in Serum by Immunoassay,HIV1 Ag SerPl Ql IA,MICRO,786
13953-5,Hepatitis B virus e Ab [Presence] in Serum by Immunoassay,HBV e Ab SerPl Ql IA,MICRO,787
2344-0,Glucose [Mass/volume] in Body fluid,Glucose Fld-mCnc,Chem,788
15205-8,Rheumatoid factor [Units/volume] in Serum by Nephlometry,Rheumatoid fact Ser Neph-aCnc,SERO,789
29770-5,Karyotype [Identifier] in Blood or Tissue Nominal,Karyotyp Bld/T,MOLPATH,790
709-6,Blasts/100 leukocytes in Blood by Manual count,Blasts/leuk NFr Bld Manual,HEM/BC,791
20444-6,Herpes simplex virus 1+2 DNA [Presence] in Unspecified specimen by Probe & target amplification method,HSV1+2 DNA XXX Ql PCR,MICRO,792
19153-6,Volume of unspecified time Urine,Specimen vol ?Tm Ur,SPEC,793
3209-4,Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay,Fact VIII Act/Nor PPP,COAG,794
7155-5,Boxelder IgE Ab [Units/volume] in Serum,Boxelder IgE Qn,Allergy,795
5866-9,Influenza virus B Ag [Presence] in Unspecified specimen by Immunoassay,FLUBV Ag XXX Ql IA,MICRO,796
13590-5,Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay,aPCR PPP,COAG,797
47528-5,Cytology report of Cervical or vaginal smear or scraping Cyto stain,Cytology Cvx/Vag Doc Cyto,CYTO,798
6106-9,Egg white IgE Ab [Units/volume] in Serum,Egg White IgE Qn,Allergy,799
2006-5,Cancer Ag 125 [Presence] in Serum or Plasma,Cancer Ag125 SerPl Ql,Chem,800
655-1,Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain.Kinyoun modified,Acid fast Mod Kiny Stn XXX,MICRO,801
3854-7,Nicotine [Mass/volume] in Urine,Nicotine Ur-mCnc,DRUG/TOX,802
16131-5,Herpes simplex virus 2 DNA [Presence] in Unspecified specimen by Probe & target amplification method,HSV2 DNA XXX Ql PCR,MICRO,803
13954-3,Hepatitis B virus e Ag [Presence] in Serum by Immunoassay,HBV e Ag SerPl Ql IA,MICRO,804
26446-5,Blasts/100 leukocytes in Blood,Blasts/leuk NFr Bld,HEM/BC,805
7792-5,Dohle body [Presence] in Blood by Light microscopy,Dohle Bod Bld Ql Smear,HEM/BC,806
2529-6,Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid,LDH Fld-cCnc,Chem,807
41399-7,Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum by Immunoassay,HSV1+2 IgM Ser IA-aCnc,MICRO,808
3034-6,Transferrin [Mass/volume] in Serum or Plasma,Transferrin SerPl-mCnc,Chem,809
10900-9,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,HBV surface Ab Ser Ql IA,MICRO,810
3284-7,Lupus anticoagulant neutralization platelet [Time] in Platelet poor plasma by Coagulation assay,LA Nt Platelet PPP,COAG,811
3414-0,Buprenorphine [Presence] in Urine,Buprenorphine Ur Ql,DRUG/TOX,812
20404-0,Fibronectin.fetal [Presence] in Vaginal fluid,Fibronectin Fetal Vag Ql,Chem,813
10998-3,Oxycodone [Presence] in Urine,Oxycodone Ur Ql,DRUG/TOX,814
10976-9,6-Monoacetylmorphine (6-MAM) [Presence] in Urine,6MAM Ur Ql,DRUG/TOX,815
2141-0,Corticotropin [Mass/volume] in Plasma,ACTH Plas-mCnc,Chem,816
13046-8,Lymphocytes Variant/100 leukocytes in Blood,Variant Lymphs/leuk NFr Bld,HEM/BC,817
5351-2,Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoassay,ENA SS-A Ab Ser Ql IA,SERO,818
6412-1,Giardia lamblia Ag [Presence] in Stool by Immunoassay,G lamblia Ag Stl Ql IA,MICRO,819
2614-6,Methemoglobin/Hemoglobin.total in Blood,MetHgb MFr Bld,Chem,820
5353-8,Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoassay,ENA SS-B Ab Ser Ql IA,SERO,821
2915-7,Renin [Enzymatic activity/volume] in Plasma,Renin Plas-cCnc,Chem,822
27416-7,SCL-70 extractable nuclear Ab [Units/volume] in Serum,ENA Scl70 Ab Ser-aCnc,SERO,823
6565-6,Trichomonas vaginalis [Identifier] in Genital specimen by Wet preparation,T vaginalis Genital Ql Wet Prep,MICRO,824
21003-9,Fungus identified in Unspecified specimen by Fungus stain,Fungus XXX Fungus Stn,MICRO,825
5639-0,Ethanol [Presence] in Blood,Ethanol Bld Ql,DRUG/TOX,826
6182-0,Mucor racemosus IgE Ab [Units/volume] in Serum,M racemosus IgE Qn,Allergy,827
49544-0,Newborn screening recommended follow-up [interpretation],NB screen recommended f/u Patient-Imp,Chem,828
3297-9,Acetaminophen [Presence] in Serum or Plasma,APAP SerPl Ql,DRUG/TOX,829
5177-1,Helicobacter pylori IgM Ab [Units/volume] in Serum by Immunoassay,H pylori IgM Ser IA-aCnc,MICRO,830
13516-0,Neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count,Neutrophils/leuk NFr CSF Manual,HEM/BC,831
4023-8,Salicylates [Presence] in Serum or Plasma,Salicylates SerPl Ql,DRUG/TOX,832
2193-1,Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma,DHEA SerPl-mCnc,Chem,833
30243-0,Choriogonadotropin.intact [Units/volume] in Serum or Plasma,HGC Intact SerPl-aCnc,Chem,834
1518-0,Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO,Glucose 2h p 75 g Glc PO SerPl-mCnc,CHAL,835
4547-6,Hemoglobin A1/Hemoglobin.total in Blood,Hgb A1 MFr Bld,HEM/BC,836
51724-3,Cefuroxime [Susceptibility],Cefuroxime Susc Islt,ABXBACT,837
15061-5,Erythropoietin (EPO) [Units/volume] in Serum or Plasma,EPO SerPl-aCnc,Chem,838
6152-3,Johnson grass IgE Ab [Units/volume] in Serum,Johnson grass IgE Qn,Allergy,839
46735-7,Endocrine disorders newborn screen interpretation,Endocrine Disorders DBS-Imp,Chem,840
6252-1,Stemphylium botryosum IgE Ab [Units/volume] in Serum,S botryosum IgE Qn,Allergy,841
32286-7,Hepatitis C virus genotype [Identifier] in Serum or Plasma by Probe & target amplification method,HCV Gentyp SerPl PCR,MICRO,842
17948-1,Fungus # 3 identified in Unspecified specimen by Culture,Fungus XXX Cult org #3,MICRO,843
5199-5,Hepatitis C virus Ab [Presence] in Serum by Immunoblot (IB),HCV Ab Ser Ql IB,MICRO,844
17947-3,Fungus # 2 identified in Unspecified specimen by Culture,Fungus XXX Cult org #2,MICRO,845
17949-9,Fungus # 4 identified in Unspecified specimen by Culture,Fungus XXX Cult org #4,MICRO,846
42637-9,Natriuretic peptide B [Mass/volume] in Blood,BNP Bld-mCnc,Chem,847
9327-8,Phosphatidylserine IgM Ab [Presence] in Serum by Immunoassay,PS IgM Ser Ql IA,COAG,848
9813-7,Cortisol [Mass/volume] in Serum or Plasma --morning specimen,Cortis AM peak SerPl-mCnc,Chem,849
1668-3,17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma,17OHP SerPl-mCnc,Chem,850
14604-3,Blood group antibodies present [Identifier] in Serum or Plasma from Blood product unit,Blood group antibodies SerPl BPU,BLDBK,851
20513-8,Turbidity [Presence] of Body fluid,Turbidity Fld Ql,SPEC,852
48035-0,Hemoglobin [Presence] in Cerebral spinal fluid,Hgb CSF Ql,HEM/BC,853
1825-9,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,A1AT SerPl-mCnc,Chem,854
5213-4,Heterophile Ab [Presence] in Serum by Latex agglutination,Heteroph Ab Ser Ql LA,MICRO,855
13440-3,Immunofixation [interpretation] for Urine,Interpretation Ur IFE-Imp,Chem,856
6039-2,Beef IgE Ab [Units/volume] in Serum,Beef IgE Qn,Allergy,857
18929-0,Gentamicin.high potency [Susceptibility],Gentamicin Synergy Susc Islt,ABXBACT,858
17862-4,Calcium [Mass/volume] in Urine,Calcium Ur-mCnc,Chem,859
6034-3,Bahia grass IgE Ab [Units/volume] in Serum,Bahia grass IgE Qn,Allergy,860
5358-7,Smooth muscle Ab [Titer] in Serum by Immunofluorescence,Smooth muscle Ab Titr Ser IF,SERO,861
5388-4,Toxoplasma gondii IgG Ab [Units/volume] in Serum by Immunoassay,T gondii IgG SerPl IA-aCnc,MICRO,862
27948-9,Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum by Immunoassay,HSV1+2 IgG Ser IA-aCnc,MICRO,863
9439-1,Casts [#/area] in Urine sediment by Microscopy high power field,Casts #/area UrnS HPF,UA,864
2745-8,pH of Capillary blood,pH BldC,Chem,865
33022-5,Carbon dioxide [Partial pressure] in Capillary blood by Transcutaneous CO2 monitor,pCO2 BldC TcCo2,Chem,866
13438-7,Protein Fractions [interpretation] in Urine by Electrophoresis,Prot Pattern Ur Elph-Imp,Chem,867
8117-4,CD19 cells/100 cells in Blood,CD19 Cells NFr Bld,CELLMARK,868
38527-8,Number of specimens received of Stool,# Spec Recd Stl,SPEC,869
35597-4,Salicylates [Mass/volume] in Serum or Plasma by Screen method,Salicylates SerPl Scn-mCnc,DRUG/TOX,870
3665-7,Gentamicin [Mass/volume] in Serum or Plasma --trough,Gentamicin Trough SerPl-mCnc,DRUG/TOX,871
1501-6,Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO,Glucose 1h p 100 g Glc PO SerPl-mCnc,CHAL,872
13527-7,Unidentified cells/100 leukocytes in Cerebral spinal fluid by Manual count,Unident Cells/leuk NFr CSF Manual,HEM/BC,873
32765-0,Yeast [Presence] in Unspecified specimen by Wet preparation,Yeast XXX Ql Wet Prep,MICRO,874
20563-3,Carboxyhemoglobin/Hemoglobin.total in Blood,COHgb MFr Bld,Chem,875
1507-3,Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO,Glucose 1h p 75 g Glc PO SerPl-mCnc,CHAL,876
14836-1,Methotrexate [Moles/volume] in Serum or Plasma,MTX SerPl-sCnc,DRUG/TOX,877
6924-5,Gliadin IgA Ab [Units/volume] in Serum,Gliadin IgA Ser-aCnc,SERO,878
18983-7,Streptomycin.high potency [Susceptibility],Streptomycin High Pot Susc Islt,ABXBACT,879
20437-0,Glucose [Mass/volume] in Serum or Plasma --3 hours post dose glucose,Glucose 3h p Glc SerPl-mCnc,CHAL,880
5876-8,Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunoassay,RSV Ag XXX Ql IA,MICRO,881
56490-6,Hemoglobin.gastrointestinal [Presence] in Stool by Immunologic method --2nd specimen,Occult Bld sp2 Stl Ql Imm,Chem,882
56491-4,Hemoglobin.gastrointestinal [Presence] in Stool by Immunologic method --3rd specimen,Occult Bld sp3 Stl Ql Imm,Chem,883
20436-2,Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucose,Glucose 2h p Glc SerPl-mCnc,CHAL,884
8665-2,Date last menstrual period,LMP Start date,H&P.HX,885
27819-2,Protein C actual/normal in Platelet poor plasma by Coagulation assay,Prot C Act/Nor PPP,COAG,886
5076-5,Cardiolipin IgA Ab [Units/volume] in Serum by Immunoassay,Cardiolipin IgA Ser IA-aCnc,COAG,887
26486-1,Monocytes/100 leukocytes in Cerebral spinal fluid,Monocytes/leuk NFr CSF,HEM/BC,888
1884-6,Apolipoprotein B [Mass/volume] in Serum or Plasma,Apo B SerPl-mCnc,Chem,889
29953-7,Nuclear Ab [Titer] in Serum,ANA Titr Ser,SERO,890
7291-8,Whole Egg IgE Ab [Units/volume] in Serum,Whole Egg IgE Qn,Allergy,891
5645-7,Ethanol [Mass/volume] in Urine,Ethanol Ur-mCnc,DRUG/TOX,892
11545-1,Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain,Acid fast Stn XXX,MICRO,893
6473-3,Microscopic observation [Identifier] in Tissue by Trichrome stain,Tri Stn Tiss,MICRO,894
20460-2,Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC),Cefuroxime Oral Islt MIC,ABXBACT,895
1514-9,Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO,Glucose 2h p 100 g Glc PO SerPl-mCnc,CHAL,896
21033-6,Yeast.budding [Presence] in Urine sediment,Yeast Budding UrnS Ql,UA,897
19941-4,Oxygen gas flow Oxygen delivery system,Gas flow.O2 O2 delivery sys,PULM,898
6073-1,Chocolate IgE Ab [Units/volume] in Serum,Chocolate IgE Qn,Allergy,899
12208-5,Eosinophils/100 leukocytes in Cerebral spinal fluid by Manual count,Eosinophil/leuk NFr CSF Manual,HEM/BC,900
12278-8,Neutrophils.band form/100 leukocytes in Cerebral spinal fluid by Manual count,Neuts Band/leuk NFr CSF Manual,HEM/BC,901
6874-2,Calcium [Mass/time] in 24 hour Urine,Calcium 24h Ur-mRate,Chem,902
13519-4,Basophils/100 leukocytes in Cerebral spinal fluid by Manual count,Basophils/leuk NFr CSF Manual,HEM/BC,903
3160-9,Volume of Semen,Specimen vol Smn,FERT,904
38908-0,Poikilocytosis [Presence] in Blood by Automated count,Poikilocytosis Bld Ql Auto,HEM/BC,905
13517-8,Lymphocytes Variant/100 leukocytes in Cerebral spinal fluid by Manual count,Variant Lymphs/leuk NFr CSF Manual,HEM/BC,906
20505-4,Bilirubin [Mass/volume] in Urine by Test strip,Bilirub Ur Strip-mCnc,UA,907
13529-3,Nucleated erythrocytes [#/volume] in Cerebral spinal fluid by Manual count,nRBC # CSF Manual,HEM/BC,908
10329-1,Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count,Monocytes/leuk NFr CSF Manual,HEM/BC,909
26472-1,Leukocytes other/100 leukocytes in Cerebral spinal fluid,WBC Other/leuk NFr CSF,HEM/BC,910
13508-7,Hematocrit [Volume Fraction] of Cerebral spinal fluid by Centrifugation,Hct VFr CSF Spun,HEM/BC,911
11135-1,Appearance of Spun Cerebral spinal fluid,Appearance spun CSF,SPEC,912
13525-1,Nonhematic cells/100 leukocytes in Cerebral spinal fluid by Manual count,Nonhematic Cells/leuk NFr CSF Manual,HEM/BC,913
1530-5,Glucose [Mass/volume] in Serum or Plasma --3 hours post 100 g glucose PO,Glucose 3h p 100 g Glc PO SerPl-mCnc,CHAL,914
28008-1,Cytomegalovirus DNA [Presence] in Blood by Probe & signal amplification method,CMV DNA Bld Ql bDNA,MICRO,915
6244-8,Sheep Sorrel IgE Ab [Units/volume] in Serum,Sheep Sorrel IgE Qn,Allergy,916
6219-0,Pork IgE Ab [Units/volume] in Serum,Pork IgE Qn,Allergy,917
11050-2,Immunoglobulin light chains.kappa [Mass/volume] in Serum,Kappa LC SerPl-mCnc,Chem,918
783-1,Promyelocytes/100 leukocytes in Blood by Manual count,Promyelocytes/leuk NFr Bld Manual,HEM/BC,919
2254-1,Estrogen [Mass/volume] in Serum or Plasma,Estrogen SerPl-mCnc,Chem,920
11064-3,Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis,BUN p dialysis SerPl-mCnc,Chem,921
6273-7,Walnut IgE Ab [Units/volume] in Serum,Walnut IgE Qn,Allergy,922
14638-1,Calculus analysis [interpretation] in Stone,Stone Analysis-Imp,Chem,923
8191-9,Cocaine [Presence] in Serum or Plasma by Screen method,Cocaine SerPl Ql Scn,DRUG/TOX,924
13068-2,Nuclear Ab pattern [interpretation] in Serum by Immunofluorescence,ANA Pat Ser IF-Imp,SERO,925
8149-7,Amphetamines [Presence] in Serum or Plasma by Screen method,Amphetamines SerPl Ql Scn,DRUG/TOX,926
6153-1,Kentucky blue grass IgE Ab [Units/volume] in Serum,Kent blue grass IgE Qn,Allergy,927
20438-8,Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucose,Glucose 1h p Glc SerPl-mCnc,CHAL,928
26524-9,Promyelocytes/100 leukocytes in Blood,Promyelocytes/leuk NFr Bld,HEM/BC,929
8234-7,Phencyclidine [Presence] in Meconium by Screen method,PCP Mec Ql Scn,DRUG/TOX,930
11065-0,Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis,BUN pre dial SerPl-mCnc,Chem,931
19141-1,Propoxyphene [Presence] in Urine,Propoxyph Ur Ql,DRUG/TOX,932
19415-9,Tetrahydrocannabinol [Presence] in Urine by Screen method,THC Ur Ql Scn,DRUG/TOX,933
35741-8,Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit = 0.01 ng/mL,PSA SerPl DL<=0.01 ng/mL-mCnc,Chem,934
6265-3,Timothy IgE Ab [Units/volume] in Serum,Timothy IgE Qn,Allergy,935
6233-1,Rough Pigweed IgE Ab [Units/volume] in Serum,Rough Pigweed IgE Qn,Allergy,936
4090-7,Vancomycin [Mass/volume] in Serum or Plasma --peak,Vancomycin Peak SerPl-mCnc,DRUG/TOX,937
2026-3,"Carbon dioxide, total [Moles/volume] in Arterial blood",CO2 BldA-sCnc,Chem,938
2714-4,Fractional oxyhemoglobin in Arterial blood,OxyHgb MFr BldA,Chem,939
22131-7,Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum,B burgdor IgG+IgM Ser Ql,MICRO,940
5404-9,Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay,VZV IgM Ser IA-aCnc,MICRO,941
2923-1,Retinol [Mass/volume] in Serum or Plasma,Vit A SerPl-mCnc,Chem,942
33718-8,Cytology report of Tissue fine needle aspirate Cyto stain,Cytology Tiss FNA Doc Cyto,CYTO,943
8112-5,CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood,CD3-CD16+CD56+ Cells NFr Bld,CELLMARK,944
19774-9,Cytology study comment Cervical or vaginal smear or scraping Cyto stain,Cytology Cmnt Cvx/Vag Cyto-Imp,CYTO,945
19128-8,Bacteria identified in Catheter tip by Culture,Bacteria Cath Tip Cult,MICRO,946
6281-0,White mulberry IgE Ab [Units/volume] in Serum,White mulberry IgE Qn,Allergy,947
24013-5,HIV 1 RNA [interpretation] in Serum,HIV1 RNA Ser-Imp,MICRO,948
17780-8,Helicobacter pylori Ag [Presence] in Stool by Immunoassay,H pylori Ag Stl Ql IA,MICRO,949
13169-8,Immunoelectrophoresis [interpretation] for Serum or Plasma,Interpretation SerPl IEP-Imp,Chem,950
15210-8,Thyroglobulin Ab [Presence] in Serum,Thyroglob Ab Ser Ql,SERO,951
4532-8,Complement total hemolytic CH50 [Units/volume] in Serum or Plasma,CH50 SerPl-aCnc,HEM/BC,952
2748-2,pH of Body fluid,pH Fld,Chem,953
26513-2,Neutrophils/100 leukocytes in Body fluid,Neutrophils/leuk NFr Fld,HEM/BC,954
8130-7,CD45 (Lymphs) cells/100 cells in Blood,CD45 Cells NFr Bld,CELLMARK,955
11276-3,Tubular cells [Presence] in Urine sediment by Light microscopy,Tubular Cells UrnS Ql Micro,UA,956
6948-4,Lamotrigine [Mass/volume] in Serum or Plasma,Lamotrigine SerPl-mCnc,DRUG/TOX,957
29641-8,Neutrophil Cytoplasmic Ab atypical [Presence] in Serum by Immunofluorescence,Atyp ANCA Ser Ql IF,SERO,958
5034-4,Streptococcus agalactiae rRNA [Presence] in Unspecified specimen by DNA probe,Gp B Strep rRNA XXX Ql Prb,MICRO,959
773-2,Nucleated erythrocytes/100 erythrocytes in Blood by Manual count,nRBC/100 RBC NFr Bld Manual,HEM/BC,960
35383-9,Galactomannan Ag [Units/volume] in Serum or Plasma,Galactomannan Ag SerPl-aCnc,MICRO,961
22587-0,Treponema pallidum Ab [Presence] in Serum,T pallidum Ab Ser Ql,MICRO,962
6178-8,Mountain Juniper IgE Ab [Units/volume] in Serum,Mt Juniper IgE Qn,Allergy,963
11266-4,Streptococcus agalactiae Ag [Presence] in Unspecified specimen,Gp B Strep Ag XXX Ql,MICRO,964
3663-2,Gentamicin [Mass/volume] in Serum or Plasma --peak,Gentamicin Peak SerPl-mCnc,DRUG/TOX,965
1927-3,Base excess in Venous blood,Base excess BldV Calc-sCnc,Chem,966
5247-2,Mitochondria Ab [Titer] in Serum by Immunofluorescence,Mitochondria Ab Titr Ser IF,SERO,967
5126-8,Cytomegalovirus IgM Ab [Units/volume] in Serum by Immunoassay,CMV IgM Ser IA-aCnc,MICRO,968
48378-4,Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free [Mass Ratio] in Serum,Kappa LC Free/Lambda Free Ser,Chem,969
15069-8,Fructosamine [Moles/volume] in Serum or Plasma,Fructosamine SerPl-sCnc,Chem,970
15218-1,Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multidisk,Food Allerg Mix2 IgE Ql,Allergy,971
28005-7,MTHFR gene p.C677T [Presence] in Blood or Tissue by Molecular genetics method,MTHFR c.677C>T Bld/T Ql,MOLPATH.MUT,972
8014-3,Rubella virus IgG Ab [Units/volume] in Serum,RUBV IgG Ser-aCnc,MICRO,973
14912-0,Smudge cells/100 leukocytes in Blood by Manual count,Smudge Cells/leuk NFr Bld Manual,HEM/BC,974
12230-9,Macrophages/100 leukocytes in Body fluid by Manual count,Macrophages/leuk NFr Fld Manual,HEM/BC,975
27038-9,Endomysium IgA Ab [Titer] in Serum by Immunofluorescence,Endomysium IgA Titr Ser IF,SERO,976
20573-2,Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Complement fixation,H capsul Myc Ab Titr Ser CF,MICRO,977
6246-3,Shrimp IgE Ab [Units/volume] in Serum,Shrimp IgE Qn,Allergy,978
42176-8,"1,3 beta glucan [Mass/volume] in Serum","1,3 beta glucan Ser-mCnc",MICRO,979
19075-1,Cells Counted Total [#] in Cerebral spinal fluid,Total Cells Counted CSF,HEM/BC,980
33910-1,Rheumatoid factor [Presence] in Serum,Rheumatoid fact Ser Ql,SERO,981
9822-8,Bacteria identified in Dialysis fluid by Culture,Bacteria Dial fld Cult,MICRO,982
931-6,Blood product source [Type],Bld Prod Source BPU,BLDBK,983
32140-6,Hemoglobin F [Presence] in Blood by Kleihauer-Betke method,Hgb F Bld Ql Kleih Betke,HEM/BC,984
53982-5,Centromere protein B Ab [Units/volume] in Serum,Centromere B Ab Ser-aCnc,SERO,985
51775-5,Chromatin Ab [Units/volume] in Serum or Plasma,Chromatin Ab SerPl-aCnc,SERO,986
19295-5,Opiates [Presence] in Urine by Screen method,Opiates Ur Ql Scn,DRUG/TOX,987
24011-9,Hepatitis C virus Ab band pattern [interpretation] in Serum by Immunoblot (IB),HCV Ab Patrn Ser IB-Imp,MICRO,988
5187-0,Hepatitis B virus core Ab [Units/volume] in Serum by Immunoassay,HBV core Ab Ser IA-aCnc,MICRO,989
2963-7,Somatotropin [Mass/volume] in Serum or Plasma,GH SerPl-mCnc,Chem,990
13530-1,Nucleated erythrocytes [#/volume] in Body fluid by Manual count,nRBC # Fld Manual,HEM/BC,991
6082-2,Codfish IgE Ab [Units/volume] in Serum,Codfish IgE Qn,Allergy,992
6156-4,Goosefoot IgE Ab [Units/volume] in Serum,Goosefoot IgE Qn,Allergy,993
6186-1,Nettle IgE Ab [Units/volume] in Serum,Nettle IgE Qn,Allergy,994
11565-9,Jo-1 extractable nuclear Ab [Units/volume] in Serum,ENA Jo1 Ab Ser-aCnc,SERO,995
30376-8,Blasts [#/volume] in Blood,Blasts # Bld,HEM/BC,996
35676-6,Chloride [Moles/volume] in unspecified time Urine,Chloride ?Tm Ur-sCnc,Chem,997
32637-1,Urease [Presence] in Tissue,Urease Tiss Ql,MICRO,998
46248-1,Borrelia burgdorferi IgG & IgM [interpretation] in Serum by Immunoassay,B burgdor IgG+IgM Ser IA-Imp,MICRO,999
1721-0,Adenosine triphosphate [Mass/volume] in Blood,ATP Bld-mCnc,Chem,1000
9780-8,Spermatozoa [#/volume] in Semen,Sperm # Smn,FERT,1001
6002-0,Platelet factor 4 [Units/volume] in Platelet poor plasma,PF4 PPP-aCnc,COAG,1002
6014-5,von Willebrand factor (vWf) ristocetin cofactor actual/normal in Platelet poor plasma by Aggregation,vWf:RCo Act/Nor PPP Aggr,COAG,1003
20475-0,Cytomegalovirus IgG Ab [interpretation] in Serum,CMV IgG Ser-Imp,MICRO,1004
33248-6,Diabetes status [Identifier],Diabetes status Patient,MISC,1005
33006-8,Cytomegalovirus DNA [#/volume] (viral load) in Unspecified specimen by Probe & target amplification method,CMV DNA # XXX PCR,MICRO,1006
22415-4,Mumps virus IgG Ab [Presence] in Serum,MuV IgG Ser Ql,MICRO,1007
6476-6,Mumps virus IgG Ab [Presence] in Serum by Immunoassay,MuV IgG Ser Ql IA,MICRO,1008
49053-2,History of neural tube defect Narrative,Hx of NTD Narr,Chem,1009
21024-5,Pathologist interpretation of Cerebral spinal fluid tests,Path Interp CSF-Imp,PATH,1010
38506-2,Thyroxine (T4) [Presence] in Dried blood spot,T4 DBS Ql,Chem,1011
13522-8,Blasts/100 leukocytes in Body fluid by Manual count,Blasts/leuk NFr Fld Manual,HEM/BC,1012
5274-6,Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay,B19V IgM Ser IA-aCnc,MICRO,1013
5273-8,Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay,B19V IgG Ser IA-aCnc,MICRO,1014
13992-3,Albumin/Protein.total in Urine by Electrophoresis,Albumin MFr Ur Elph,Chem,1015
5393-4,Treponema pallidum Ab [Presence] in Serum by Immunofluorescence,T pallidum Ab Ser Ql IF,MICRO,1016
13990-7,Alpha 1 globulin/Protein.total in Urine by Electrophoresis,Alpha1 Glob MFr Ur Elph,Chem,1017
801-1,Sickle cells [Presence] in Blood by Light microscopy,Sickle Cells Bld Ql Smear,HEM/BC,1018
5568-1,Acetone [Mass/volume] in Serum or Plasma,Acetone SerPl-mCnc,DRUG/TOX,1019
7407-0,White Hickory IgE Ab [Units/volume] in Serum,White Hickory IgE Qn,Allergy,1020
46420-6,Leukocyte clumps [#/area] in Urine sediment by Microscopy high power field,WBC clumps #/area UrnS HPF,UA,1021
30471-7,Levetiracetam [Mass/volume] in Serum or Plasma,Levetiracetam SerPl-mCnc,DRUG/TOX,1022
40750-2,Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunofluorescence,EBV VCA IgG Ser Ql IF,MICRO,1023
6019-4,Almond IgE Ab [Units/volume] in Serum,Almond IgE Qn,Allergy,1024
41874-9,White Birch IgE Ab [Units/volume] in Serum,White Birch IgE Qn,Allergy,1025
2466-1,IgG subclass 1 [Mass/volume] in Serum,IgG1 Ser-mCnc,Chem,1026
6968-2,Proteinase 3 Ab [Units/volume] in Serum,Proteinase3 Ab Ser-aCnc,SERO,1027
42768-2,HIV 1 & 2 Ab [interpretation] in Serum Narrative,HIV 1 & 2 Ab Ser-Imp,MICRO,1028
16126-5,Helicobacter pylori IgG Ab [Presence] in Serum,H pylori IgG Ser Ql,MICRO,1029
11258-1,Hepatitis B virus DNA [Units/volume] in Serum,HBV DNA Ser-aCnc,MICRO,1030
667-6,Microscopic observation [Identifier] in Unspecified specimen by KOH preparation,KOH Prep XXX,MICRO,1031
1747-5,Albumin [Mass/volume] in Body fluid,Albumin Fld-mCnc,Chem,1032
9586-9,Borrelia burgdorferi Ab [interpretation] in Serum,B burgdor Ab Ser-Imp,MICRO,1033
681-7,Microscopic observation [Identifier] in Unspecified specimen by Wright stain,Wright Stn XXX,MICRO,1034
6942-7,Albumin [Mass/volume] in Urine by Electrophoresis,Albumin Ur Elph-mCnc,Chem,1035
6969-0,Myeloperoxidase Ab [Units/volume] in Serum,Myeloperoxidase Ab Ser-aCnc,SERO,1036
6183-8,Mugwort IgE Ab [Units/volume] in Serum,Mugwort IgE Qn,Allergy,1037
3719-2,Lithium [Mass/volume] in Serum or Plasma,Lithium SerPl-mCnc,DRUG/TOX,1038
2469-5,IgG subclass 4 [Mass/volume] in Serum,IgG4 Ser-mCnc,Chem,1039
2467-9,IgG subclass 2 [Mass/volume] in Serum,IgG2 Ser-mCnc,Chem,1040
2468-7,IgG subclass 3 [Mass/volume] in Serum,IgG3 Ser-mCnc,Chem,1041
32146-3,Platelets Large [Presence] in Blood by Light microscopy,Lg Platelets Bld Ql Smear,HEM/BC,1042
14277-8,Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence,c-ANCA Titr Ser IF,SERO,1043
14278-6,Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence,p-ANCA Titr Ser IF,SERO,1044
17864-0,Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE),Ca-I SerPl ISE-mCnc,Chem,1045
48344-6,Kaolin activated time in Platelet poor plasma,ACT PPP Kaolin induc,COAG,1046
28637-7,Base deficit in Venous cord blood,Base deficit BldCoV-sCnc,Chem,1047
18500-9,Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep,Thin Prep Cvx,CYTO,1048
13987-3,Alpha 2 globulin/Protein.total in 24 hour Urine by Electrophoresis,Alpha2 Glob 24h MFr Ur Elph,Chem,1049
13989-9,Gamma globulin/Protein.total in 24 hour Urine by Electrophoresis,Gamma glob 24h MFr Ur Elph,Chem,1050
78012-2,Streptococcus pyogenes Ag [Presence] in Throat by Rapid immunoassay,S pyo Ag Throat Ql IA.rapid,MICRO,1051
34661-9,Actin IgG Ab [Units/volume] in Serum or Plasma,Actin IgG SerPl-aCnc,SERO,1052
41274-2,Alpha-1-Fetoprotein interpretation [interpretation] in Serum or Plasma,AFP Interp SerPl-Imp,Chem,1053
33719-6,Flow cytometry study,,ATTACH.CLINRPT,1054
5158-1,Epstein Barr virus capsid IgG Ab [Titer] in Serum by Immunofluorescence,EBV VCA IgG Titr Ser IF,MICRO,1055
24476-4,F2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,F2 gene Mut Anal Bld/T,MOLPATH.MUT,1056
3052-8,Triiodothyronine (T3).reverse [Mass/volume] in Serum or Plasma,T3Reverse SerPl-mCnc,Chem,1057
25700-6,Immunofixation [interpretation] for Serum or Plasma,Interpretation SerPl IFE-Imp,Chem,1058
4049-3,Theophylline [Mass/volume] in Serum or Plasma,Theophylline SerPl-mCnc,DRUG/TOX,1059
11878-6,Number of fetuses by US,# Fetuses US,OB.US,1060
2147-7,Cortisol Free [Mass/time] in 24 hour Urine,Cortis F 24h Ur-mRate,Chem,1061
21020-3,Bacteria identified in Unspecified specimen by Anaerobe+Aerobe culture,Bacteria XXX Anaerobe+Aerobe Cult,MICRO,1062
19108-0,Histoplasma capsulatum Ag [Presence] in Serum,H capsul Ag Ser Ql,MICRO,1063
44525-4,Histoplasma capsulatum Ag [Presence] in Serum by Immunoassay,H capsul Ag Ser Ql IA,MICRO,1064
2115-4,Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma,B-HCG Free SerPl-sCnc,Chem,1065
32167-9,Clarity of Urine,Clarity Ur,SPEC,1066
26518-1,Polymorphonuclear cells/100 leukocytes in Body fluid,Polys/leuk NFr Fld,HEM/BC,1067
19076-9,Cells Counted Total [#] in Unspecified specimen,Total Cells Counted XXX,HEM/BC,1068
33673-5,Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of protamine sulfate,TT imm SO4 PPP,COAG,1069
32133-1,Lactate [Moles/volume] in Plasma venous,Lactate PlasV-sCnc,Chem,1070
12286-1,Drugs identified in Urine by Screen method,Drugs Ur Scn,DRUG/TOX,1071
6263-8,American Sycamore IgE Ab [Units/volume] in Serum,Amer Sycamore IgE Qn,Allergy,1072
5095-5,Coccidioides immitis Ab [Presence] in Serum by Immune diffusion (ID),C immitis Ab Ser Ql ID,MICRO,1073
8187-7,Benzoylecgonine [Presence] in Meconium,BZE Mec Ql,DRUG/TOX,1074
13994-9,Beta globulin/Protein.total in Urine by Electrophoresis,B-Globulin MFr Ur Elph,Chem,1075
26523-1,Promyelocytes [#/volume] in Blood,Promyelocytes # Bld,HEM/BC,1076
6098-8,Dog dander IgE Ab [Units/volume] in Serum,Dog Dander IgE Qn,Allergy,1077
22310-7,Helicobacter pylori Ab [Presence] in Serum,H pylori Ab Ser Ql,MICRO,1078
20124-4,Ventilation mode [Identifier] Ventilator,Ventilation mode Vent,PULM,1079
6107-7,Egg yolk IgE Ab [Units/volume] in Serum,Egg Yolk IgE Qn,Allergy,1080
6604-3,Influenza virus identified in Unspecified specimen by Organism specific culture,FLUV XXX Cult,MICRO,1081
28647-6,pH of Venous cord blood,pH BldCoV,Chem,1082
6800-7,Spermatozoa Motile/100 spermatozoa in Semen,Sperm Motile NFr Smn,FERT,1083
6718-1,Cashew Nut IgE Ab [Units/volume] in Serum,Cashew nut IgE Qn,Allergy,1084
5181-3,Hepatitis A virus IgM Ab [Units/volume] in Serum by Immunoassay,HAV IgM Ser IA-aCnc,MICRO,1085
1961-2,Bicarbonate [Moles/volume] in Capillary blood,HCO3 BldC-sCnc,Chem,1086
28646-8,pH of Arterial cord blood,pH BldCoA,Chem,1087
11051-0,Immunoglobulin light chains.lambda [Mass/volume] in Serum,Lambda LC SerPl-mCnc,Chem,1088
32032-5,Phosphatidylserine IgG Ab [Units/volume] in Serum by Immunoassay,PS IgG Ser IA-aCnc,COAG,1089
18488-7,Calcium [Mass/volume] in 24 hour Urine,Calcium 24h Ur-mCnc,Chem,1090
7793-3,Howell-Jolly bodies [Presence] in Blood by Light microscopy,Howell-Jolly Bod Bld Ql Smear,HEM/BC,1091
35668-3,Gentamicin [Mass/volume] in Serum or Plasma,Gentamicin SerPl-mCnc,DRUG/TOX,1092
11274-8,Elliptocytes [Presence] in Blood by Light microscopy,Elliptocytes Bld Ql Smear,HEM/BC,1093
46995-7,HLA-DP+DQ+DR (class II) Ab in Serum,HLA-DP+DQ+DR Ab NFr Ser,HLA,1094
46994-0,HLA-A+B+C (class I) Ab in Serum,HLA-A+B+C Ab NFr Ser,HLA,1095
6208-3,Pecan or Hickory Nut IgE Ab [Units/volume] in Serum,Pecan/Hick Nut IgE Qn,Allergy,1096
17851-7,Herpes simplex virus 2 IgG Ab [Presence] in Serum,HSV2 IgG Ser Ql,MICRO,1097
43180-9,Herpes simplex virus 2 IgG Ab [Presence] in Serum by Immunoassay,HSV2 IgG SerPl Ql IA,MICRO,1098
30166-3,Thyroid stimulating immunoglobulins actual/normal in Serum,TSI Act/Nor Ser,Chem,1099
9631-3,Viscosity of Semen,Visc Smn,SPEC,1100
10585-8,Round cells [#/volume] in Semen,Rnd Cells # Smn,FERT,1101
33217-1,Spermatozoa Agglutinated [Presence] in Semen,Sperm Agglutinated Smn Ql,FERT,1102
5218-3,Histoplasma capsulatum Ab [Presence] in Serum by Immune diffusion (ID),H capsul Ab Ser Ql ID,MICRO,1103
27822-6,Protein S actual/normal in Platelet poor plasma by Coagulation assay,Prot S Act/Nor PPP,COAG,1104
17793-1,Immunoglobulin light chains [Mass/volume] in 24 hour Urine,BJ Protein 24h Ur-mCnc,Chem,1105
17850-9,Herpes simplex virus 1 IgG Ab [Presence] in Serum,HSV1 IgG Ser Ql,MICRO,1106
51916-5,Herpes simplex virus 1 IgG Ab [Presence] in Serum by Immunoassay,HSV1 IgG SerPl Ql IA,MICRO,1107
31844-4,Hepatitis B virus e Ag [Presence] in Serum,HBV e Ag Ser Ql,MICRO,1108
20450-3,Alpha-1-Fetoprotein [Multiple of the median] in Serum or Plasma,AFP MoM SerPl,Chem,1109
48343-8,Hemoglobin.other/Hemoglobin.total in Blood,Hgb Other MFr Bld,HEM/BC,1110
5160-7,Epstein Barr virus capsid IgM Ab [Titer] in Serum by Immunofluorescence,EBV VCA IgM Titr Ser IF,MICRO,1111
29615-2,Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method,HBV DNA # SerPl PCR,MICRO,1112
21032-8,Thrombin time [interpretation] in Blood,TT Bld-Imp,COAG,1113
5791-9,Fungi.yeastlike [#/area] in Urine sediment by Microscopy high power field,Yeast Like Fungi #/area UrnS HPF,UA,1114
20423-0,Beta lactamase organism identified in Isolate,B-Lactamase Organism Islt,MICRO,1115
8146-3,Amphetamines [Presence] in Meconium by Screen method,Amphetamines Mec Ql Scn,DRUG/TOX,1116
20991-6,Antithrombin [interpretation] in Platelet poor plasma,AT III PPP-Imp,COAG,1117
33720-4,Blood bank consult,,ATTACH.CLINRPT,1118
2483-6,Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma,IGF BP3 SerPl-mCnc,Chem,1119
34712-0,Clostridium difficile [Presence] in Stool,C dif Stl Ql,MICRO,1120
33594-3,Platelet factor 4 [Presence] in Platelet poor plasma,PF4 PPP Ql,COAG,1121
8169-5,Tetrahydrocannabinol [Presence] in Meconium by Screen method,THC Mec Ql Scn,DRUG/TOX,1122
2258-2,Estrone (E1) [Mass/volume] in Serum or Plasma,Estrone SerPl-mCnc,Chem,1123
17849-1,Reticulocytes/100 erythrocytes in Blood by Automated count,Retics/100 RBC NFr Auto,HEM/BC,1124
8216-4,Opiates [Presence] in Meconium by Screen method,Opiates Mec Ql Scn,DRUG/TOX,1125
27816-8,von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunologic method,vWF Ag Act/Nor PPP IA,COAG,1126
8116-6,CD19 cells [#/volume] in Blood,CD19 Cells # Bld,CELLMARK,1127
7798-2,Smudge cells [Presence] in Blood by Light microscopy,Smudge Cells Bld Ql Smear,HEM/BC,1128
9795-6,Composition in Stone,Compn Stone,PATH,1129
5390-0,Toxoplasma gondii IgM Ab [Units/volume] in Serum by Immunoassay,T gondii IgM Ser IA-aCnc,MICRO,1130
32218-0,Cyclic citrullinated peptide Ab [Units/volume] in Serum by Immunoassay,cCP Ab Ser IA-aCnc,SERO,1131
46266-3,Myeloperoxidase Ab [Units/volume] in Serum by Immunoassay,Myeloperoxidase Ab Ser IA-aCnc,SERO,1132
20479-2,Measles virus IgG Ab [Presence] in Serum,MeV IgG Ser Ql,MICRO,1133
35275-7,Measles virus IgG Ab [Presence] in Serum by Immunoassay,MeV IgG Ser Ql IA,MICRO,1134
5781-0,Crystals [type] in Synovial fluid by Light microscopy,Crystals Snv Micro,HEM/BC,1135
26043-0,HLA-B27 [Presence] by Probe & target amplification method,HLA-B27 Ql PCR,HLA,1136
16136-4,Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum,B2 Glycoprot1 IgM Ser-aCnc,SERO,1137
44449-7,Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum by Immunoassay,B2 Glycoprot1 IgM SerPl IA-aCnc,SERO,1138
19296-3,Opiates tested for in Urine by Screen method Nominal,Opiates Tested Ur Scn,DRUG/TOX,1139
14115-0,Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine,Collagen NTx/Creat Ur-sRto,Chem,1140
1521-4,Glucose [Mass/volume] in Serum or Plasma --2 hours post meal,Glucose 2h p meal SerPl-mCnc,CHAL,1141
5290-2,Reagin Ab [Presence] in Cerebral spinal fluid by VDRL,VDRL CSF Ql,MICRO,1142
5817-2,Urate crystals [Presence] in Urine sediment by Light microscopy,Urate Cry UrnS Ql Micro,UA,1143
46267-1,Proteinase 3 Ab [Units/volume] in Serum by Immunoassay,Proteinase3 Ab Ser IA-aCnc,SERO,1144
2270-7,Fat [Presence] in Stool,Fat Stl Ql,Chem,1145
6278-6,White Ash IgE Ab [Units/volume] in Serum,White Ash IgE Qn,Allergy,1146
7369-2,Perennial rye grass IgE Ab [Units/volume] in Serum,Per rye grass IgE Qn,Allergy,1147
8091-1,Ribonucleoprotein extractable nuclear Ab [Presence] in Serum,ENA RNP Ab Ser Ql,SERO,1148
41222-1,Yeast [Presence] in Body fluid by Light microscopy,Yeast Fld Ql Micro,MICRO,1149
38505-4,Thyroglobulin recovery in Serum or Plasma,Thyroglob Recovery MFr SerPl,Chem,1150
16135-6,Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum,B2 Glycoprot1 IgG Ser-aCnc,SERO,1151
44448-9,Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum by Immunoassay,B2 Glycoprot1 IgG SerPl IA-aCnc,SERO,1152
6076-4,Clam IgE Ab [Units/volume] in Serum,Clam IgE Qn,Allergy,1153
593-4,Legionella sp identified in Unspecified specimen by Organism specific culture,Legionella XXX Cult,MICRO,1154
33437-5,Oxygen [Partial pressure] in Capillary blood by Transcutaneous O2 monitor,pO2 BldC TcO2,Chem,1155
48683-7,Streptococcus agalactiae DNA [Presence] in Unspecified specimen by Probe & target amplification method,Gp B Strep DNA XXX Ql PCR,MICRO,1156
20574-0,Histoplasma capsulatum yeast phase Ab [Titer] in Serum by Complement fixation,H capsul Yst Ab Titr Ser CF,MICRO,1157
49539-0,Cytomegalovirus IgM Ab [Presence] in Serum by Immunofluorescence,CMV IgM Ser Ql IF,MICRO,1158
33721-2,Bone marrow Pathology biopsy report,,ATTACH.CLINRPT,1159
5127-6,Cytomegalovirus IgM Ab [Titer] in Serum by Immunofluorescence,CMV IgM Titr Ser IF,MICRO,1160
33773-3,Karyotype [Identifier] in Amniotic fluid Nominal,Karyotyp Amn,MOLPATH,1161
49051-6,Gestational age in weeks,GA (weeks),OB.US,1162
7789-1,Acanthocytes [Presence] in Blood by Light microscopy,Acanthocytes Bld Ql Smear,HEM/BC,1163
8338-6,Body weight Measured --ante partum,Weight ante partum Measured,BDYWGT.MOLEC,1164
5117-7,Cryoglobulin [Presence] in Serum,Cryoglob Ser Ql,Chem,1165
2752-4,pH of Semen,pH Smn,Chem,1166
15359-3,dRVVT actual/?normal (normalized LA screen),Screen dRVVT/normal,COAG,1167
2077-6,Chloride [Moles/volume] in Sweat,Chloride Sweat-sCnc,Chem,1168
2077-6,Chloride [Moles/volume] in Sweat,Chloride Sweat-sCnc,Chem,1168
41499-5,Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay,L pneumo1 Ag Ur Ql IA,MICRO,1169
3141-9,Body weight Measured,Weight Measured,BDYWGT.ATOM,1170
5348-8,SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoassay,ENA Scl70 Ab Ser Ql IA,SERO,1171
15761-0,Sweetgum IgE Ab RAST class in Serum,Sweet gum IgE RAST Ql,Allergy,1172
2615-3,Methemoglobin/Hemoglobin.total in Arterial blood,MetHgb MFr BldA,Chem,1173
5053-4,Aspergillus sp Ab [Titer] in Serum by Complement fixation,Aspergillus Ab Titr Ser CF,MICRO,1174
33247-8,Weight of Sweat,Specimen wt Sweat Qn,SPEC,1175
5183-9,Hepatitis A virus Ab [Units/volume] in Serum by Immunoassay,HAV Ab SerPl IA-aCnc,MICRO,1176
29893-5,HIV 1 Ab [Presence] in Serum by Immunoassay,HIV1 Ab SerPl Ql IA,MICRO,1177
20465-1,Choriogonadotropin [Multiple of the median] in Serum or Plasma,HCG MoM SerPl,Chem,1178
20466-9,Estriol (E3).unconjugated [Multiple of the median] in Serum or Plasma,u Estriol MoM SerPl,Chem,1179
38404-0,CFTR gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative,CFTR Mut Anal Bld/T,MOLPATH.MUT,1180
27923-2,Ubiquinone 10 [Mass/volume] in Serum or Plasma,Ubiquinone10 SerPl-mCnc,Chem,1181
26512-4,Neutrophils/100 leukocytes in Cerebral spinal fluid,Neutrophils/leuk NFr CSF,HEM/BC,1182
48039-2,Fibronectin.fetal [Presence] in Unspecified specimen,Fibronectin Fetal XXX Ql,Chem,1183
5631-7,Copper [Mass/volume] in Serum or Plasma,Copper SerPl-mCnc,DRUG/TOX,1184
5880-0,Rotavirus Ag [Presence] in Stool by Immunoassay,RV Ag Stl Ql IA,MICRO,1185
2671-6,Normetanephrine [Mass/time] in 24 hour Urine,Normetanephrine 24h Ur-mRate,Chem,1186
1924-0,Base deficit in Venous blood,Base deficit BldV-sCnc,Chem,1187
49573-9,HIV genotype [Susceptibility] in Isolate by Genotype method Narrative,HIV Gentyp Islt Nar,ABXBACT,1188
15191-0,Lupus anticoagulant neutralization dilute phospholipid [Presence] in Platelet poor plasma,LA Nt dPL PPP Ql,COAG,1189
5356-1,Smith extractable nuclear Ab [Presence] in Serum by Immunoassay,ENA SM Ab Ser Ql IA,SERO,1190
23761-0,Neutrophils/100 leukocytes in Blood by Manual count,Neutrophils/leuk NFr Bld Manual,HEM/BC,1191
5297-7,Rheumatoid factor [Presence] in Serum by Latex agglutination,Rheumatoid fact Ser Ql LA,SERO,1192
5301-7,Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay,ENA RNP Ab Ser Ql IA,SERO,1193
9783-2,Ehrlichia chaffeensis IgG Ab [Titer] in Serum,E chaffeensis IgG Titr Ser,MICRO,1194
25156-1,Eosinophils [Presence] in Urine sediment by Light microscopy,Eosinophil UrnS Ql Micro,UA,1195
19839-0,Breath rate spontaneous --on ventilator,Breaths.spontaneous on vent,PULM,1196
2778-9,Phosphate [Mass/volume] in Urine,Phosphate Ur-mCnc,Chem,1197
13988-1,Beta globulin/Protein.total in 24 hour Urine by Electrophoresis,B-Globulin 24h MFr Ur Elph,Chem,1198
4621-9,Hemoglobin S [Presence] in Blood,Hgb S Bld Ql,HEM/BC,1199
26471-3,Leukocytes other/100 leukocytes in Blood,WBC Other/leuk NFr Bld,HEM/BC,1200
46082-4,Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay,FLUAV Ag Nph Ql IA,MICRO,1201
46083-2,Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay,FLUBV Ag Nph Ql IA,MICRO,1202
2357-2,Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells,G6PD RBC-cCnc,Chem,1203
28645-0,Carbon dioxide [Partial pressure] in Venous cord blood,pCO2 BldCoV,Chem,1204
2900-9,Pyridoxine (Vitamin B6) [Mass/volume] in Serum or Plasma,Vit B6 SerPl-mCnc,Chem,1205
5809-9,Reducing substances [Presence] in Urine,Reducing Subs Ur Ql,UA,1206
28649-2,Oxygen [Partial pressure] in Venous cord blood,pO2 BldCoV,Chem,1207
6825-4,Crystals [type] in Body fluid by Light microscopy,Crystals Fld Micro,HEM/BC,1208
20458-6,Rubella virus IgG Ab [interpretation] in Serum,RUBV IgG Ser-Imp,MICRO,1209
27818-4,Protein C actual/normal in Platelet poor plasma by Chromogenic method    *NOTE: enzymatic method,Prot C Act/Nor PPP Chro,COAG,1210
7691-9,Scallop IgE Ab [Units/volume] in Serum,Scallop IgE Qn,Allergy,1211
20474-3,Bacteria identified in Tissue by Biopsy culture,Bacteria Tiss Bx Cult,MICRO,1212
28641-9,Bicarbonate [Moles/volume] in Venous cord blood,HCO3 BldCoV-sCnc,Chem,1213
12234-1,Mesothelial cells/100 leukocytes in Body fluid by Manual count,Mesothl Cell/leuk NFr Fld Manual,HEM/BC,1214
23877-4,Anaplasma phagocytophilum IgG Ab [Titer] in Serum by Immunofluorescence,A phagocytoph IgG Titr Ser IF,MICRO,1215
28644-3,Carbon dioxide [Partial pressure] in Arterial cord blood,pCO2 BldCoA,Chem,1216
2956-1,Sodium [Moles/time] in 24 hour Urine,Sodium 24h Ur-sRate,Chem,1217
28648-4,Oxygen [Partial pressure] in Arterial cord blood,pO2 BldCoA,Chem,1218
14252-1,Smooth muscle Ab [Presence] in Serum,Smooth muscle Ab Ser Ql,SERO,1219
21108-6,Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum,B2 Glycoprot1 IgA Ser-aCnc,SERO,1220
44447-1,Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum by Immunoassay,B2 Glycoprot1 IgA SerPl IA-aCnc,SERO,1221
9784-0,Ehrlichia chaffeensis IgM Ab [Titer] in Serum,E chaffeensis IgM Titr Ser,MICRO,1222
49701-6,pH of Blood adjusted to patients actual temperature,pH temp adj Bld,Chem,1223
6891-6,Testosterone.bioavailable/Testosterone.total in Serum or Plasma,Testosterone.free+WB MFr SerPl,Chem,1224
11261-5,Bacteria identified in Vaginal fluid by Aerobe culture,Bacteria Vag Aerobe Cult,MICRO,1225
23878-2,Anaplasma phagocytophilum IgM Ab [Titer] in Serum by Immunofluorescence,A phagocytoph IgM Titr Ser IF,MICRO,1226
2112-1,Choriogonadotropin.beta subunit (Pregnancy test) [Presence] in Urine,B-HCG Preg Ur Ql,Chem,1227
49047-4,Globulin [Mass/volume] in Urine by Electrophoresis,Globulin Ur Elph-mCnc,Chem,1228
28640-1,Bicarbonate [Moles/volume] in Arterial cord blood,HCO3 BldCoA-sCnc,Chem,1229
1527-1,Glucose [Mass/volume] in Serum or Plasma --30 minutes post 75 g glucose PO,Glucose 30M p 75 g Glc PO SerPl-mCnc,CHAL,1230
10912-4,Lead [Mass/volume] in Serum or Plasma,Lead SerPl-mCnc,DRUG/TOX,1231
57804-7,Number of occult blood specimens recommended by testing kit protocol [#] in Stool,# Occ bld spec recommended Stl,Chem,1232
32207-3,Platelet distribution width [Entitic volume] in Blood by Automated count,PDW Bld Auto,HEM/BC,1233
12190-5,Creatinine [Mass/volume] in Body fluid,Creat Fld-mCnc,Chem,1234
3174-0,Antithrombin [Units/volume] in Platelet poor plasma by Chromogenic method,AT III PPP Chro-aCnc,COAG,1235
33393-0,Coarse Granular Casts [#/area] in Urine sediment by Microscopy low power field,Coarse Gran Casts #/area UrnS LPF,UA,1236
9490-4,Aspergillus flavus Ab [Presence] in Serum,A flavus Ab Ser Ql,MICRO,1237
26447-3,Blasts/100 leukocytes in Cerebral spinal fluid,Blasts/leuk NFr CSF,HEM/BC,1238
8095-2,Smooth muscle Ab [Titer] in Serum,Smooth muscle Ab Titr Ser,SERO,1239
2232-7,Epinephrine [Mass/time] in 24 hour Urine,Epineph 24h Ur-mRate,Chem,1240
6136-6,Hazelnut IgE Ab [Units/volume] in Serum,Hazelnut IgE Qn,Allergy,1241
9660-2,HIV 1 gp160 Ab [Presence] in Serum by Immunoblot (IB),HIV1 gp160 Ab Ser Ql IB,MICRO,1242
2873-8,Gamma globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis,Gamma glob CSF Elph-mCnc,Chem,1243
9668-5,HIV 1 p55 Ab [Presence] in Serum by Immunoblot (IB),HIV1 p55 Ab Ser Ql IB,MICRO,1244
9667-7,HIV 1 p51 Ab [Presence] in Serum by Immunoblot (IB),HIV1 p51 Ab Ser Ql IB,MICRO,1245
24469-9,Hemoglobin XXX/Hemoglobin.total in Blood by Electrophoresis,Hgb XXX MFr Bld Elph,HEM/BC,1246
771-6,Nucleated erythrocytes [#/volume] in Blood by Automated count,nRBC # Bld Auto,HEM/BC,1247
9664-4,HIV 1 p24 Ab [Presence] in Serum by Immunoblot (IB),HIV1 p24 Ab Ser Ql IB,MICRO,1248
9661-0,HIV 1 gp120 Ab [Presence] in Serum by Immunoblot (IB),HIV1 gp120 Ab Ser Ql IB,MICRO,1249
9666-9,HIV 1 p31 Ab [Presence] in Serum by Immunoblot (IB),HIV1 p31 Ab Ser Ql IB,MICRO,1250
11070-0,Microscopic observation [Identifier] in Urine by Cyto stain,Cyto Ur,CYTO,1251
6687-8,Citrate [Mass/time] in 24 hour Urine,Citrate 24h Ur-mRate,Chem,1252
1854-9,Androstenedione [Mass/volume] in Serum or Plasma,Androst SerPl-mCnc,Chem,1253
13993-1,Alpha 2 globulin/Protein.total in Urine by Electrophoresis,Alpha2 Glob MFr Ur Elph,Chem,1254
5785-1,Eosinophils [#/area] in Urine sediment by Microscopy high power field,Eosinophil #/area UrnS HPF,UA,1255
13995-6,Gamma globulin/Protein.total in Urine by Electrophoresis,Gamma glob MFr Ur Elph,Chem,1256
2668-2,Norepinephrine [Mass/time] in 24 hour Urine,Norepineph 24h Ur-mRate,Chem,1257
5354-6,Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID),ENA SS-B Ab Ser Ql ID,SERO,1258
85991-8,Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum,S pneum Da 14 IgG Ser-mCnc,MICRO,1259
85992-6,Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay,S pneum Da 14 IgG Ser IA-mCnc,MICRO,1260
1869-7,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,Apo A-I SerPl-mCnc,Chem,1261
33332-8,Linezolid [Susceptibility] by Gradient strip,Linezolid Islt Grad strip,ABXBACT,1262
5352-0,Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID),ENA SS-A Ab Ser Ql ID,SERO,1263
2640-1,Myoglobin [Presence] in Urine,Myoglobin Ur Ql,Chem,1264
2998-3,Thiamine [Mass/volume] in Blood,Vit B1 Bld-mCnc,Chem,1265
38544-3,Spermatozoa [#/volume] in Semen --pre washing,Sperm Pre Wash # Smn,FERT,1266
38540-1,Spermatozoa Motile/100 spermatozoa in Semen --pre washing,Sperm Motile Pre Wash NFr Smn,FERT,1267
3746-5,Meperidine [Presence] in Urine,Meperidine Ur Ql,DRUG/TOX,1268
12195-4,Creatinine renal clearance/1.73 sq M in 24 hour Urine,Creat Cl/1.73 sq M 24h Ur+SerPl-ArVRat,Chem,1269
2218-6,Dopamine [Mass/time] in 24 hour Urine,Dopamine 24h Ur-mRate,Chem,1270
19049-6,Metanephrine [Mass/time] in 24 hour Urine,Metaneph 24h Ur-mRate,Chem,1271
28643-5,Oxygen saturation (SO2) in Venous cord blood,SaO2 % BldCoV,Chem,1272
5057-5,Blastomyces dermatitidis Ab [Titer] in Serum by Complement fixation,B dermat Ab Titr Ser CF,MICRO,1273
6092-1,Crab IgE Ab [Units/volume] in Serum,Crab IgE Qn,Allergy,1274
13926-1,Glutamate decarboxylase 65 Ab [Units/volume] in Serum,GAD65 Ab Ser-aCnc,SERO,1275
2513-0,Ketones [Presence] in Serum or Plasma,Ketones SerPl Ql,Chem,1276
2518-9,Lactate [Moles/volume] in Arterial blood,Lactate BldA-sCnc,Chem,1277
6007-9,Protein C [Units/volume] in Platelet poor plasma by Coagulation assay,Prot C PPP-aCnc,COAG,1278
14708-2,Endomysium Ab [Titer] in Serum,Endomysium Ab Titr Ser,SERO,1279
7984-8,Parvovirus B19 IgM Ab [Units/volume] in Serum,B19V IgM Ser-aCnc,MICRO,1280
11039-5,C reactive protein [Presence] in Serum or Plasma,CRP SerPl Ql,Chem,1281
32680-1,Fine Granular Casts [#/area] in Urine sediment by Microscopy low power field,Fine Gran Casts #/area UrnS LPF,UA,1282
30340-4,Epstein Barr virus capsid IgM Ab [Presence] in Serum,EBV VCA IgM Ser Ql,MICRO,1283
24115-8,Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay,EBV VCA IgM Ser Ql IA,MICRO,1284
28642-7,Oxygen saturation (SO2) in Arterial cord blood,SaO2 % BldCoA,Chem,1285
25489-6,Normetanephrine [Moles/volume] in Serum or Plasma,Normetanephrine SerPl-sCnc,Chem,1286
19942-2,Oxygen gas flow setting Oxymizer,Gas flow.O2 setting Oxymiser,PULM,1287
18319-4,Neutrophils.vacuolated [Presence] in Blood by Light microscopy,Neuts Vac Bld Ql Smear,HEM/BC,1288
15530-9,Alternaria alternata IgE Ab RAST class in Serum,A alternata IgE RAST Ql,Allergy,1289
3256-5,Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunologic method,Fibrinogen Ag PPP IA-mCnc,COAG,1290
35789-7,Daptomycin [Susceptibility],Daptomycin Susc Islt,ABXBACT,1291
21365-2,Leptin [Mass/volume] in Serum or Plasma,Leptin SerPl-mCnc,Chem,1292
21441-1,Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by DNA probe,HPV Low Risk DNA Cvx Ql Prb,MICRO,1293
14956-7,Microalbumin [Mass/time] in 24 hour Urine,Microalbumin 24h Ur-mRate,Chem,1294
3087-4,Urate [Mass/time] in 24 hour Urine,Urate 24h Ur-mRate,Chem,1295
5863-6,Influenza virus A Ag [Presence] in Unspecified specimen by Immunofluorescence,FLUAV Ag XXX Ql IF,MICRO,1296
34524-9,Neutrophils.band form [Presence] in Blood by Automated count,Neuts Band Bld Ql Auto,HEM/BC,1297
23841-0,Choriogonadotropin.beta subunit [Multiple of the median] adjusted in Serum or Plasma,B-HCG adj MoM SerPl,Chem,1298
1857-2,Angiotensin converting enzyme [Enzymatic activity/volume] in Blood,ACE Bld-cCnc,Chem,1299
31797-4,Cytomegalovirus Ag [Presence] in Unspecified specimen,CMV Ag XXX Ql,MICRO,1300
6379-2,Cytomegalovirus Ag [Presence] in Unspecified specimen by Immunoassay,CMV Ag XXX Ql IA,MICRO,1301
16264-4,Calcium oxalate monohydrate crystals [Presence] in Stone by Infrared spectroscopy,COM Cry Stone Ql IR,Chem,1302
49542-4,Date and time of pheresis procedure,Date+time Pheresis,BLDBK,1303
30339-6,Epstein Barr virus capsid IgG Ab [Presence] in Serum,EBV VCA IgG Ser Ql,MICRO,1304
24114-1,Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunoassay,EBV VCA IgG Ser Ql IA,MICRO,1305
32554-8,Thiamine [Moles/volume] in Blood,Vit B1 Bld-sCnc,Chem,1306
14316-4,Benzodiazepines [Presence] in Urine by Screen method,Benzodiaz Ur Ql Scn,DRUG/TOX,1307
9796-4,Color of Stone,Color Stone,SPEC,1308
9802-0,Size [Entitic volume] of Stone,Size Stone,PATH,1309
2428-1,Homocysteine [Mass/volume] in Serum or Plasma,Hcys SerPl-mCnc,Chem,1310
35538-8,Baker's yeast IgG Ab [Mass/volume] in Serum,Baker's yeast IgG-mCnc,Allergy,1311
48050-9,Neutrophils [Presence] in Stool by Wright stain,Neutrophils Stl Ql Wright Stn,HEM/BC,1312
20593-0,CD19 cells/100 cells in Unspecified specimen,CD19 Cells NFr XXX,CELLMARK,1313
5685-3,Mercury [Mass/volume] in Blood,Mercury Bld-mCnc,DRUG/TOX,1314
2605-4,Meat fibers [Presence] in Stool by Light microscopy,Meat Fibers Stl Ql Micro,Chem,1315
730-2,Leukocytes other/100 leukocytes in Blood by Manual count,WBC Other/leuk NFr Bld Manual,HEM/BC,1316
8249-5,Transitional cells [Presence] in Urine sediment by Light microscopy,Trans Cells UrnS Ql Micro,UA,1317
30427-9,Macrophages/100 leukocytes in Body fluid,Macrophages/leuk NFr Fld,HEM/BC,1318
19835-8,Breath rate setting Ventilator synchronized intermittent mandatory,Breaths setting SIMV,PULM,1319
27395-3,Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum,S pneum Da 18C IgG Ser-mCnc,MICRO,1320
40913-6,Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay,S pneum Da 18C IgG Ser IA-mCnc,MICRO,1321
15212-4,Lipase [Enzymatic activity/volume] in Body fluid,Lipase Fld-cCnc,Chem,1322
3507-1,Codeine [Presence] in Urine,Codeine Ur Ql,DRUG/TOX,1323
86024-7,Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum,S pneum Da sero 19F IgG Ser-mCnc,MICRO,1324
86021-3,Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay,S pneum Da sero 19F IgG Ser IA-mCnc,MICRO,1325
86064-3,Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum,S pneum Da 23F IgG Ser-mCnc,MICRO,1326
86061-9,Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay,S pneum Da 23F IgG Ser IA-mCnc,MICRO,1327
86107-0,Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum,S pneum Da 4 IgG Ser-mCnc,MICRO,1328
86108-8,Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay,S pneum Da 4 IgG Ser IA-mCnc,MICRO,1329
4575-7,Hemoglobin E/Hemoglobin.total in Blood,Hgb E MFr Bld,HEM/BC,1330
30153-1,Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum,S pneum Da 9V IgG Ser-mCnc,MICRO,1331
40926-8,Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay,S pneum Da 9V IgG Ser IA-mCnc,MICRO,1332
35127-0,Hemoglobin A2.prime/Hemoglobin.total in Blood ,Hgb A2.prime MFr Bld,HEM/BC,1333
31156-3,Hemoglobin Barts/Hemoglobin.total in Blood,Hgb Barts MFr Bld,HEM/BC,1334
4569-0,Hemoglobin D/Hemoglobin.total in Blood,Hgb D MFr Bld,HEM/BC,1335
33593-5,Hemoglobin G - Coushatta/Hemoglobin.total in Blood,Hgb G-Coush MFr Bld,HEM/BC,1336
35125-4,Hemoglobin Lepore/Hemoglobin.total in Blood,Hgb Lepore MFr Bld,HEM/BC,1337
35126-2,Hemoglobin O - Arab/Hemoglobin.total in Blood,Hgb O-Arab MFr Bld,HEM/BC,1338
13986-5,Albumin/Protein.total in 24 hour Urine by Electrophoresis,Albumin 24h MFr Ur Elph,Chem,1339
6165-5,Lobster IgE Ab [Units/volume] in Serum,Lobster IgE Qn,Allergy,1340
21709-1,MTHFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,MTHFR gene Mut Anal Bld/T,MOLPATH.MUT,1341
29573-3,Phenylalanine [Moles/volume] in Dried blood spot,Phe DBS-sCnc,Chem,1342
35572-7,Phenylalanine/Tyrosine [Molar ratio] in Dried blood spot,Phe/Tyr DBS-sRto,Chem,1343
2609-6,Metanephrines [Mass/time] in 24 hour Urine,MetanephS 24h Ur-mRate,Chem,1344
35571-9,Tyrosine [Moles/volume] in Dried blood spot,Tyrosine DBS-sCnc,Chem,1345
13984-0,Alpha 1 globulin/Protein.total in 24 hour Urine by Electrophoresis,Alpha1 Glob 24h MFr Ur Elph,Chem,1346
38415-6,MTHFR gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative,MTHFR gene Mut Anal Bld/T,MOLPATH.MUT,1347
42484-6,Protein.monoclonal/Protein.total in 24 hour Urine by Electrophoresis,M Protein 24h MFr Ur Elph,Chem,1348
10863-9,Endomysium IgA Ab [Titer] in Serum,Endomysium IgA Titr Ser,SERO,1349
3830-7,Morphine [Presence] in Urine,Morphine Ur Ql,DRUG/TOX,1350
3122-9,Vanillylmandelate [Mass/time] in 24 hour Urine,VMA 24h Ur-mRate,Chem,1351
5693-7,Methanol [Mass/volume] in Serum or Plasma,Methanol SerPl-mCnc,DRUG/TOX,1352
13499-9,HIV 1 Ab band pattern [interpretation] in Serum by Immunoblot (IB),HIV1 Ab Patrn Ser IB-Imp,MICRO,1353
49540-8,Acid citrate dextrose [Volume] in Blood product unit,Acid citrate dextrose Vol BPU,BLDBK,1354
5292-8,Reagin Ab [Presence] in Serum by VDRL,VDRL Ser Ql,MICRO,1355
31102-7,Protein S actual/normal in Platelet poor plasma by Chromogenic method    *NOTE: enzymatic method,Prot S Act/Nor PPP Chro,COAG,1356
25157-9,Epithelial casts [Presence] in Urine sediment by Light microscopy,Epith Casts UrnS Ql Micro,UA,1357
33333-6,Colistin [Susceptibility] by Gradient strip,Colistin Islt Grad strip,ABXBACT,1358
35675-8,Calcium [Mass/volume] in unspecified time Urine,Calcium ?Tm Ur-mCnc,Chem,1359
588-4,Legionella pneumophila Ag [Presence] in Unspecified specimen by Immunofluorescence,L pneumo Ag XXX Ql IF,MICRO,1360
8150-5,Amphetamines [Mass/volume] in Urine,Amphetamines Ur-mCnc,DRUG/TOX,1361
10449-7,Glucose [Mass/volume] in Serum or Plasma --1 hour post meal,Glucose 1h p meal SerPl-mCnc,CHAL,1362
17607-3,Volume of Cerebral spinal fluid,Specimen vol CSF,SPEC,1363
43583-4,Lipoprotein a [Moles/volume] in Serum or Plasma,LPa SerPl-sCnc,Chem,1364
9426-8,Barbiturates [Mass/volume] in Urine,Barbiturates Ur-mCnc,DRUG/TOX,1365
10704-5,Ova and parasites identified in Stool by Light microscopy,O+P Stl Micro,MICRO,1366
9428-4,Benzodiazepines [Mass/volume] in Urine,Benzodiaz Ur-mCnc,DRUG/TOX,1367
31032-6,Baker's yeast IgA Ab [Units/volume] in Serum,Baker's yeast IgA Qn,Allergy,1368
47320-7,Baker's yeast IgA Ab [Units/volume] in Serum by Immunoassay,Baker's yeast IgA Qn IA,ALLERGY,1369
22086-3,Aspergillus niger Ab [Presence] in Serum,A niger Ab Ser Ql,MICRO,1370
6164-8,Virginia Live Oak IgE Ab [Units/volume] in Serum,Virg Live Oak IgE Qn,Allergy,1371
33915-0,Anabasine [Mass/volume] in Urine,Anabasine Ur-mCnc,DRUG/TOX,1372
13358-7,Collection time of Semen,Collect Tme Smn,SPEC,1373
2837-3,Pregnenolone [Mass/volume] in Serum or Plasma,Preg SerPl-mCnc,Chem,1374
34519-9,HFE gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative,HFE gene Mut Anal Bld/T,MOLPATH.MUT,1375
28545-2,Mucus [#/area] in Urine sediment by Microscopy low power field,Mucous Threads #/area UrnS LPF,UA,1376
6113-5,Gum-Tree IgE Ab [Units/volume] in Serum,Gum-Tree IgE Qn,Allergy,1377
27118-9,Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum,S pneum Da 6B IgG Ser-mCnc,MICRO,1378
40905-2,Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay,S pneum Da 6B IgG Ser IA-mCnc,MICRO,1379
12856-1,HIV 1 p65 Ab [Presence] in Serum by Immunoblot (IB),HIV1 p65 Ab Ser Ql IB,MICRO,1380
19077-7,Cells identified in Body fluid,Cells Fld,HEM/BC,1381
86080-9,Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum,S pneum Da 3 IgG Ser-mCnc,MICRO,1382
86081-7,Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay,S pneum Da 3 IgG Ser IA-mCnc,MICRO,1383
25296-5,Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum,S pneum Da 7F IgG Ser-mCnc,MICRO,1384
40911-0,Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay,S pneum Da 7F IgG Ser IA-mCnc,MICRO,1385
86147-6,Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum,S pneum Da 8 IgG Ser-mCnc,MICRO,1386
86148-4,Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay,S pneum Da 8 IgG Ser IA-mCnc,MICRO,1387
86169-0,Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum,S pneum Da 9N IgG Ser-mCnc,MICRO,1388
86166-6,Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay,S pneum Da 9N IgG Ser IA-mCnc,MICRO,1389
15048-2,Creatine kinase.BB/Creatine kinase.total in Serum or Plasma by Electrophoresis,CK BB CFr SerPl Elph,Chem,1390
12187-1,Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by Electrophoresis,CK MB CFr SerPl Elph,Chem,1391
15049-0,Creatine kinase.MM/Creatine kinase.total in Serum or Plasma by Electrophoresis,CK MM CFr SerPl Elph,Chem,1392
9662-8,HIV 1 gp41 Ab [Presence] in Serum by Immunoblot (IB),HIV1 gp41 Ab Ser Ql IB,MICRO,1393
85954-6,Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum,S pneum Da 1 IgG Ser-mCnc,MICRO,1394
85955-3,Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay,S pneum Da 1 IgG Ser IA-mCnc,MICRO,1395
26019-0,Creatine Kinase.macromolecular type 1/Creatine kinase.total in Serum or Plasma,CK Macro1 CFr SerPl,Chem,1396
26020-8,Creatine Kinase.macromolecular type 2/Creatine kinase.total in Serum or Plasma,CK Macro2 CFr SerPl,Chem,1397
41763-4,Rubella virus IgG Ab [Titer] in Serum,RUBV IgG Titr Ser,MICRO,1398
42483-8,Protein.monoclonal/Protein.total in Urine by Electrophoresis,M Protein MFr Ur Elph,Chem,1399
12859-5,HIV 1 p18 Ab [Presence] in Serum by Immunoblot (IB),HIV1 p18 Ab Ser Ql IB,MICRO,1400
6050-9,Brazil Nut IgE Ab [Units/volume] in Serum,Brazil Nut IgE Qn,Allergy,1401
85977-7,Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum,S pneum Da 12F IgG Ser-mCnc,MICRO,1402
85974-4,Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay,S pneum Da 12F IgG Ser IA-mCnc,MICRO,1403
21619-2,APOE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,APOE gene Mut Anal Bld/T,MOLPATH.MUT,1404
3086-6,Urate [Mass/volume] in Urine,Urate Ur-mCnc,Chem,1405
18267-5,CD16+CD56+ cells/100 cells in Blood,CD16+CD56+ Cells NFr Bld,CELLMARK,1406
48560-7,Human papilloma virus genotype [Identifier] in Unspecified specimen by Probe & target amplification method,HPV Gentyp XXX PCR,MICRO,1407
33536-4,Miscellaneous allergen IgE Ab RAST class in Serum,Misc Allergen IgE RAST Ql,Allergy,1408
14288-5,Carnitine [Moles/volume] in Serum or Plasma,Carnitine SerPl-sCnc,Chem,1409
20402-4,CD16+CD56+ cells [#/volume] in Blood,CD16+CD56+ Cells # Bld,CELLMARK,1410
2333-3,Gastrin [Mass/volume] in Serum or Plasma,Gastrin SerPl-mCnc,Chem,1411
11778-8,Delivery date Estimated,Deliv date Clin est,OB.US,1412
42810-2,Hemoglobin [Entitic mass] in Reticulocytes,Hgb Retic Qn,HEM/BC,1413
5191-2,Hepatitis B virus e Ag [Units/volume] in Serum by Immunoassay,HBV e Ag Ser IA-aCnc,MICRO,1414
26458-0,Erythrocytes [#/volume] in Synovial fluid,RBC # Snv,HEM/BC,1415
14664-7,Color of Synovial fluid,Color Snv,SPEC,1416
8214-9,Opiates [Presence] in Meconium,Opiates Mec Ql,DRUG/TOX,1417
14286-9,Carnitine free (C0) [Moles/volume] in Serum or Plasma,Carnitine Free SerPl-sCnc,Chem,1418
27939-8,Collagen crosslinked N-telopeptide [Moles/volume] in Urine,Collagen NTx Ur-sCnc,Chem,1419
16130-7,Herpes simplex virus 1 DNA [Presence] in Unspecified specimen by Probe & target amplification method,HSV1 DNA XXX Ql PCR,MICRO,1420
32766-8,Trichomonas vaginalis [Presence] in Unspecified specimen by Wet preparation,T vaginalis XXX Ql Wet Prep,MICRO,1421
17284-1,Mitochondria Ab [Presence] in Serum by Immunofluorescence,Mitochondria Ab Ser Ql IF,SERO,1422
16268-5,Calcium phosphate crystals [Presence] in Stone by Infrared spectroscopy,Ca Phos Cry Stone Ql IR,Chem,1423
7905-3,Hepatitis B virus surface Ag [Presence] in Serum by Neutralization test,HBV surface Ag SerPl Ql Nt,MICRO,1424
19126-2,Bacteria identified in Bone marrow by Aerobe culture,Bacteria Mar Aerobe Cult,MICRO,1425
6158-0,Latex IgE Ab [Units/volume] in Serum,Ltx IgE Qn,Allergy,1426
3282-1,aPTT W excess hexagonal phase phospholipid in Platelet poor plasma by Coagulation assay,aPTT Hex PL PPP,COAG,1427
32031-7,Phosphatidylserine IgA Ab [Units/volume] in Serum by Immunoassay,PS IgA Ser IA-aCnc,COAG,1428
6266-1,Tomato IgE Ab [Units/volume] in Serum,Tomato IgE Qn,Allergy,1429
6009-5,Protein C Ag [Units/volume] in Platelet poor plasma by Immunologic method,Prot C Ag PPP IA-aCnc,COAG,1430
936-5,Blood product unit [Identifier],Bld Unit Id BPU,BLDBK,1431
9820-2,Cryptococcus sp Ag [Titer] in Serum by Latex agglutination,Cryptoc Ag Titr Ser LA,MICRO,1432
11013-0,DNA double strand Ab [Titer] in Serum,dsDNA Ab Titr Ser,SERO,1433
31080-5,Cannabinoids [Presence] in Meconium by Screen method,Cannabinoids Mec Ql Scn,DRUG/TOX,1434
5909-7,Blood smear finding [Identifier] in Blood by Light microscopy,Bld Smear Interp,HEM/BC,1435
22296-8,Epstein Barr virus nuclear Ab [Presence] in Serum,EBV NA Ab Ser Ql,MICRO,1436
575-1,Fungus identified in Skin by Culture,Fungus Skin Cult,MICRO,1437
5820-6,WBC casts [#/area] in Urine sediment by Microscopy low power field,WBC Casts #/area UrnS LPF,UA,1438
2999-1,Thiamine [Mass/volume] in Serum or Plasma,Vit B1 SerPl-mCnc,Chem,1439
35452-2,HIV 1 gp40 Ab [Presence] in Serum by Immunoblot (IB),HIV1 gp40 Ab Ser Ql IB,MICRO,1440
20449-5,Borrelia burgdorferi Ab [Presence] in Serum by Immunoassay,B burgdor Ab Ser Ql IA,MICRO,1441
6174-7,Milk IgE Ab [Units/volume] in Serum,Milk IgE Qn,Allergy,1442
13047-6,Plasma cells/100 leukocytes in Blood,Plasma Cells/leuk NFr Bld,HEM/BC,1443
20999-9,Cell Fractions/Differential [interpretation] in Body fluid,Cell Fract Fld-Imp,HEM/BC,1444
16250-3,Codeine [Mass/volume] in Urine by Confirmatory method,Codeine Ur Cfm-mCnc,DRUG/TOX,1445
15283-5,Silver Birch IgE Ab [Units/volume] in Serum,Silver Birch IgE Qn,Allergy,1446
1903-4,Ascorbate [Mass/volume] in Serum or Plasma,Vit C SerPl-mCnc,Chem,1447
40527-4,Cocaine [Presence] in Meconium,Cocaine Mec Ql,DRUG/TOX,1448
1695-6,5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine,5OH-indoleacetate 24h Ur-mRate,Chem,1449
1549-5,Glucose [Mass/volume] in Serum or Plasma --pre 100 g glucose PO,Glucose pre 100 g Glc PO SerPl-mCnc,CHAL,1450
21525-1,Sodium [Moles/volume] in 24 hour Urine,Sodium 24h Ur-sCnc,Chem,1451
14906-2,Rh [Type] in Cord blood,Rh BldCo,BLDBK,1452
20112-9,Tidal volume setting Ventilator,VT setting Vent,PULM,1453
8144-8,Amphetamines [Presence] in Meconium,Amphetamines Mec Ql,DRUG/TOX,1454
6242-2,Sesame Seed IgE Ab [Units/volume] in Serum,Sesame Seed IgE Qn,Allergy,1455
21023-7,Neutrophil cytoplasmic Ab [Titer] in Serum,ANCA Ab Titr Ser,SERO,1456
7983-0,Parvovirus B19 IgG Ab [Units/volume] in Serum,B19V IgG Ser-aCnc,MICRO,1457
30361-0,HIV 2 Ab [Presence] in Serum by Immunoassay,HIV 2 Ab SerPl Ql IA,MICRO,1458
781-5,Promyelocytes [#/volume] in Blood by Manual count,Promyelocytes # Bld Manual,HEM/BC,1459
51892-8,ABO group [Type] in Cord blood,ABO Group BldCo,BLDBK,1460
42803-7,Bacteria identified in Isolate,Bacteria Islt,MICRO,1461
25631-3,Parvovirus B19 IgM Ab [Titer] in Serum,B19V IgM Titr Ser,MICRO,1462
32787-4,Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum,p-ANCA Titr Ser,SERO,1463
19429-0,Propoxyphene [Presence] in Urine by Screen method,Propoxyph Ur Ql Scn,DRUG/TOX,1464
2282-2,Folate [Mass/volume] in Blood,Folate Bld-mCnc,Chem,1465
16251-1,Morphine [Mass/volume] in Urine by Confirmatory method,Morphine Ur Cfm-mCnc,DRUG/TOX,1466
32585-2,Epstein Barr virus DNA [#/volume] (viral load) in Unspecified specimen by Probe & target amplification method,EBV DNA # XXX PCR,MICRO,1467
15410-4,Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay,VZV IgG Ser Ql IA,MICRO,1468
5357-9,Smith extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID),ENA SM Ab Ser Ql ID,SERO,1469
5036-9,Streptococcus pyogenes rRNA [Presence] in Unspecified specimen by DNA probe,S pyo rRNA XXX Ql Prb,MICRO,1470
40974-8,Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum,S pneum Da 19A IgG Ser-mCnc,MICRO,1471
40915-1,Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay,S pneum Da 19A IgG Ser IA-mCnc,MICRO,1472
31019-3,10-Hydroxycarbazepine [Mass/volume] in Serum or Plasma,10OH-Carbazepine SerPl-mCnc,DRUG/TOX,1473
11040-3,Cortisol Free [Mass/volume] in Urine,Cortis F Ur-mCnc,Chem,1474
9704-8,Spermatozoa [Morphology] in Semen,Sperm Smn,FERT,1475
601-5,Fungus identified in Blood by Culture,Fungus Bld Cult,MICRO,1476
19803-6,Specimen site,Specimen site,ENDO.GI,1477
2779-7,Phosphate [Mass/time] in 24 hour Urine,Phosphate 24h Ur-mRate,Chem,1478
21695-2,HFE gene p.C282Y [Presence] in Blood or Tissue by Molecular genetics method,HFE p.C282Y Bld/T Ql,MOLPATH.MUT,1479
38256-4,Cells Counted Total [#] in Body fluid,Total Cells Counted Fld,HEM/BC,1480
10587-4,Sexual abstinence duration,Sex Abstin duration Time Patient,FERT,1481
41479-7,BK virus DNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method,BKV DNA # SerPl PCR,MICRO,1482
21260-5,Epstein Barr virus nuclear Ab [Titer] in Serum by Immunofluorescence,EBV NA Ab Titr Ser IF,MICRO,1483
35270-8,Candida sp Ab [Presence] in Serum by Immune diffusion (ID),Candida Ab Ser Ql ID,MICRO,1484
14194-5,Spermatozoa Progressive/100 spermatozoa in Semen,Sperm Prog NFr Smn,FERT,1485
6190-3,Oat IgE Ab [Units/volume] in Serum,Oat IgE Qn,Allergy,1486
6222-4,Queen Palm IgE Ab [Units/volume] in Serum,Queen Palm IgE Qn,Allergy,1487
27820-0,Protein C Ag actual/normal in Platelet poor plasma by Immunologic method,Prot C Ag Act/Nor PPP IA,COAG,1488
10579-1,Leukocytes [#/volume] in Semen,WBC # Smn,FERT,1489
30247-1,Cytomegalovirus DNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method,CMV DNA # SerPl PCR,MICRO,1490
30165-5,Phosphatidylcholine/Albumin [Mass ratio] in Amniotic fluid,PC/Alb Amn,Chem,1491
12782-9,Protein fractions.oligoclonal bands [interpretation] in Cerebral spinal fluid by Electrophoresis,Oligoclonal Bands CSF Elph-Imp,Chem,1492
3422-3,Caffeine [Mass/volume] in Serum or Plasma,Caffeine SerPl-mCnc,DRUG/TOX,1493
6892-4,Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Dialysis,T4 Free SerPl Dialy-mCnc,Chem,1494
6151-5,Italian Cypress IgE Ab [Units/volume] in Serum,Italian Cypress IgE Qn,Allergy,1495
5946-9,aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma,aPTT imm NP PPP,COAG,1496
6230-7,Rice IgE Ab [Units/volume] in Serum,Rice IgE Qn,Allergy,1497
10525-4,Microscopic observation [Identifier] in Unspecified specimen by Cyto stain,Cyto XXX,CYTO,1498
40692-6,Volume of Semen--pre washing,Specimen vol Pre Wash Smn,FERT,1499
11884-4,Gestational age Estimated,GA Clin est,OB.US,1500
19171-8,Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid,AFP Amn-aCnc,Chem,1501
7287-6,Dog Fennel IgE Ab [Units/volume] in Serum,Dog Fennel IgE Qn,Allergy,1502
44528-8,Histoplasma capsulatum M Ab [Presence] in Serum,H capsul M Ab Ser Ql,MICRO,1503
12227-5,Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood,WBC nRBC cor # Bld,HEM/BC,1504
3545-1,Propoxyphene [Mass/volume] in Urine,Propoxyph Ur-mCnc,DRUG/TOX,1505
20473-5,Polymorphonuclear cells [Presence] in Unspecified specimen by Wright stain,Polys XXX Ql Wright Stn,HEM/BC,1506
35732-7,Histoplasma capsulatum H Ab [Presence] in Serum by Immune diffusion (ID),H capsul H Ab Ser Ql ID,MICRO,1507
19261-7,Amphetamines [Presence] in Urine by Screen method,Amphetamines Ur Ql Scn,DRUG/TOX,1508
11235-9,Fentanyl [Presence] in Urine,Fentanyl Ur Ql,DRUG/TOX,1509
5221-7,HIV 1 Ab [Presence] in Serum by Immunoblot (IB),HIV1 Ab SerPl Ql IB,MICRO,1510
6109-3,White Elm IgE Ab [Units/volume] in Serum,White Elm IgE Qn,Allergy,1511
10353-1,Bacteria identified in Nose by Aerobe culture,Bacteria Nose Aerobe Cult,MICRO,1512
7124-1,Bayberry Pollen IgE Ab [Units/volume] in Serum,Bayberry Poln IgE Qn,Allergy,1513
8251-1,Service comment,Service Cmnt XXX-Imp,MISC,1514
38996-5,Neutrophils [Presence] in Urine by Light microscopy,Neutrophils Ur Ql Micro,UA,1515
15197-7,Lymphocytes Fissured/100 leukocytes in Blood by Manual count,Cleft Lymphs/leuk NFr Bld Manual,HEM/BC,1516
14207-5,Streptococcal DNAse B [Titer] in Serum,Strep DNAse B Titr Ser,MICRO,1517
44547-8,Human papilloma virus DNA [Presence] in Unspecified specimen by Probe & signal amplification method,HPV DNA XXX Ql bDNA,MICRO,1518
28543-7,Basophils/100 leukocytes in Body fluid,Basophils/leuk NFr Fld,HEM/BC,1519
6012-9,von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by Immunologic method,vWF Ag PPP IA-aCnc,COAG,1520
7902-0,Helicobacter pylori IgG Ab [Units/volume] in Serum,H pylori IgG Ser-aCnc,MICRO,1521
10728-4,Trichomonas sp identified in Genital specimen by Organism specific culture,Trichomonas Genital Cult,MICRO,1522
8118-2,CD2 cells/100 cells in Blood,CD2 Cells NFr Bld,CELLMARK,1523
38496-6,Retinyl palmitate [Mass/volume] in Serum or Plasma,Retinyl Palmitate SerPl-mCnc,Chem,1524
48053-3,Turbidity [Presence] of Synovial fluid,Turbidity Snv Ql,SPEC,1525
33984-6,Coagulation factor X activity actual/normal in Platelet poor plasma by Chromogenic method,Fact X Act/Nor PPP Chro,COAG,1526
49839-4,Eosinophils [Presence] in Urine sediment by Wright stain,Eosinophil UrnS Ql Wright Stn,HEM/BC,1527
5669-7,Isopropanol [Mass/volume] in Serum or Plasma,Isopropanol SerPl-mCnc,DRUG/TOX,1528
7816-2,Blastomyces dermatitidis Ab [Presence] in Serum,B dermat Ab Ser Ql,MICRO,1529
7477-3,Mango Pollen IgE Ab [Units/volume] in Serum,Mango Poln IgE Qn,Allergy,1530
36913-2,FMR1 gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative,FMR1 gene Mut Anal Bld/T,MOLPATH.MUT,1531
13943-6,Fructose [Presence] in Semen,Fructose Smn Ql,Chem,1532
34441-6,Spermatozoa [Velocity] in Semen,Sperm Smn Qn,FERT,1533
7110-0,Groundsel Tree IgE Ab [Units/volume] in Serum,Groundsel Tree IgE Qn,Allergy,1534
2464-6,IgG [Mass/volume] in Cerebral spinal fluid,IgG CSF-mCnc,Chem,1535
6195-2,Cocksfoot IgE Ab [Units/volume] in Serum,Cocksfoot IgE Qn,Allergy,1536
4059-2,Tobramycin [Mass/volume] in Serum or Plasma --trough,Tobramycin Trough SerPl-mCnc,DRUG/TOX,1537
48051-7,Erythrocytes [Presence] in Vaginal fluid,RBC Vag Ql,HEM/BC,1538
19710-3,Tramadol [Presence] in Urine by Screen method,Tramadol Ur Ql Scn,DRUG/TOX,1539
22297-6,Epstein Barr virus nuclear Ab [Titer] in Serum,EBV NA Ab Titr Ser,MICRO,1540
27823-4,Protein S Ag actual/normal in Platelet poor plasma by Immunologic method,Prot S Ag Act/Nor PPP IA,COAG,1541
560-3,Chlamydia sp identified in Unspecified specimen by Organism specific culture,Chlamydia XXX Cult,MICRO,1542
20427-1,Acetylcholine receptor Ab [Moles/volume] in Serum,AChR Ab Ser-sCnc,SERO,1543
48038-4,Pathologist interpretation of Synovial fluid tests,Path Interp Snv-Imp,PATH,1544
4551-8,Hemoglobin A2/Hemoglobin.total in Blood,Hgb A2 MFr Bld,HEM/BC,1545
47383-5,Nuclear Ab [Presence] in Serum by Immunoassay,ANA Ser Ql IA,SERO,1546
9557-0,CD2 cells [#/volume] in Blood,CD2 Cells # Bld,CELLMARK,1547
41476-3,Rickettsia rickettsii IgG Ab [Presence] in Serum by Immunoassay,R rickettsi IgG Ser Ql IA,MICRO,1548
9804-6,Weight of Stone,Wt Stone,PATH,1549
20468-5,Thiamine [Moles/volume] in Serum or Plasma,Vit B1 SerPl-sCnc,Chem,1550
33242-9,Fungi.filamentous [Presence] in Urine by Computer assisted method,Filament Fungi Ur Ql Comp Assist,UA,1551
27821-8,Protein S Free Ag actual/normal in Platelet poor plasma by Immunologic method,Prot S Free Ag Act/Nor PPP IA,COAG,1552
3175-7,Antithrombin Ag [Units/volume] in Platelet poor plasma by Immunologic method,AT III Ag PPP IA-aCnc,COAG,1553
49572-1,Second trimester triple maternal screen [interpretation] in Serum or Plasma Narrative,2nd trimester 3 screen SerPl-Imp,Chem,1554
23301-5,Mycoplasma sp DNA [Presence] in Unspecified specimen by Probe & target amplification method,Mycoplasma DNA XXX Ql PCR,MICRO,1555
5256-3,Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay,M pneumo IgM Ser IA-aCnc,MICRO,1556
21760-4,FRAXE gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method,FRAXE gene CGG Rpt Bld/T Ql,MOLPATH.TRINUC,1557
16117-4,Babesia microti IgG Ab [Titer] in Serum,Bab microti IgG Titr Ser,MICRO,1558
41475-5,Rickettsia rickettsii IgM Ab [Presence] in Serum by Immunoassay,R rickettsi IgM Ser Ql IA,MICRO,1559
21416-3,Neisseria gonorrhoeae DNA [Presence] in Urine by Probe & target amplification method,N gonorrhoea DNA Ur Ql PCR,MICRO,1560
24119-0,Cytomegalovirus IgM Ab [Presence] in Serum by Immunoassay,CMV IgM SerPl Ql IA,MICRO,1561
21582-2,Tryptase [Mass/volume] in Serum or Plasma,Tryptase SerPl-mCnc,Chem,1562
5255-5,Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay,M pneumo IgG Ser IA-aCnc,MICRO,1563
13947-7,Coccidioides immitis IgG Ab [Presence] in Serum by Immunoassay,C immitis IgG Ser Ql IA,MICRO,1564
2251-7,Estriol (E3) [Mass/volume] in Serum or Plasma,Estriol SerPl-mCnc,Chem,1565
24125-7,Androgen free Index in Serum or Plasma,Androgen FAI SerPl-sRto,Chem,1566
13948-5,Coccidioides immitis IgM Ab [Presence] in Serum by Immunoassay,C immitis IgM Ser Ql IA,MICRO,1567
25474-8,Metanephrines [Moles/volume] in Serum or Plasma,MetanephS SerPl-sCnc,Chem,1568
49580-4,HIV 1+2 Ab [Presence] in Unspecified specimen by Rapid test,HIV1+2 Ab XXX Ql IA.rapid,MICRO,1569
6021-0,Apple IgE Ab [Units/volume] in Serum,Apple IgE Qn,Allergy,1570
26451-5,Eosinophils/100 leukocytes in Cerebral spinal fluid,Eosinophil/leuk NFr CSF,HEM/BC,1571
5908-9,Platelets Giant [Presence] in Blood by Light microscopy,Giant Platelets Bld Ql Smear,HEM/BC,1572
16118-2,Babesia microti IgM Ab [Titer] in Serum,Bab microti IgM Titr Ser,MICRO,1573
4057-6,Tobramycin [Mass/volume] in Serum or Plasma --peak,Tobramycin Peak SerPl-mCnc,DRUG/TOX,1574
30525-0,Age,Age,MISC,1575
32546-4,Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells,G6PD RBC-cCnt,Chem,1576
32164-6,Cells [#/volume] in Synovial fluid by Manual count,Cells # Snv Manual,HEM/BC,1577
9811-1,Chromogranin A [Mass/volume] in Serum or Plasma,CgA SerPl-mCnc,Chem,1578
10355-6,Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain,Wright Gie Stn Mar,MICRO,1579
1848-1,Androstanolone [Mass/volume] in Serum or Plasma,Androstanolone SerPl-mCnc,Chem,1580
3969-3,Phenytoin Free [Mass/volume] in Serum or Plasma,Phenytoin Free SerPl-mCnc,DRUG/TOX,1581
6270-3,Tuna IgE Ab [Units/volume] in Serum,Tuna IgE Qn,Allergy,1582
7613-3,Pistachio IgE Ab [Units/volume] in Serum,Pistachio IgE Qn,Allergy,1583
14083-0,Epstein Barr virus early Ab [Titer] in Serum by Immunofluorescence,EBV EA Ab Titr Ser IF,MICRO,1584
18182-6,Osmolality of Serum or Plasma by calculation,Osmolality SerPl Calc,Chem,1585
41279-1,Borrelia burgdorferi IgG Ab/IgM Ab [Ratio] in Serum,B burgdor IgG/IgM Ser-Rto,MICRO,1586
7883-2,Epstein Barr virus nuclear IgG Ab [Presence] in Serum,EBV NA IgG Ser Ql,MICRO,1587
20425-5,Cardiolipin IgM Ab [interpretation] in Serum,Cardiolipin IgM Ser-Imp,COAG,1588
1746-7,Albumin [Mass/volume] in Cerebral spinal fluid,Albumin CSF-mCnc,Chem,1589
20424-8,Cardiolipin IgG Ab [interpretation] in Serum,Cardiolipin IgG Ser-Imp,COAG,1590
26479-6,Lymphocytes/100 leukocytes in Cerebral spinal fluid,Lymphocytes/leuk NFr CSF,HEM/BC,1591
3043-7,Triglyceride [Mass/volume] in Blood,Trigl Bld-mCnc,Chem,1592
609-8,Bacteria identified in Eye by Aerobe culture,Bacteria Eye Aerobe Cult,MICRO,1593
15643-0,Clam IgE Ab RAST class in Serum,Clam IgE RAST Ql,Allergy,1594
14869-2,Pathologist review of Blood tests,Path Rev Bld -Imp,BLDBK,1595
5814-9,Triple phosphate crystals [Presence] in Urine sediment by Light microscopy,Tri-Phos Cry UrnS Ql Micro,UA,1596
30193-7,Acylcarnitine/Carnitine.free (C0) [Molar ratio] in Serum or Plasma,Acylcarnitine/C0 SerPl-sRto,Chem,1597
8047-3,Varicella zoster virus IgG Ab [Units/volume] in Serum,VZV IgG Ser-aCnc,MICRO,1598
38476-8,Mullerian inhibiting substance [Mass/volume] in Serum or Plasma,MIS SerPl-mCnc,Chem,1599
5834-7,Adenovirus Ag [Presence] in Unspecified specimen by Immunofluorescence,HAdV Ag XXX Ql IF,MICRO,1600
6257-0,Strawberry IgE Ab [Units/volume] in Serum,Strawberry IgE Qn,Allergy,1601
28009-9,Volume of Urine,Specimen vol Ur,SPEC,1602
19111-4,Mother's hospital number,Mother's hospital #,CLIN,1603
13349-6,Leukocytes [#/volume] in Stool by Manual count,WBC # Stl Manual,HEM/BC,1604
1992-7,Calcitonin [Mass/volume] in Serum or Plasma,Calcit SerPl-mCnc,Chem,1605
26607-2,Cystathionine [Moles/volume] in Serum or Plasma,Cystathionin SerPl-sCnc,Chem,1606
16263-6,Calcium oxalate dihydrate crystals [Presence] in Stone by Infrared spectroscopy,COD Cry Stone Ql IR,Chem,1607
47387-6,Neisseria gonorrhoeae DNA [Presence] in Genital specimen by Probe & target amplification method,N gonorrhoea DNA Genital Ql PCR,MICRO,1608
698-1,Neisseria gonorrhoeae [Presence] in Unspecified specimen by Organism specific culture,N gonorrhoea XXX Ql Cult,MICRO,1609
5646-5,Ethylene glycol [Mass/volume] in Serum or Plasma,Ethylene Glycol SerPlBld-mCnc,DRUG/TOX,1610
7917-8,HIV 1 Ab [Presence] in Serum,HIV1 Ab Ser Ql,MICRO,1611
17122-3,CD19+Kappa+ cells/100 cells in Blood,CD19+Kappa+ Cells NFr Bld,CELLMARK,1612
32786-6,Thyroperoxidase Ab [Titer] in Serum or Plasma,Thyroperoxidase Ab Titr SerPl,SERO,1613
5724-0,Selenium [Mass/volume] in Serum or Plasma,Selenium SerPl-mCnc,DRUG/TOX,1614
6209-1,Pecan or Hickory Tree IgE Ab [Units/volume] in Serum,Pecan/Hick Tree IgE Qn,Allergy,1615
4633-4,Hemoglobin F/Hemoglobin.total in Blood by Kleihauer-Betke method,Hgb F MFr Bld Kleih Betke,HEM/BC,1616
4821-5,HLA-B27 [Presence],HLA-B27 Ql,HLA,1617
22203-4,Clostridium tetani IgG Ab [Units/volume] in Serum,C tetani IgG Ser-aCnc,MICRO,1618
6237-2,Salmon IgE Ab [Units/volume] in Serum,Salmon IgE Qn,Allergy,1619
48049-1,Eosinophils [Presence] in Stool by Wright stain,Eosinophil Stl Ql Wright Stn,HEM/BC,1620
5202-7,Herpes simplex virus Ab [Units/volume] in Serum by Immunoassay,HSV Ab Ser IA-aCnc,MICRO,1621
12308-3,Hydrocodone [Presence] in Urine,Hydrocodone Ur Ql,DRUG/TOX,1622
9834-3,Hydromorphone [Presence] in Urine,Hydromorphone Ur Ql,DRUG/TOX,1623
42192-5,Nidus [Presence] in Stone,Nidus Stone Ql,PATH,1624
16249-5,Oxycodone [Mass/volume] in Urine by Confirmatory method,Oxycodone Ur Cfm-mCnc,DRUG/TOX,1625
30437-8,Monocytes+Macrophages/100 leukocytes in Body fluid,Monos+Macros/leuk NFr Fld,HEM/BC,1626
6035-0,Banana IgE Ab [Units/volume] in Serum,Banana IgE Qn,Allergy,1627
19643-6,Oxycodone [Presence] in Urine by Confirmatory method,Oxycodone Ur Ql Cfm,DRUG/TOX,1628
18325-1,Oxymorphone [Presence] in Urine by Confirmatory method,Oxymorphone Ur Ql Cfm,DRUG/TOX,1629
47226-6,Fetal lung maturity [interpretation] in Amniotic fluid,FLM Amn-Imp,Chem,1630
17395-5,Oxymorphone [Mass/volume] in Urine by Confirmatory method,Oxymorphone Ur Cfm-mCnc,DRUG/TOX,1631
19074-4,Carnitine esters [Moles/volume] in Serum or Plasma,Carn esters SerPl-sCnc,Chem,1632
12598-9,Fat.neutral [Presence] in Stool,Neutral Fat Stl Ql,Chem,1633
17123-1,CD19+Lambda+ cells/100 cells in Blood,CD19+Lambda+ Cells NFr Bld,CELLMARK,1634
36922-3,TPMT gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative,TPMT gene Mut Anal Bld/T,MOLPATH.MUT,1635
6194-5,Orange IgE Ab [Units/volume] in Serum,Orange IgE Qn,Allergy,1636
5170-6,Gliadin IgG Ab [Units/volume] in Serum,Gliadin IgG Ser-aCnc,SERO,1637
26528-0,Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin,Cortis 1h p ACTH SerPl-mCnc,CHAL,1638
49581-2,Reference lab test identifier and name [Identifier],Ref Lab Test ID+Name,MISC,1639
12210-1,Eosinophils/100 leukocytes in Urine sediment by Manual count,Eosinophil/leuk NFr UrnS Manual,UA,1640
7042-5,Penicillin V [Susceptibility] by Gradient strip,Penicillin V Islt Grad strip,ABXBACT,1641
7041-7,Penicillin G [Susceptibility] by Gradient strip,Penicillin G Islt Grad strip,ABXBACT,1641
29901-6,HTLV 1+2 Ab [Presence] in Serum by Immunoassay,HTLV I+II Ab Ser Ql IA,MICRO,1642
22110-1,Bartonella henselae IgG Ab [Titer] in Serum,B henselae IgG Titr Ser,MICRO,1643
14251-3,Mitochondria M2 IgG Ab [Units/volume] in Serum,Mitochondria M2 IgG Ser-aCnc,SERO,1644
26530-6,Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose corticotropin,Cortis 30M p ACTH SerPl-mCnc,CHAL,1645
19593-3,6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method,6MAM Ur Cfm-mCnc,DRUG/TOX,1646
59417-6,Oxygen saturation in Arterial blood by Pulse oximetry --resting,SaO2 Resting % BldA PulseOx,HEMODYN.MOLEC,1647
59412-7,Oxygen saturation in Arterial blood by Pulse oximetry --post exercise,SaO2 p Exc % BldA PulseOx,HEMODYN.MOLEC,1648
6448-5,Legionella pneumophila Ag [Presence] in Urine by Radioimmunoassay (RIA),L pneumo Ag Ur Ql RIA,MICRO,1649
6137-4,Hazelnut Pollen IgE Ab [Units/volume] in Serum,Hazelnut Poln IgE Qn,Allergy,1650
5644-0,Ethanol [Presence] in Urine,Ethanol Ur Ql,DRUG/TOX,1651
3093-2,Urea nitrogen [Mass/volume] in Body fluid,Urea nit Fld-mCnc,Chem,1652
2701-1,Oxalate [Mass/time] in 24 hour Urine,Oxalate 24h Ur-mRate,Chem,1653
1007-4,Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells,DAT Poly-Sp Reag RBC Ql,BLDBK,1654
59841-7,Vendor name [Identifier] in Unspecified specimen,Vendor name XXX,Chem,1655
19768-1,Reviewing cytologist who read Cyto stain of Cervical or vaginal smear or scraping,Reviewing cytologist,CYTO,1656
5381-9,Thyroglobulin Ab [Titer] in Serum by Latex agglutination,Thyroglob Ab Titr Ser LA,SERO,1657
808-6,Leukocytes [#/volume] in Pleural fluid by Manual count,WBC # Plr Manual,HEM/BC,1658
35331-8,Oxcarbazepine [Mass/volume] in Serum or Plasma,Oxcarbazepine SerPl-mCnc,DRUG/TOX,1659
14862-7,Oxalate [Moles/time] in 24 hour Urine,Oxalate 24h Ur-sRate,Chem,1660
25835-0,HIV 1 RNA [Presence] in Serum or Plasma by Probe & target amplification method,HIV1 RNA SerPl Ql PCR,MICRO,1661
35051-2,Leukocytes other [#/volume] in Body fluid,WBC Other # Fld,HEM/BC,1662
7893-1,Gliadin Ab [Units/volume] in Serum,Gliadin Ab Ser-aCnc,SERO,1663
15015-1,Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma,ALP Liver CFr SerPl,Chem,1664
33917-6,Nornicotine [Mass/volume] in Urine,Nornicotine Ur-mCnc,DRUG/TOX,1665
15013-6,Alkaline phosphatase.bone/Alkaline phosphatase.total in Serum or Plasma,ALP Bone CFr SerPl,Chem,1666
24378-2,Platelet aggregation epinephrine induced [Presence] in Platelet rich plasma,PA Epineph PRP Ql,COAG,1667
6062-4,Casein IgE Ab [Units/volume] in Serum,Casein IgE Qn,Allergy,1668
6220-8,Potato IgE Ab [Units/volume] in Serum,Potato IgE Qn,Allergy,1669
6873-4,Beta hydroxybutyrate [Moles/volume] in Serum or Plasma,B-OH-Butyr SerPl-sCnc,Chem,1670
47440-3,Hepatitis B virus core Ab [Presence] in Serum from donor,HBV core Ab Ser Donr Ql,MICRO,1671
44533-8,HIV 1+2 Ab [Presence] in Serum from donor,HIV1+2 Ab Ser Donr Ql,MICRO,1672
44538-7,HTLV 1+2 Ab [Presence] in Serum from donor,HTLV I+II Ab Ser Donr Ql,MICRO,1673
5877-6,Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunofluorescence,RSV Ag XXX Ql IF,MICRO,1674
49846-9,Hepatitis C virus Ag [Presence] in Blood or Marrow from donor,HCV core Ag Bld/Mar Donr Ql,MICRO,1675
9632-1,Aspergillus fumigatus Ab [Presence] in Serum,A fumigatus Ab Ser Ql,MICRO,1676
2032-1,Carboxyhemoglobin/Hemoglobin.total in Venous blood,COHgb MFr BldV,Chem,1677
19050-4,Metanephrines [Mass/volume] in 24 hour Urine,MetanephS 24h Ur-mCnc,Chem,1678
47364-5,Hepatitis B virus surface Ag [Presence] in Serum from donor by Immunoassay,HBV surface Ag Ser Donr Ql IA,MICRO,1679
13942-8,Spermatozoa Motile [Presence] in Semen by Light microscopy,Sperm Motile Smn Ql Micro,FERT,1680
22463-4,Reagin Ab [Presence] in Serum from donor,Reagin Ab Ser Donr Ql,MICRO,1681
10622-9,Spermatozoa Normal/100 spermatozoa in Semen,Sperm Norm NFr Smn,FERT,1682
19088-4,Collection of urine specimen start date,Collect Start Date Ur,SPEC,1683
47441-1,Hepatitis C virus Ab [Presence] in Serum from donor,HCV Ab Ser Donr Ql,MICRO,1684
19089-2,Collection of urine specimen start time,Collect Start Tme Ur,SPEC,1685
15174-6,Cryocrit of Serum by Spun Westergren,Cryocrit Ser Spun Westergren,Chem,1686
5000-5,Cytomegalovirus DNA [Presence] in Unspecified specimen by Probe & target amplification method,CMV DNA XXX Ql PCR,MICRO,1687
19086-8,Collection of urine specimen end date,Collect End Date Ur,SPEC,1688
19087-6,Collection of urine specimen end time,Collect End Tme Ur,SPEC,1689
7558-0,Oyster IgE Ab [Units/volume] in Serum,Oyster IgE Qn,Allergy,1690
29280-5,Fibrin D-dimer [Presence] in Platelet poor plasma by Latex agglutination,D Dimer PPP Ql LA,COAG,1691
43399-5,JAK2 gene p.V617F [Presence] in Blood or Tissue by Molecular genetics method,JAK2 p.V617F Bld/T Ql,MOLPATH.MUT,1692
13462-7,Apolipoprotein A-I/Apolipoprotein B [Mass ratio] in Serum or Plasma,Apo A-I/Apo B SerPl,Chem,1693
49295-9,Protein Fractions [interpretation] in Cerebral spinal fluid by Electrophoresis Narrative,Prot Pattern CSF Elph-Imp,Chem,1694
43441-5,Bacteria identified in Bronchoalveolar lavage by Aerobe culture,Bacteria BAL Aerobe Cult,MICRO,1695
21482-5,Protein [Mass/volume] in 24 hour Urine,Prot 24h Ur-mCnc,Chem,1696
2597-3,Magnesium [Moles/volume] in Red Blood Cells,Magnesium RBC-sCnc,Chem,1697
2669-0,Normetanephrine [Mass/volume] in Serum or Plasma,Normetanephrine SerPl-mCnc,Chem,1698
35603-0,Clonazepam [Mass/volume] in Serum or Plasma by Screen method,Clonazepam SerPl Scn-mCnc,DRUG/TOX,1699
21422-1,Normetanephrine [Mass/volume] in 24 hour Urine,Normetanephrine 24h Ur-mCnc,Chem,1700
13327-2,Parainfluenza virus Ag [Presence] in Unspecified specimen by Immunofluorescence,HPIV Ag XXX Ql IF,MICRO,1701
26517-3,Polymorphonuclear cells/100 leukocytes in Cerebral spinal fluid,Polys/leuk NFr CSF,HEM/BC,1702
3193-0,Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay,Fact V Act/Nor PPP,COAG,1703
2895-1,Protoporphyrin.zinc [Mass/volume] in Red Blood Cells,ZPP RBC-mCnc,Chem,1704
6367-7,Clostridium tetani IgG Ab [Units/volume] in Serum by Immunoassay,C tetani IgG Ser IA-aCnc,MICRO,1705
41480-5,BK virus DNA [#/volume] (viral load) in Urine by Probe & target amplification method,BKV DNA # Ur PCR,MICRO,1706
31788-3,Cryptococcus sp Ag [Presence] in Cerebral spinal fluid,Cryptoc Ag CSF Ql,MICRO,1707
31843-6,Helicobacter pylori Ag [Presence] in Stool,H pylori Ag Stl Ql,MICRO,1708
888-8,Blood group antibodies identified in Serum or Plasma,Blood group antibodies SerPl,BLDBK,1709
25987-9,Testosterone Free [Moles/volume] in Serum or Plasma by Radioimmunoassay (RIA),Testost Free SerPl RIA-sCnc,Chem,1710
40464-0,Drugs identified in Urine by Confirmatory method,Drugs Ur Cfm,DRUG/TOX,1711
13227-4,Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum,C diphtheriae IgG Ser-aCnc,MICRO,1712
58787-3,Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum by Immunoassay,C diphtheriae IgG Ser IA-aCnc,MICRO,1713
32284-2,BK virus DNA [Units/volume] (viral load) in Serum or Plasma by Probe & target amplification method,BKV DNA SerPl PCR-aCnc,MICRO,1714
19287-2,Cannabinoids tested for in Urine by Screen method Nominal,Cannabinoids Tested Ur Scn,DRUG/TOX,1715
17852-5,Ureaplasma urealyticum [Presence] in Unspecified specimen by Organism specific culture,U urealyticum XXX Ql Cult,MICRO,1716
6078-0,Cockroach IgE Ab [Units/volume] in Serum,Roach IgE Qn,Allergy,1717
15388-2,Mycoplasma hominis [Presence] in Unspecified specimen by Organism specific culture,M hominis XXX Ql Cult,MICRO,1718
31036-7,Gatifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC),Gatifloxacin Islt MIC,ABXBACT,1719
23871-7,Hepatitis C virus NS5 Ab [Presence] in Serum by Immunoblot (IB),HCV NS5 Ab Ser Ql IB,MICRO,1720
15917-8,Peanut IgE Ab RAST class in Serum,Peanut IgE RAST Ql,Allergy,1721
9610-7,Hepatitis C virus c33c Ab [Presence] in Serum by Immunoblot (IB),HCV C33c Ab Ser Ql IB,MICRO,1722
9609-9,Hepatitis C virus 22-3 Ab [Presence] in Serum by Immunoblot (IB),HCV22-3 Ab Ser Ql IB,MICRO,1723
3187-2,Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay,Fact IX Act/Nor PPP,COAG,1724
43993-5,Age at delivery,Age at delivery,OB.US,1725
23860-0,Erythrocytes [#/volume] in Body fluid by Automated count,RBC # Fld Auto,HEM/BC,1726
3096-5,Urea nitrogen [Mass/time] in 24 hour Urine,UUN 24h Ur-mRate,Chem,1727
6998-9,Ceftriaxone [Susceptibility] by Gradient strip,Ceftriaxone Islt Grad strip,ABXBACT,1728
25630-5,Parvovirus B19 IgG Ab [Titer] in Serum,B19V IgG Titr Ser,MICRO,1729
2350-7,Glucose [Mass/volume] in Urine,Glucose Ur-mCnc,Chem,1730
19098-3,Erythrocytes [Presence] in Amniotic fluid,RBC Amn Ql,HEM/BC,1731
12229-1,Macrophages/100 leukocytes in Cerebral spinal fluid by Manual count,Macrophages/leuk NFr CSF Manual,HEM/BC,1732
20446-1,Herpes simplex virus IgG Ab [interpretation] in Serum by Immunoassay,HSV IgG Ser IA-Imp,MICRO,1733
6059-0,Candida albicans IgE Ab [Units/volume] in Serum,C albicans IgE Qn,Allergy,1734
13337-1,CD8+HLA-DR+ cells/100 cells in Blood,CD8+HLA-DR+ Cells NFr Bld,CELLMARK,1735
21112-8,Birth date,Birth Date,MISC,1736
25435-9,Herpes simplex virus IgM Ab [Presence] in Serum,HSV IgM Ser Ql,MICRO,1737
49835-2,CD19+IgD+ cells/100 cells in Unspecified specimen,CD19+IgD+ cells NFr XXX,CELLMARK,1738
32632-2,HEXA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,HEXA gene Mut Anal Bld/T,MOLPATH.MUT,1739
49041-7,Testosterone [Mass/volume] in Serum or Plasma by Detection limit = 1.0 ng/dL,Testost SerPl DL<=1.0 ng/dL-mCnc,Chem,1740
5096-3,Coccidioides immitis Ab [Titer] in Serum by Complement fixation,C immitis Ab Titr Ser CF,MICRO,1741
7774-3,Cow whey IgE Ab [Units/volume] in Serum,Cow Whey IgE Qn,Allergy,1742
5052-6,Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID),Aspergillus Ab Ser Ql ID,MICRO,1743
29675-6,Parvovirus B19 IgG Ab [Presence] in Serum,B19V IgG Ser Ql,MICRO,1744
29660-8,Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay,B19V IgG Ser Ql IA,MICRO,1745
7981-4,Parvovirus B19 IgM Ab [Presence] in Serum,B19V IgM Ser Ql,MICRO,1746
40658-7,Parvovirus B19 IgM Ab [Presence] in Serum by Immunoassay,B19V IgM Ser Ql IA,MICRO,1747
32147-1,Reducing substances [Mass/volume] in Urine,Reducing Subs Ur-mCnc,UA,1748
22111-9,Bartonella henselae IgM Ab [Titer] in Serum,B henselae IgM Titr Ser,MICRO,1749
22362-8,HTLV 1+2 Ab [Presence] in Serum,HTLV I+II Ab Ser Ql,MICRO,1750
2892-8,Protoporphyrin Free [Mass/volume] in Blood,FEP Bld-mCnc,Chem,1751
3198-9,Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay,Fact VII Act/Nor PPP,COAG,1752
49042-5,Testosterone Free [Mass/volume] in Serum or Plasma by Detection limit = 1.0 ng/dL,Testost Free SerPl DL<=1.0 ng/dL-mCnc,Chem,1753
10386-1,Albumin given [Volume],Albumin Gvn Vol,BLDBK,1754
13589-7,Activated protein C resistance [Presence] in Blood by Probe & target amplification method,aPCR Bld Ql PCR,COAG,1755
16201-6,Oxazepam [Mass/volume] in Urine by Confirmatory method,Oxazepam Ur Cfm-mCnc,DRUG/TOX,1756
8087-9,Parietal cell Ab [Units/volume] in Serum,PCA Ab Ser-aCnc,SERO,1757
8220-6,Opiates [Mass/volume] in Urine,Opiates Ur-mCnc,DRUG/TOX,1758
16228-9,Nordiazepam [Mass/volume] in Urine by Confirmatory method,Nordiazepam Ur Cfm-mCnc,DRUG/TOX,1759
23876-6,HIV 1 RNA [Units/volume] (viral load) in Plasma by Probe & signal amplification method,HIV1 RNA Plas bDNA-aCnc,MICRO,1760
42621-3,Mycoplasma hominis DNA [Presence] in Blood by Probe & target amplification method,M hominis DNA Bld Ql PCR,MICRO,1761
4477-6,Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma,C1INH SerPl-mCnc,HEM/BC,1762
6138-2,Helminthosporium halodes IgE Ab [Units/volume] in Serum,S rostrata IgE Qn,Allergy,1763
2216-0,Dopamine [Mass/volume] in Serum or Plasma,Dopamine SerPl-mCnc,Chem,1764
6037-6,Barley IgE Ab [Units/volume] in Serum,Barley IgE Qn,Allergy,1765
7632-3,Privet IgE Ab [Units/volume] in Serum,Privet IgE Qn,Allergy,1766
10580-9,Liquefaction [Time] in Semen,Liquefaction Time Smn,FERT,1767
6460-0,Bacteria identified in Sputum by Culture,Bacteria Spt Cult,MICRO,1768
20416-4,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method,HCV RNA # SerPl PCR,MICRO,1769
13941-0,Lymphocytes/100 leukocytes in Body fluid by Manual count,Lymphocytes/leuk NFr Fld Manual,HEM/BC,1770
47252-2,Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by Probe & target amplification method,HCV RNA SerPl PCR-Log#,MICRO,1771
41487-0,Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay,C parvum Ag Stl Ql IA,MICRO,1772
14116-8,IgG synthesis rate [Mass/time] in Serum & CSF by calculation,IgG Synth Rate Ser+CSF Calc-mRate,Chem,1773
29539-4,HIV 1 RNA [Log #/volume] (viral load) in Plasma by Probe & signal amplification method,HIV1 RNA Plas bDNA-Log#,MICRO,1774
33630-5,HIV protease gene mutations detected [Identifier] in Isolate,HIV PI gene Mut Det Islt,ABXBACT,1775
21821-4,"t(9,22)(ABL1,BCR) Translocation [Presence] in Blood or Tissue by Molecular genetics method","t(9;22)(ABL1,BCR) Bld/T Ql",MOLPATH.TRNLOC,1776
33893-9,Karyotype [Identifier] in Bone marrow Nominal,Karyotyp Mar,MOLPATH,1777
20398-4,Nuclear Ab Pattern Homogenous [Titer] in Serum,ANA Homogen Titr Ser,SERO,1778
5583-0,Arsenic [Mass/volume] in Blood,Arsenic Bld-mCnc,DRUG/TOX,1779
5234-0,Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoassay,ENA Jo1 Ab Ser Ql IA,SERO,1780
16074-7,Walnut IgE Ab RAST class in Serum,Walnut IgE RAST Ql,Allergy,1781
35622-0,Nordiazepam [Mass/volume] in Serum or Plasma by Screen method,Nordiazepam SerPl Scn-mCnc,DRUG/TOX,1782
15014-4,Alkaline phosphatase.intestinal/Alkaline phosphatase.total in Serum or Plasma,ALP Intest CFr SerPl,Chem,1783
20431-3,Microscopic observation [Identifier] in Unspecified specimen by Smear,Smear XXX,MICRO,1784
49588-7,First trimester maternal screen with nuchal translucency [interpretation] Narrative,1st trimester scn+NT Patient-Imp,Chem,1785
611-4,Bacteria identified in Body fluid by Culture,Bacteria Fld Cult,MICRO,1786
23905-3,Mycophenolate [Mass/volume] in Serum or Plasma,Mycophenolate SerPl-mCnc,DRUG/TOX,1787
31112-6,Reticulocytes/100 erythrocytes in Blood by Manual,Retics/100 RBC NFr Manual,HEM/BC,1788
25418-5,Mumps virus IgG Ab [Units/volume] in Serum by Immunoassay,MuV IgG Ser IA-aCnc,MICRO,1789
65757-7,Pathology biopsy report in Kidney Narrative,Kidney Path Bx report,PATH,1790
65752-8,Pathology biopsy report in Liver Narrative,Liver Path Bx report,PATH,1791
65751-0,Pathology biopsy report in Muscle Narrative,Muscle Path Bx report,PATH,1792
65754-4,Pathology biopsy report in Skin Narrative,Skin Path Bx report,PATH,1793
2217-8,Dopamine [Mass/volume] in Urine,Dopamine Ur-mCnc,Chem,1794
11046-0,Epinephrine [Mass/volume] in Urine,Epineph Ur-mCnc,Chem,1795
2667-4,Norepinephrine [Mass/volume] in Urine,Norepineph Ur-mCnc,Chem,1796
25383-1,Cow milk IgE Ab RAST class in Serum,Cow Milk IgE RAST Ql,Allergy,1797
6234-9,Saltwort IgE Ab [Units/volume] in Serum,Saltwort IgE Qn,Allergy,1798
3786-1,Methaqualone [Presence] in Urine,Methaqualone Ur Ql,DRUG/TOX,1799
11060-1,Reducing substances [Presence] in Stool,Reducing Subs Stl Ql,Chem,1800
20469-3,Acetone [Presence] in Serum or Plasma by Screen method,Acetone SerPl Ql Scn,DRUG/TOX,1801
50970-3,XXX blood group Ab [Titer] in Serum or Plasma by Antihuman globulin,XXX blood group Ab Titr SerPl AHG,BLDBK,1802
22315-6,Hepatitis A virus IgM Ab [Units/volume] in Serum,HAV IgM Ser-aCnc,MICRO,1803
17713-9,Topiramate [Mass/volume] in Serum or Plasma,Topiramate SerPl-mCnc,DRUG/TOX,1804
19125-4,Meconium [Presence] in Amniotic fluid,Meconium Amn Ql,Chem,1805
49578-8,Aminocaproate cutoff [Mass/volume] in Serum or Plasma,Amicaproate CtO SerPl-mCnc,DRUG/TOX,1806
2749-0,pH of Gastric fluid,pH Gast,Chem,1807
11559-2,Fractional oxyhemoglobin in Blood,OxyHgb MFr Bld,Chem,1808
7415-3,Cladosporium sphaerospermum IgE Ab [Units/volume] in Serum,C sphaerospermum IgE Qn,Allergy,1809
34696-5,Collection method [Type] of Semen,Collection method Smn,SPEC,1810
7901-2,Helicobacter pylori IgA Ab [Units/volume] in Serum,H pylori IgA Ser-aCnc,MICRO,1811
38494-1,Metanephrine Free [Mass/volume] in Serum or Plasma,Metaneph Free SerPl-mCnc,Chem,1812
13627-5,Erythrocytes [Presence] in Semen by Light microscopy,RBC Smn Ql Micro,FERT,1813
15192-8,Lymphocytes Variant [Presence] in Blood by Automated count,Variant Lymphs Bld Ql Auto,HEM/BC,1814
2030-5,Carboxyhemoglobin/Hemoglobin.total in Arterial blood,COHgb MFr BldA,Chem,1815
11034-6,Acetylcholine receptor binding Ab [Moles/volume] in Serum,AChR Bind Ab Ser-sCnc,SERO,1816
5838-8,Cytomegalovirus [Presence] in Unspecified specimen by Organism specific culture,CMV XXX Ql Cult,MICRO,1817
24312-1,Treponema pallidum Ab [Presence] in Serum by Agglutination,T pallidum Ab Ser Ql Aggl,MICRO,1818
35595-8,Acetaminophen [Mass/volume] in Serum or Plasma by Screen method,APAP SerPl Scn-mCnc,DRUG/TOX,1819
550-4,Bordetella pertussis Ag [Presence] in Unspecified specimen by Immunofluorescence,B pert Ag XXX Ql IF,MICRO,1820
25148-8,Calcium oxalate crystals [#/area] in Urine sediment by Microscopy high power field,CaOx Cry #/area UrnS HPF,UA,1821
14117-6,IgG index in Serum & CSF,IgG/Alb clear Ser+CSF-Rto,Chem,1822
26509-0,Neutrophils.band form/100 leukocytes in Cerebral spinal fluid,Neuts Band/leuk NFr CSF,HEM/BC,1823
12209-3,Eosinophils/100 leukocytes in Body fluid by Manual count,Eosinophil/leuk NFr Fld Manual,HEM/BC,1824
666-8,Microscopic observation [Identifier] in Unspecified specimen by India ink prep,India Ink Prep XXX,MICRO,1825
12215-0,Fatty acids.very long chain [Moles/volume] in Serum or Plasma,VLCFA SerPl-sCnc,Chem,1826
19734-3,Chicken droppings IgE Ab [Units/volume] in Serum,Chicken Drop IgE Qn,Allergy,1827
2638-5,Myelin basic protein [Mass/volume] in Cerebral spinal fluid,MBP CSF-mCnc,Chem,1828
14875-9,Phenylalanine [Moles/volume] in Serum or Plasma,Phe SerPl-sCnc,Chem,1829
20643-3,Glutamine [Moles/volume] in Serum or Plasma,Glutamine SerPl-sCnc,Chem,1830
20636-7,Alanine [Moles/volume] in Serum or Plasma,Alanine SerPl-sCnc,Chem,1831
5005-4,Epstein Barr virus DNA [Presence] in Unspecified specimen by Probe & target amplification method,EBV DNA XXX Ql PCR,MICRO,1832
25473-0,Metanephrine [Moles/volume] in Serum or Plasma,Metaneph SerPl-sCnc,Chem,1833
20661-5,Valine [Moles/volume] in Serum or Plasma,Valine SerPl-sCnc,Chem,1834
3861-2,Nordiazepam [Presence] in Urine,Nordiazepam Ur Ql,DRUG/TOX,1835
12361-2,Oxazepam [Presence] in Urine,Oxazepam Ur Ql,DRUG/TOX,1836
9624-8,Vanillylmandelate [Mass/volume] in Urine,VMA Ur-mCnc,Chem,1837
14121-8,Pyruvate [Moles/volume] in Blood,Pyruvate Bld-sCnc,Chem,1838
46268-9,ABO & Rh group [Type] in Blood from Blood product unit--after transfusion reaction,ABO + Rh p transf rx Bld BPU,BLDBK,1839
3436-3,Carboxy tetrahydrocannabinol [Mass/volume] in Urine,CarboxyTHC Ur-mCnc,DRUG/TOX,1840
41163-7,Treponema pallidum DNA [Presence] in Unspecified specimen by Probe & target amplification method,T pallidum DNA XXX Ql PCR,MICRO,1841
20648-2,Isoleucine [Moles/volume] in Serum or Plasma,Isoleucine SerPl-sCnc,Chem,1842
20649-0,Leucine [Moles/volume] in Serum or Plasma,Leucine SerPl-sCnc,Chem,1843
24139-8,Cockroach IgG Ab [Units/volume] in Serum,Roach IgG Qn,Allergy,1844
11183-1,Macadamia IgE Ab [Units/volume] in Serum,Macadamia IgE Qn,Allergy,1845
44607-0,HIV 1 [interpretation] in Serum by Immunoassay,HIV1 SerPl IA-Imp,MICRO,1846
8015-0,Rubella virus IgM Ab [Units/volume] in Serum,RUBV IgM Ser-aCnc,MICRO,1847
6239-8,Lenscale IgE Ab [Units/volume] in Serum,Lenscale IgE Qn,Allergy,1848
5116-9,Corynebacterium diphtheriae Ab [Units/volume] in Serum by Immunoassay,C diphtheriae Ab Ser IA-aCnc,MICRO,1849
1777-2,Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma,ALP Bone SerPl-cCnc,Chem,1850
22568-0,Streptolysin O Ab [Titer] in Serum,ASO Ab Titr Ser,MICRO,1851
13538-4,"Carbon dioxide, total [Moles/volume] in Urine",CO2 Ur-sCnc,Chem,1852
14976-5,Lecithin/Sphingomyelin [Ratio] in Amniotic fluid,Lecithin/Sphingomyelin Amn-Rto,Chem,1853
19201-3,Prostate Specific Ag Free [Units/volume] in Serum or Plasma,PSA Free SerPl-aCnc,Chem,1854
18482-0,Yeast [Presence] in Unspecified specimen by Organism specific culture,Yeast XXX Ql Cult,MICRO,1855
32789-0,Viscosity of Semen Qualitative,Visc Smn Ql,SPEC,1856
7445-0,Lactalbumin alpha IgE Ab [Units/volume] in Serum,A-Lactalb IgE Qn,Allergy,1857
35670-9,Tobramycin [Mass/volume] in Serum or Plasma,Tobramycin SerPl-mCnc,DRUG/TOX,1858
17819-4,Albumin/Protein.total in unspecified time Urine by Electrophoresis,Albumin ?Tm MFr Ur Elph,Chem,1859
17811-1,Alpha 1 globulin/Protein.total in unspecified time Urine by Electrophoresis,Alpha1 Glob ?Tm MFr Ur Elph,Chem,1860
17813-7,Alpha 2 globulin/Protein.total in unspecified time Urine by Electrophoresis,Alpha2 Glob ?Tm MFr Ur Elph,Chem,1861
17815-2,Beta globulin/Protein.total in unspecified time Urine by Electrophoresis,B-Globulin ?Tm MFr Ur Elph,Chem,1862
17817-8,Gamma globulin/Protein.total in unspecified time Urine by Electrophoresis,Gamma glob ?Tm MFr Ur Elph,Chem,1863
21027-8,Platelet aggregation [interpretation] in Platelet poor plasma,PA PPP-Imp,COAG,1864
13088-0,Complement total hemolytic CH100 [Units/volume] in Serum or Plasma,CH100 SerPl-aCnc,HEM/BC,1865
34165-1,Granulocytes Immature [Presence] in Blood by Automated count,Imm Granulocytes Bld Ql Auto,HEM/BC,1866
8072-1,Insulin Ab [Units/volume] in Serum,Insulin Ab Ser-aCnc,SERO,1867
20660-7,Tyrosine [Moles/volume] in Serum or Plasma,Tyrosine SerPl-sCnc,Chem,1868
20401-6,Nuclear Ab pattern.speckled [Titer] in Serum,ANA Speckled Titr Ser,SERO,1869
533-0,Mycobacterium sp identified in Blood by Organism specific culture,Mycobacterium Bld Cult,MICRO,1870
20651-6,Methionine [Moles/volume] in Serum or Plasma,Methionine SerPl-sCnc,Chem,1871
9360-9,Bartonella quintana IgG Ab [Titer] in Serum,B quintana IgG Titr Ser,MICRO,1872
23870-9,Hepatitis C virus 100+5-1-1 Ab [Presence] in Serum by Immunoblot (IB),HCV100+5-1-1 Ab Ser Ql IB,MICRO,1873
59408-5,Oxygen saturation in Arterial blood by Pulse oximetry,SaO2 % BldA PulseOx,HEMODYN.MOLEC,1874
9812-9,Cortisol [Mass/volume] in Serum or Plasma --evening specimen,Cortis PM SerPl-mCnc,Chem,1875
2700-3,Oxalate [Mass/volume] in Urine,Oxalate Ur-mCnc,Chem,1876
4991-6,Borrelia burgdorferi DNA [Presence] in Unspecified specimen by Probe & target amplification method,B burgdor DNA XXX Ql PCR,MICRO,1877
22070-7,HP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,HP gene Mut Anal Bld/T,MOLPATH.MUT,1878
6286-9,Wormwood IgE Ab [Units/volume] in Serum,Wormwood IgE Qn,Allergy,1879
32220-6,Liver kidney microsomal 1 Ab [Units/volume] in Serum,LKM-1 Ab Ser-aCnc,SERO,1880
9326-0,Phosphatidylserine IgG Ab [Presence] in Serum by Immunoassay,PS IgG Ser Ql IA,COAG,1881
9361-7,Bartonella quintana IgM Ab [Titer] in Serum,B quintana IgM Titr Ser,MICRO,1882
20637-5,Arginine [Moles/volume] in Serum or Plasma,Arginine SerPl-sCnc,Chem,1883
20640-9,Citrulline [Moles/volume] in Serum or Plasma,Citrulline SerPl-sCnc,Chem,1884
20644-1,Glycine [Moles/volume] in Serum or Plasma,Glycine SerPl-sCnc,Chem,1885
20656-5,Serine [Moles/volume] in Serum or Plasma,Serine SerPl-sCnc,Chem,1886
20658-1,Threonine [Moles/volume] in Serum or Plasma,Threonine SerPl-sCnc,Chem,1887
20657-3,Taurine [Moles/volume] in Serum or Plasma,Taurine SerPl-sCnc,Chem,1888
6029-3,Aureobasidium pullulans IgE Ab [Units/volume] in Serum,A pullulans IgE Qn,Allergy,1889
20642-5,Glutamate [Moles/volume] in Serum or Plasma,Glutamate SerPl-sCnc,Chem,1890
20645-8,Histidine [Moles/volume] in Serum or Plasma,Histidine SerPl-sCnc,Chem,1891
20655-7,Proline [Moles/volume] in Serum or Plasma,Proline SerPl-sCnc,Chem,1892
18903-5,Chloramphenicol [Susceptibility],Chloramphen Susc Islt,ABXBACT,1893
17788-1,Large unstained cells/100 leukocytes in Blood by Automated count,LUC/leuk NFr Bld Auto,HEM/BC,1894
14246-3,Phosphatidylserine IgM Ab [Units/volume] in Serum,PS IgM Ser-aCnc,COAG,1895
3218-5,Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay,Fact X Act/Nor PPP,COAG,1896
49058-1,Activated partial thromboplastin time (aPTT) in Blood drawn from CRRT circuit by Coagulation assay,aPTT BldCRRT,COAG,1897
6061-6,Carrot IgE Ab [Units/volume] in Serum,Carrot IgE Qn,Allergy,1898
20781-1,Cryptosporidium sp [Presence] in Stool by Acid fast stain,Cryptosp Stl Ql Acid fast Stn,MICRO,1899
32217-2,von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasma,vWF multimers PPP Ql,COAG,1900
22412-1,Saccharopolyspora rectivirgula Ab [Presence] in Serum,S rectivirgula Ab Ser Ql,MICRO,1901
20652-4,Ornithine [Moles/volume] in Serum or Plasma,Ornithine SerPl-sCnc,Chem,1902
6733-0,Pigeon serum Ab [Presence] in Serum by Immune diffusion (ID),Pigeon Serum Ab Ql ID,Allergy,1903
20650-8,Lysine [Moles/volume] in Serum or Plasma,Lysine SerPl-sCnc,Chem,1904
10853-0,Isospora belli [Presence] in Unspecified specimen by Acid fast stain.Kinyoun modified,I belli XXX Ql Acid fast Mod Kiny Stn,MICRO,1905
5869-3,Parainfluenza virus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence,HPIV1 Ag XXX Ql IF,MICRO,1906
7059-9,Vancomycin [Susceptibility] by Gradient strip,Vancomycin Islt Grad strip,ABXBACT,1907
2159-2,Creatinine [Mass/volume] in Amniotic fluid,Creat Amn-mCnc,Chem,1908
1974-5,Bilirubin [Mass/volume] in Body fluid,Bilirub Fld-mCnc,Chem,1909
20638-3,Asparagine [Moles/volume] in Serum or Plasma,Asparagine SerPl-sCnc,Chem,1910
12201-0,Cryoglobulin [Presence] in Serum by 1 day cold incubation,Cryoglob Ser Ql 1D Cold Inc,Chem,1911
20499-0,Phosphatidylglycerol/Surfactant.total in Amniotic fluid,PG MFr Amn,Chem,1912
50758-2,Herpes simplex virus 1 IgM Ab [Titer] in Serum by Immunofluorescence,HSV1 IgM Titr Ser IF,MICRO,1913
26927-4,Herpes simplex virus 2 IgM Ab [Titer] in Serum by Immunofluorescence,HSV2 IgM Titr Ser IF,MICRO,1914
16195-0,Benzodiazepines [Presence] in Urine by Confirmatory method,Benzodiaz Ur Ql Cfm,DRUG/TOX,1915
6081-4,Coconut IgE Ab [Units/volume] in Serum,Coconut IgE Qn,Allergy,1916
721-1,Free Hemoglobin [Mass/volume] in Plasma,Hgb Free Plas-mCnc,HEM/BC,1917
31209-0,Islet cell 512 Ab [Units/volume] in Serum,Islet Cell512 Ab Ser-aCnc,SERO,1918
1779-8,Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma,ALP Liver SerPl-cCnc,Chem,1919
2334-1,Hemoglobin.gastrointestinal [Presence] in Gastric fluid    *NOTE: from occult blood,Gastrocult Gast Ql,Chem,1920
16085-3,Wheat IgE Ab RAST class in Serum,Wheat IgE RAST Ql,Allergy,1921
29591-5,Enterovirus RNA [Presence] in Unspecified specimen by Probe & target amplification method,EV RNA XXX Ql PCR,MICRO,1922
24103-4,Plasma cells [#/volume] in Blood by Manual count,Plasma Cells # Bld Manual,HEM/BC,1923
6038-4,American Beech IgE Ab [Units/volume] in Serum,Amer Beech IgE Qn,Allergy,1924
38168-1,Major crossmatch [interpretation] by Low ionic strenght saline (LISS),Maj XM SerPl LISS-Imp,BLDBK,1925
2142-8,Cortisol [Mass/volume] in Saliva,Cortis Sal-mCnc,Chem,1926
15568-9,Soybean IgE Ab RAST class in Serum,Soybean IgE RAST Ql,Allergy,1927
43734-3,aPTT in Platelet poor plasma by Coagulation 1:1 saline,aPTT PPP 1:1 saline,COAG,1928
75513-2,dRVVT with 1:1 PNP (LA mix),Mixing dRVVT,COAG,1929
16982-1,HTLV 1+2 Ab [Presence] in Serum by Immunoblot (IB),HTLV I+II Ab Ser Ql IB,MICRO,1930
20420-6,Prostatic acid phosphatase [Mass/volume] in Serum,PACP Ser-mCnc,Chem,1931
6125-9,Gluten IgE Ab [Units/volume] in Serum,Gluten IgE Qn,Allergy,1932
30374-3,Basophils/100 leukocytes in Cerebral spinal fluid,Basophils/leuk NFr CSF,HEM/BC,1933
3714-3,Lidocaine [Mass/volume] in Serum or Plasma,Lidocain SerPl-mCnc,DRUG/TOX,1934
10526-2,Microscopic observation [Identifier] in Sputum by Cyto stain,Cyto Spt,CYTO,1935
7796-6,Platelet clump [Presence] in Blood by Light microscopy,Platelet Clump Bld Ql Smear,HEM/BC,1936
5959-2,Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma,PT imm NP PPP,COAG,1937
29559-2,Haemophilus ducreyi DNA [Presence] in Unspecified specimen by Probe & target amplification method,H ducreyi DNA XXX Ql PCR,MICRO,1938
18743-5,Autopsy report,Autopsy report,ATTACH.CLINRPT,1939
6901-3,Insulin Free [Units/volume] in Serum or Plasma,Insulin Free SerPl-aCnc,Chem,1940
6121-8,Fusarium moniliforme IgE Ab [Units/volume] in Serum,F moniliforme IgE Qn,Allergy,1941
49838-6,Neural tube defect risk in population,Neural tube defect risk pop,Chem,1942
6090-5,Cottonwood IgE Ab [Units/volume] in Serum,Cottonwood IgE Qn,Allergy,1943
30192-9,Acetylcholine receptor modulation Ab/Acetylcholine Ab.total in Serum,AChR Mod Ab/AChR Total SFr Ser,SERO,1944
6287-7,Baker's yeast IgE Ab [Units/volume] in Serum,Baker's yeast IgE Qn,Allergy,1945
6349-5,Chlamydia trachomatis [Presence] in Unspecified specimen by Organism specific culture,C trach XXX Ql Cult,MICRO,1946
4635-9,Free Hemoglobin [Mass/volume] in Serum,Hgb Free Ser-mCnc,HEM/BC,1947
46128-5,Tissue transglutaminase IgA Ab [Units/volume] in Serum by Immunoassay,tTG IgA Ser IA-aCnc,SERO,1948
2711-0,Oxygen saturation (SO2) in Venous blood,SaO2 % BldV,HEMODYN.MOLEC,1949
7797-4,Rouleaux [Presence] in Blood by Light microscopy,Rouleaux Bld Ql Smear,HEM/BC,1950
8277-6,Body surface area,BSA,BDYSURF.ATOM,1951
765-8,Neutrophils.hypersegmented [Presence] in Blood by Light microscopy,Neuts Hyperseg Bld Ql Smear,HEM/BC,1952
1926-5,Base excess in Capillary blood,Base excess BldC Calc-sCnc,Chem,1953
7795-8,Pappenheimer bodies [Presence] in Blood by Light microscopy,Pappenheimer Bod Bld Ql Smear,HEM/BC,1954
20456-0,Fungi.yeastlike [Presence] in Urine sediment by Light microscopy,Yeast Like Fungi UrnS Ql Micro,UA,1955
2716-9,Fractional oxyhemoglobin (HbO2) in Venous blood,OxyHgb MFr BldV,Chem,1956
5819-8,Waxy casts [#/area] in Urine sediment by Microscopy low power field,Waxy Casts #/area UrnS LPF,UA,1957
5807-3,RBC casts [#/area] in Urine sediment by Microscopy low power field,RBC Casts #/area UrnS LPF,UA,1958
38995-7,Mixed cellular casts [#/area] in Urine sediment by Microscopy low power field,Mixed Cell Casts #/area UrnS LPF,UA,1959
46138-4,Urate crystals [#/area] in Urine sediment by Microscopy high power field,Urate Cry #/area UrnS HPF,UA,1960
5335-5,Rubella virus IgM Ab [Units/volume] in Serum by Immunoassay,RUBV IgM Ser IA-aCnc,MICRO,1961
25154-6,Unidentified crystals [#/area] in Urine sediment by Microscopy high power field,Unident Crys #/area UrnS HPF,UA,1962
33215-5,Neutrophils.agranular [Presence] in Blood by Light microscopy,Agran Neuts Bld Ql Smear,HEM/BC,1963
5788-5,Oval fat bodies (globules) [#/area] in Urine sediment by Microscopy high power field,Oval fat bodies #/area UrnS HPF,UA,1964
2272-3,Fat [Presence] in Urine,Fat Ur Ql,Chem,1965
10380-4,Stomatocytes [Presence] in Blood by Light microscopy,Stomatocytes Bld Ql Smear,HEM/BC,1966
7817-0,Borrelia burgdorferi IgG Ab [Units/volume] in Serum,B burgdor IgG Ser-aCnc,MICRO,1967
5062-5,Borrelia burgdorferi IgG Ab [Units/volume] in Serum by Immunoassay,B burgdor IgG Ser IA-aCnc,MICRO,1968
5786-9,Epithelial casts [#/area] in Urine sediment by Microscopy low power field,Epith Casts #/area UrnS LPF,UA,1969
33216-3,Platelets agranular [Presence] in Blood by Light microscopy,Agran Platelets Bld Ql Smear,HEM/BC,1970
18311-1,Pelger Huet cells [Presence] in Blood by Light microscopy,Pelger Huet Cells Bld Ql Smear,HEM/BC,1971
11281-3,Auer rods [Presence] in Blood by Light microscopy,Auer Bodies Bld Ql Smear,HEM/BC,1972
30003-8,Microalbumin [Mass/volume] in 24 hour Urine,Microalbumin 24h Ur-mCnc,Chem,1973
5784-4,Cystine crystals [Presence] in Urine sediment by Light microscopy,Cystine Cry UrnS Ql Micro,UA,1974
5775-2,Calcium phosphate crystals [Presence] in Urine sediment by Light microscopy,Ca Phos Cry UrnS Ql Micro,UA,1975
5789-3,Fatty casts [#/area] in Urine sediment by Microscopy low power field,Fatty Casts #/area UrnS LPF,UA,1976
5773-7,Calcium carbonate crystals [Presence] in Urine sediment by Light microscopy,Ca Carbonate Cry UrnS Ql Micro,UA,1977
20624-3,Creatinine [Mass/volume] in 24 hour Urine,Creat 24h Ur-mCnc,Chem,1978
14958-3,Microalbumin/Creatinine [Mass ratio] in 24 hour Urine,Microalbumin/Creat 24h Ur,Chem,1979
33647-9,Protein.monoclonal/Protein.total in Serum or Plasma by Electrophoresis,M Protein MFr SerPl Elph,Chem,1980
716-1,Heinz bodies [Presence] in Blood by Light microscopy,Heinz Bod Bld Ql Smear,HEM/BC,1981
5798-4,Leucine crystals [Presence] in Urine sediment by Light microscopy,Leucine Cry UrnS Ql Micro,UA,1982
2027-1,"Carbon dioxide, total [Moles/volume] in Venous blood",CO2 BldV-sCnc,Chem,1983
5815-6,Tyrosine crystals [Presence] in Urine sediment by Light microscopy,Tyrosine Cry UrnS Ql Micro,UA,1984
5766-1,Ammonium urate crystals [Presence] in Urine sediment by Light microscopy,Amm Urate Cry UrnS Ql Micro,UA,1985
30350-3,Hemoglobin [Mass/volume] in Venous blood,Hgb BldV-mCnc,HEM/BC,1986
27200-5,Nuclear Ab [Units/volume] in Serum,ANA Ser-aCnc,SERO,1987
25149-6,Calcium phosphate crystals [#/area] in Urine sediment by Microscopy high power field,Ca Phos Cry #/area UrnS HPF,UA,1988
25158-7,Oval fat bodies (globules) [Presence] in Urine sediment by Light microscopy,Oval fat bodies UrnS Ql Micro,UA,1989
18487-9,Broad casts [#/area] in Urine sediment by Microscopy low power field,Broad Casts #/area UrnS LPF,UA,1990
24015-0,Influenza virus A+B Ag [Presence] in Unspecified specimen,FLUAV+FLUBV Ag XXX Ql,MICRO,1991
6437-8,Influenza virus A+B Ag [Presence] in Unspecified specimen by Immunoassay,FLUAV+FLUBV Ag XXX Ql IA,MICRO,1992
20457-8,Fungi.filamentous [Presence] in Urine sediment by Light microscopy,Filament Fungi UrnS Ql Micro,UA,1993
5812-3,Sulfonamide crystals [Presence] in Urine sediment by Light microscopy,Sulfonamide cry UrnS Ql Micro,UA,1994
5771-1,Bilirubin crystals [Presence] in Urine sediment by Light microscopy,Bilirub Cry UrnS Ql Micro,UA,1995
25147-0,Calcium carbonate crystals [#/area] in Urine sediment by Microscopy high power field,Ca Carbonate Cry #/area UrnS HPF,UA,1996
40729-6,Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay,HSV IgM Ser Ql IA,MICRO,1997
53835-5,"1,5-Anhydroglucitol [Mass/volume] in Serum or Plasma","1,5-Anhydroglucitol SerPl-mCnc",Chem,1998
5777-8,Cholesterol crystals [Presence] in Urine sediment by Light microscopy,Cholest Cry UrnS Ql Micro,UA,1999
20455-2,Leukocytes [Presence] in Urine sediment by Light microscopy,WBC UrnS Ql Micro,UA,2000
33905-1,Trichomonas sp [#/area] in Urine sediment by Microscopy high power field,Trichomonas #/area UrnS HPF,UA,2001
45068-4,Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Cervix by Probe and target amplification method,C trach+GC DNA Cvx Ql PCR,MICRO,2001
30394-1,Granulocytes [#/volume] in Blood,Granulocytes # Bld,HEM/BC,2002
5795-0,Hippurate crystals [Presence] in Urine sediment by Light microscopy,Hippurate Cry UrnS Ql Micro,UA,2003
18312-9,Platelet satellitism [Presence] in Blood by Light microscopy,Platelet Satel Bld Ql Smear,HEM/BC,2004
5776-0,Calcium sulfate crystals [Presence] in Urine sediment by Light microscopy,Ca Sulfate Cry UrnS Ql Micro,UA,2005
27071-0,CD45 cells [#/volume] in Blood,CD45 Cells # Bld,CELLMARK,2006
11043-7,Cryofibrinogen [Presence] in Plasma,Cryofib Plas Ql,Chem,2007
32033-3,Phosphatidylserine IgM Ab [Units/volume] in Serum by Immunoassay,PS IgM Ser IA-aCnc,COAG,2008
20578-1,Vancomycin [Mass/volume] in Serum or Plasma,Vancomycin SerPl-mCnc,DRUG/TOX,2009
33256-9,Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood by Automated count,WBC nRBC cor # Bld Auto,HEM/BC,2010
708-8,Blasts [#/volume] in Blood by Manual count,Blasts # Bld Manual,HEM/BC,2011
18309-5,Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Manual count,nRBC/100 WBC Bld Manual-Rto,HEM/BC,2012
5156-5,Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunoassay,EBV NA IgG Ser Ql IA,MICRO,2013
51928-0,Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay,ENA RNP Ab Ser IA-aCnc,SERO,2014
33569-5,Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoassay,ENA SS-A Ab Ser IA-aCnc,SERO,2015
45142-7,Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoassay,ENA SS-B Ab Ser IA-aCnc,SERO,2016
43182-5,Smith extractable nuclear Ab [Units/volume] in Serum by Immunoassay,ENA SM Ab Ser IA-aCnc,SERO,2017
53151-7,Valine/Phenylalanine [Molar ratio] in Dried blood spot,Valine/Phe DBS-sRto,Chem,3000
47799-2,Valine [Moles/volume] in Dried blood spot,Valine DBS-sCnc,Chem,3000
53159-0,Tryptophan [Moles/volume] in Dried blood spot,Tryptophan DBS-sCnc,Chem,3000
48633-2,Trypsinogen I Free [Mass/volume] in Dried blood spot,Trypsinogen I Free DBS-mCnc,Chem,3000
29575-8,Thyrotropin [Units/volume] in Dried blood spot,TSH DBS-aCnc,Chem,3000
68325-0,Thrombin time actual/?Normal,Thrombin time/normal,COAG,3000
47784-4,Threonine [Moles/volume] in Dried blood spot,Threonine DBS-sCnc,Chem,3000
64119-1,Third most predominant hemoglobin in Dried blood spot,3rd most predominant Hb DBS,Chem,3000
70159-9,Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in Dried blood spot,Tdecenoylcarn/C14 DBS-sRto,Chem,3000
53195-4,Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot,Tdecenoylcarn/C16 DBS-sRto,Chem,3000
53194-7,Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in Dried blood spot,Tdecenoylcarn/C12:1 DBS-sRto,Chem,3000
53193-9,Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot,Tdecenoylcarn/C2 DBS-sRto,Chem,3000
53191-3,Tetradecenoylcarnitine (C14:1) [Moles/volume] in Dried blood spot,Tdecenoylcarn DBS-sCnc,Chem,3000
53192-1,Tetradecanoylcarnitine (C14) [Moles/volume] in Dried blood spot,Tdecanoylcarn DBS-sCnc,Chem,3000
53190-5,Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Dried blood spot,Tdecadienoylcarn DBS-sCnc,Chem,3000
62320-7,T-cell receptor excision circle [#/volume] in Dried blood spot by Probe and target amplification method,TREC # DBS PCR,Chem,3000
53231-7,Succinylacetone [Moles/volume] in Dried blood spot,Succinylacetone DBS-sCnc,Chem,3000
53241-6,Stearoylcarnitine (C18) [Moles/volume] in Dried blood spot,Stearoylcarn DBS-sCnc,Chem,3000
64118-3,Second most predominant hemoglobin in Dried blood spot,2nd most predominant Hb DBS,Chem,3000
68326-8,Reptilase time actual/?Normal,Reptilase time/normal,COAG,3000
6683-7,Reptilase time,Reptilase time,COAG,3000
5894-1,Prothrombin time (PT) actual/?Normal,Prothrombin time/nomal,COAG,3000
75211-3,Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in Dried blood spot,C3+C16 DBS-sCnc,Chem,3000
53164-0,Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot,Propionylcarn/C16 DBS-sRto,Chem,3000
53162-4,Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in Dried blood spot,Propionylcarn/C0 DBS-sRto,Chem,3000
53163-2,Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot,Propionylcarn/C2 DBS-sRto,Chem,3000
53160-8,Propionylcarnitine (C3) [Moles/volume] in Dried blood spot,Propionylcarn DBS-sCnc,Chem,3000
53199-6,Palmitoylcarnitine (C16) [Moles/volume] in Dried blood spot,Palmitoylcarn DBS-sCnc,Chem,3000
53198-8,Palmitoleylcarnitine (C16:1) [Moles/volume] in Dried blood spot,Palmitoleylcarn DBS-sCnc,Chem,3000
73696-7,Oxygen saturation.preductal-oxygen saturation.postductal [Mass fraction difference] in Bld.preductal and Bld.postductal,SaO2%.pre-post MFrDiff Bld.pre+post,Chem,3000
59407-7,Oxygen saturation in Blood Preductal by Pulse oximetry,SaO2 % Bld Preductal PulseOx,Chem,3000
59418-4,Oxygen saturation in Blood Postductal by Pulse oximetry,SaO2 % Bld Postductal PulseOx,Chem,3000
53202-8,Oleoylcarnitine (C18:1) [Moles/volume] in Dried blood spot,Oleoylcarn DBS-sCnc,Chem,3000
53177-2,Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot,Octanoylcarn/C10 DBS-sRto,Chem,3000
53176-4,Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot,Octanoylcarn/C2 DBS-sRto,Chem,3000
53175-6,Octanoylcarnitine (C8) [Moles/volume] in Dried blood spot,Octanoylcarn DBS-sCnc,Chem,3000
73967-2,Noninvasive prenatal fetal aneuploidy test panel - Plasma cell-free DNA,NPT fetal anpldy Pnl Plas.cfDNA,PANEL.MOLPATH,3000
75547-0,Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA,NIP aneu microdel pnl WBC.DNA+cfDNA,PANEL.MOLPATH,3000
77019-8,Noninvasive prenatal fetal 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing ,Noninv fet 18+21 aneu pnl Plas.cfDNA Seq,PANEL.MOLPATH,3000
77018-0,Noninvasive prenatal fetal 13 and 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing ,Noninv fet 13+18+21 aneu pnl cfDNA seq,PANEL.MOLPATH,3000
54109-4,Newborn hearing screen of Ear - right,NB hearing scn Ear-R,Chem,3000
54108-6,Newborn hearing screen of Ear - left,NB hearing scn Ear-L,Chem,3000
54106-0,Newborn hearing screen method,NB hearing scn meth,Chem,3000
43384-7,Neisseria sp identified in Urethra by Organism specific culture,Neisseria Urth Cult,MICRO,3000
80369-2,Neisseria sp identified in Rectum by Organism specific culture,Neisseria Rectum Cult,MICRO,3000
80366-8,Neisseria gonorrhoeae rRNA [Presence] in Rectum by Probe and target amplification method,N gonorrhoea rRNA Rectum Ql PCR,MICRO,3000
57289-1,Neisseria gonorrhoeae rRNA [Presence] in Nasopharynx by Probe and target amplification method,N gonorrhoea rRNA Nph Ql PCR,MICRO,3000
21415-5,Neisseria gonorrhoeae DNA [Presence] in Urethra by Probe and target amplification method,N gonorrhoea DNA Urth Ql PCR,MICRO,3000
53879-3,Neisseria gonorrhoeae Ag [Presence] in Urethra,N gonorrhoea rRNA Vag Ql PCR,MICRO,3000
32705-6,Neisseria gonorrhoeae Ag [Presence] in Genital specimen,N gonorrhoea DNA Vag Ql PCR,MICRO,3000
693-2,Neisseria gonorrhoeae [Presence] in Vaginal fluid by Organism specific culture,N gonorrhoea Vag Ql Cult,MICRO,3000
697-3,Neisseria gonorrhoeae [Presence] in Urethra by Organism specific culture,N gonorrhoea Urth Ql Cult,MICRO,3000
80368-4,Neisseria gonorrhoeae [Presence] in Rectum by Organism specific culture,N gonorrhoea Rectum Ql Cult,MICRO,3000
30099-6,Neisseria gonorrhoeae [Presence] in Conjunctival specimen by Organism specific culture,N gonorrhoea Conjunct Ql Cult,MICRO,3000
688-2,Neisseria gonorrhoeae [Presence] in Cervix by Organism specific culture,N gonorrhoea Cvx Ql Cult,MICRO,3000
64117-5,Most predominant hemoglobin in Dried blood spot,Most predominant Hb DBS,Chem,3000
67709-6,Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Dried blood spot,C4-DC+C5-OH DBS-sCnc,Chem,3000
53181-4,Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in Dried blood spot,Me-malonylcarn/C5OH DBS-sRto,Chem,3000
45222-7,Methylmalonylcarnitine (C4-DC) [Moles/volume] in Dried blood spot,Me-malonylcarn DBS-sCnc,Chem,3000
53187-1,Methylglutarylcarnitine (C6-DC) [Moles/volume] in Dried blood spot,MeGlutarylcarn DBS-sCnc,Chem,3000
53156-6,Methionine/Phenylalanine [Molar ratio] in Dried blood spot,Methionine/Phe DBS-sRto,Chem,3000
53397-6,Methionine/Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Molar ratio] in Dried blood spot,Methionine/Aile+Ile+Leu+Hyp DBS-sRto,Chem,3000
47700-0,Methionine [Moles/volume] in Dried blood spot,Methionine DBS-sCnc,Chem,3000
45217-7,Linoleoylcarnitine (C18:2) [Moles/volume] in Dried blood spot,Linoleoylcarn DBS-sCnc,Chem,3000
53240-8,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Propionylcarnitine (C3) [Molar ratio] in Dried blood spot,Isovaleryl+MeButyrylcarn/C3 DBS-sRto,Chem,3000
53401-6,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot,Isovaleryl+MeButyrylcarn/C8 DBS-sRto,Chem,3000
53238-2,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in Dried blood spot,Isovaleryl+MeButyrylcarn/C0 DBS-sRto,Chem,3000
53239-0,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot,Isovaleryl+MeButyrylcarn/C2 DBS-sRto,Chem,3000
45216-9,Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Dried blood spot,Isovaleryl+MeButyrylcarn DBS-sCnc,Chem,3000
45211-0,Hexanoylcarnitine (C6) [Moles/volume] in Dried blood spot,Hexanoylcarn DBS-sCnc,Chem,3000
64122-5,Hemoglobins that can be presumptively identified based on available controls in Dried blood spot,Hb pres ID based on avail contr DBS,Chem,3000
67701-3,Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot,Glut+3OHhexanoylcarn/C16 DBS-sRto,Chem,3000
67711-2,Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot,Glut+3OHhexanoylcarn/C8 DBS-sRto,Chem,3000
67710-4,Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in Dried blood spot,Glut+3OHhexanoylcarn DBS-sCnc,Chem,3000
53186-3,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot,Glut+3OHdecanoylcarn/C16 DBS-sRto,Chem,3000
53185-5,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot,Glut+3OHdecanoylcarn/C8 DBS-sRto,Chem,3000
53403-2,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in Dried blood spot,Glut+3OHdecanoylcarn/C4 DBS-sRto,Chem,3000
53184-8,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in Dried blood spot,Glut+3OHdecanoylcarn/C5OH DBS-sRto,Chem,3000
53183-0,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Dried blood spot,Glut+3OHdecanoylcarn DBS-sCnc,Chem,3000
33288-2,Galactose 1 phosphate uridyl transferase [Presence] in Dried blood spot,Gal1PUT DBS Ql,Chem,3000
42906-8,Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Dried blood spot,Gal1PUT DBS-cCnc,Chem,3000
54084-9,Galactose [Mass/volume] in Dried blood spot,Galactose DBS-mCnc,Chem,3000
64120-9,Fourth most predominant hemoglobin in Dried blood spot,4th most predominant Hb DBS,Chem,3000
64121-7,Fifth most predominant hemoglobin in Dried blood spot,5th most predominant Hb DBS,Chem,3000
50410-0,dRVVT/?dRVVT W excess phospholipid (screen to confirm ratio),dRVVT screen to confirm ratio,COAG,3000
75512-4,dRVVT with 1:1 PNP actual/?normal (normalized LA mix),Mixing dRVVT/normal,COAG,3000
75511-6,dRVVT W excess phospholipid percent correction,dRVVT % correction,COAG,3000
68916-6,dRVVT W excess phospholipid actual/?normal (normalized LA confirm),Confirm dRVVT/normal,COAG,3000
57838-5,dRVVT W excess phospholipid (LA confirm),Confirm dRVVT,COAG,3000
45200-3,Dodecenoylcarnitine (C12:1) [Moles/volume] in Dried blood spot,Dodecenoylcarn DBS-sCnc,Chem,3000
45199-7,Dodecanoylcarnitine (C12) [Moles/volume] in Dried blood spot,Dodecanoylcarn DBS-sCnc,Chem,3000
45198-9,Decenoylcarnitine (C10:1) [Moles/volume] in Dried blood spot,Decenoylcarn DBS-sCnc,Chem,3000
45197-1,Decanoylcarnitine (C10) [Moles/volume] in Dried blood spot,Decanoylcarn DBS-sCnc,Chem,3000
53345-5,Cortisol [Mass/volume] in Dried blood spot,Cortis DBS-mCnc,Chem,3000
53399-2,Citrulline/Tyrosine [Molar ratio] in Dried blood spot,Citrulline/Tyr DBS-sRto,Chem,3000
53157-4,Citrulline/Phenylalanine [Molar ratio] in Dried blood spot,Citrulline/Phe DBS-sRto,Chem,3000
54092-2,Citrulline/Arginine [Molar ratio] in Dried blood spot,Citrulline/Arginine DBS-sRto,Chem,3000
42892-0,Citrulline [Moles/volume] in Dried blood spot,Citrulline DBS-sCnc,Chem,3000
80362-7,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by Probe and target amplification method,C trach+GC rRNA Vag Ql PCR,MICRO,3000
80360-1,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urine by Probe and target amplification method,C trach+GC rRNA Ur Ql PCR,MICRO,3000
80365-0,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Rectum by Probe and target amplification method,C trach+GC rRNA Rectum Ql PCR,MICRO,3000
80361-9,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe and target amplification method,C trach+GC rRNA Cvx Ql PCR,MICRO,3000
70164-9,Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Urine by Probe and target amplification method,C trach+GC pnl Vag PCR,PANEL.MICRO,3000
53926-2,Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by Probe and target amplification method,C trach rRNA Vag Ql PCR,MICRO,3000
80364-3,Chlamydia trachomatis rRNA [Presence] in Rectum by Probe and target amplification method,C trach rRNA Rectum Ql PCR,MICRO,3000
57288-3,Chlamydia trachomatis rRNA [Presence] in Nasopharynx by Probe and target amplification method,C trach rRNA Nph Ql PCR,MICRO,3000
80363-5,Chlamydia trachomatis DNA [Presence] in Rectum by Probe and target amplification method,C trach DNA Rectum Ql PCR,MICRO,3000
45086-6,Chlamydia trachomatis DNA [Presence] in Nasopharynx by Probe and target amplification method,C trach DNA Nph Ql PCR,MICRO,3000
45084-1,Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Vaginal fluid by Probe and target amplification method,C trach DNA Vag Ql PCR,MICRO,3000
6351-1,Chlamydia trachomatis Ag [Presence] in Conjunctival specimen by Immunofluorescence,C trach Ag Conjunct Ql IF,MICRO,3000
14464-2,Chlamydia trachomatis [Presence] in Vaginal fluid by Organism specific culture,C trach Vag Ql Cult,MICRO,3000
14465-9,Chlamydia trachomatis [Presence] in Urethra by Organism specific culture,C trach Urth Ql Cult,MICRO,3000
80367-6,Chlamydia trachomatis [Presence] in Rectum by Organism specific culture,C trach Rectum Ql Cult,MICRO,3000
45094-0,Chlamydia trachomatis [Presence] in Conjunctival specimen by Organism specific culture,C trach Conjunct Ql Cult,MICRO,3000
14463-4,Chlamydia trachomatis [Presence] in Cervix by Organism specific culture,C trach Cvx Ql Cult,MICRO,3000
54083-1,CFTR gene mutations found [Identifier] in Dried blood spot Nominal,CFTR Mut Anal DBS,Chem,3000
73697-5,CCHD newborn screening protocol used [Type],CCHD NBS used Patient,Chem,3000
73700-7,CCHD newborn screening interpretation,CCHD NBS interp,Chem,3000
53236-6,Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in Dried blood spot,C0+C2+C3+C16+C18/Cit DBS-sRto,Chem,3000
38481-8,Carnitine free (C0) [Moles/volume] in Dried blood spot,Carnitine Free DBS-sCnc,Chem,3000
75217-0,Biotinidase [Enzymatic activity/volume] in Dried blood spot,Biotinidase DBS-cCnc,Chem,3000
53200-2,Argininosuccinate/Arginine [Molar ratio] in Dried blood spot,Argininosuccinate/Arginine DBS-sRto,Chem,3000
53062-6,Argininosuccinate [Moles/volume] in Dried blood spot,Argininosuccinate DBS-sCnc,Chem,3000
53398-4,Arginine/Phenylalanine [Molar ratio] in Dried blood spot,Arginine/Phe DBS-sRto,Chem,3000
47562-4,Arginine [Moles/volume] in Dried blood spot,Arginine DBS-sCnc,Chem,3000
75884-7,aPTT.lupus sensitive/?aPTT.lupus sensitive W excess phospholipid (screen to confirm ratio),aPTT screen to confirm ratio,COAG,3000
75509-0,aPTT.lupus sensitive with 1:1 PNP actual/?Normal (normalized LA mix),Mixing aPTT/normal,COAG,3000
75510-8,aPTT.lupus sensitive with 1:1 PNP (LA mix),Mixing aPTT,COAG,3000
75507-4,aPTT.lupus sensitive W excess phospholipid percent correction,aPTT % correction,COAG,3000
75508-2,aPTT.lupus sensitive W excess phospholipid actual/?Normal (normalized LA confirm),Confirm aPTT/normal,COAG,3000
75506-6,aPTT.lupus sensitive W excess phospholipid (LA confirm),Confirm aPTT,COAG,3000
48022-8,aPTT.lupus sensitive actual/?normal (normalized LA screen),Screen aPTT/normal,COAG,3000
34571-0,aPTT.lupus sensitive (LA screen),Screen aPTT,COAG,3000
53343-0,Androstenedione [Mass/volume] in Dried blood spot,Androst DBS-mCnc,Chem,3000
53393-5,Alloisoleucine+Isoleucine+Leucine+Hydroxyproline+Valine/Phenylalanine+Tyrosine [Molar ratio] in Dried blood spot,Aile+Ile+Leu+Hyp+Val/Phe+Tyr DBS-sRto,Chem,3000
53153-3,Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Phenylalanine [Molar ratio] in Dried blood spot,Aile+Ile+Leu+Hyp/Phe DBS-sRto,Chem,3000
53154-1,Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Alanine [Molar ratio] in Dried blood spot,Aile+Ile+Leu+Hyp/Alanine DBS-sRto,Chem,3000
53152-5,Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Moles/volume] in Dried blood spot,Aile+Ile+Leu+Hyp DBS-sCnc,Chem,3000
50157-7,Acetylcarnitine (C2) [Moles/volume] in Dried blood spot,Acetylcarn DBS-sCnc,Chem,3000
53197-0,3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in Dried blood spot,3OH-Tdecenoylcarn DBS-sCnc,Chem,3000
50281-5,3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Dried blood spot,3OH-Tdecanoylcarn DBS-sCnc,Chem,3000
53196-2,3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in Dried blood spot,3OH-Tdecadienoylcar DBS-sCnc,Chem,3000
50132-0,3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Dried blood spot,3OH-stearoylcarn DBS-sCnc,Chem,3000
53201-0,3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot,3OH-Palmitoylcarn/C16 DBS-sRto,Chem,3000
50125-4,3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Dried blood spot,3OH-Palmitoylcarn DBS-sCnc,Chem,3000
50121-3,3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Dried blood spot,3OH-Palmitoleylcarn DBS-sCnc,Chem,3000
50113-0,3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Dried blood spot,3OH-Oleoylcarn DBS-sCnc,Chem,3000
50109-8,3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Dried blood spot,3OH-Linoleoylcarn DBS-sCnc,Chem,3000
53172-3,3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot,3OH-Isovalerylcarn/C8 DBS-sRto,Chem,3000
53171-5,3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in Dried blood spot,3OH-Isovalerylcarn/C0 DBS-sRto,Chem,3000
50106-4,3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Dried blood spot,3OH-Isovalerylcarn DBS-sCnc,Chem,3000
53188-9,3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in Dried blood spot,3-OH-dodecenoylcarn DBS-sCnc,Chem,3000
53189-7,3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in Dried blood spot,3OH-Dodecanoylcarn DBS-sCnc,Chem,3000
53182-2,3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in Dried blood spot,3-OH-decenoylcarn DBS-sCnc,Chem,3000
53341-4,21-Deoxycortisol [Mass/volume] in Dried blood spot,21DC DBS-mCnc,Chem,3000
53336-4,17-Hydroxyprogesterone+Androstenedione/Cortisol [Mass Ratio] in Dried blood spot,17OHCS+Androst/Cortis DBS,Chem,3000
38473-5,17-Hydroxyprogesterone [Mass/volume] in Dried blood spot,17OHP DBS-mCnc,Chem,3000
53338-0,11-Deoxycortisol [Mass/volume] in Dried blood spot,11DC DBS-mCnc,Chem,3000
53347-1,11-Deoxycorticosterone [Mass/volume] in Dried blood spot,11DOC DBS-mCnc,Chem,3000
